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SUMMARY 
 
This study investigates the impacts of regional characteristics on the early-stage 
performance of New Technology-Based Firms (NTBFs) in catch-up regions where a mature 
industrial cluster has yet to be formed. It hypothesized that the average NTBF performance in a 
region is a function of its scientist job market conditions, cultural diversity, venture capital, 
academic research, industrial structure, and local entrepreneurial climate. Using the events of 
Initial Public Offerings (IPO) and Merger & Acquisitions (M&A) as an indicator of early-stage 
success of NTBFs, this study constructs a set of Zero-Inflated-Negative-Binomial (ZINB) 
models to predict the spatial distribution of such events in the U.S. biopharmaceutical and 
Information Technology (IT) service industries during the period from 1996 to 2005.  
Several empirical findings emerge from this study. First, the local entrepreneurial climate 
plays a significant and positive role on NTBF performance in both industries. Second, the 
positive impact of cultural diversity is more significant in the IT service industry than in the 
biopharmaceutical industry. Third, the scientist job market size and absolute salary level have 
positive impacts on NTBF performance, but the effect of relative salary level is negative. Fourth, 
proximity to venture capital firms has positive but non-linear effects, but the adverse effect of 
excess venture capital is stronger in the IT service industry. Fifth, there is little evidence of the 
direct effects of academic research in determining the NTBF performance in both industries. 
Finally, industrial specialization is significant and positive only in the IT service industry. The 
results suggest that promoting local entrepreneurial climate and cultural diversity are two 
effective policy instruments for catch-up regions to foster their NTBF growth. 
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CHAPTER 1: INTRODUCTION AND OVERVIEW 
 
The structure of the local environment not only influences individual entrepreneurs’ 
desire to undertake risky ventures, but also affects their ability to perceive opportunities and 
mobilize resources (Thornton and Flynn 2003). The presence of industrial clusters, or the 
geographical concentration of interrelated industries, is one of the most striking features of high-
tech industries (Porter 1990). In the U.S. context, the bulk of high tech firms cluster in the 
Silicon Valley, Boston 128, Seattle, Austin, and San Diego, and the rest distribute sparsely 
across the country. This dissertation explores the conditions and mechanisms that enable new 
technology-based firms (NTBFs) to emerge and thrive in catch- up regions, where a mature 
industrial cluster has yet to be formed. In particular, this study investigates what location-specific 
characteristics can enhance a catch-up region’s attractiveness to entrepreneurial talents and its 
capacity of conducting radical innovations which could lead to brand new products, service, or 
industry.  This chapter consists of three sections. Section 1.1 discusses the role of NTBFs in 
regional transformation. Section 1.2 summarizes a variety of views regarding the relationship 
between the size of industrial cluster and firm performance, and how this study contributes to the 
extant literature. The last section 1.3 presents an overview of this study.  
 
1.1. The Role of NTBFs in Regional Transformation 
In this study, NTBFs refer to a subset of small firms that are newly established, 
independently operated, and focused on commercializing technologies developed in public or 
private labs (Bollinger et al, 1983; Storey &Tether, 1998). These firms are distinguished from 
the majority of small businesses by aggressively pursuing new and innovative products or 
 2
services (Acs and Storey 2004; NGA 2004). In the face of intensifying competition from newly 
emerging low-cost countries and widespread outsourcing practice of large companies, recent 
academic literature has placed increasing emphasis on fostering “homegrown” NTBFs as a 
sustainable strategy to reinvigorate a regional economy (Feldman and Francis 2004). In the 
meantime, state and local governments launched various policy initiatives to foster 
“homegrown” NTBFs in one or more high-tech fields with a belief that each location has a 
unique industrial heritage and therefore can create a high tech cluster of niche capabilities. For 
example, from 2001 to 2004, the number of states that were targeting the bioscience for 
development increased from 14 to 40, and now all 50 states have technology-based economic 
development initiatives that are available to bioscience companies (Biotechnology Industry 
Organization, 2005). Other newly targeted technology fields include but are not limited to 
nanotechnology, stem cell, and fuel cell. The origins of this considerable interest in NTBFs can, 
in some part, be traced to these firms’ unique nature of innovation and their role in sparking 
regional transformation.  
NTBFs are those founded by independent entrepreneurs and inventors, and thus provide a 
unique organizational environment conducive to radical innovation. Schumpeter (1934, p. 66) 
observed that innovations are embodied in “new firms which generally do not arise out of the old 
ones but start producing beside them.” Utterback and Abernathy (1979) argue that the character 
and atmosphere of NTBFs is particularly suited to encouraging major product innovations. To 
compete against the existing large firms, NTBFs basically have to respond to market needs with 
high performance products or services, and thus place a high priority on product innovation as a 
competitive strategy. A study commissioned by the US Small Business Administration (1995) 
shows that a critical share of innovative breakthroughs of the past two centuries came from small 
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and newly founded ventures and their affiliated entrepreneurs. More recently, Baumol (2005) 
argues that the market mechanism assigns the search for radical inventions to the NTBFs and 
their subsequent development to the large firms. Therefore, this division of innovative efforts 
between small and large firms is not transitory. He further points out that the existence of this 
type of specialization does not suggest that large enterprises are inefficient or ineffective 
innovators. Rather, it is the combined work of the two together that makes possible the ultimate 
success of technological commercialization.  
From the perspective of regional economic development, a relevant policy question is 
whether and how NTBFs can emerge and thrive in a catch-up region characterized by “low 
levels of clustering, a weak endowment of relevant institutions, a lack of interaction and of 
networks” (Todtling & Trip, 2005, p. 1204). A region’s economy often changes in an 
incremental manner that is heavily shaped by the established institutional and industrial structure 
(Fuchs & Shapira, 2005). If NTBFs can achieve superior performance even in isolated locations 
lacking a critical mass of industrial cluster, these firms can function as key drivers in sparking 
regional transformation or even breakthrough. Such events can help those catch-up regions 
diverge from the traditional declining industries and enter into more lucrative high technology 
industries or other development opportunities (Fuchs & Shapira, 2005). Otherwise, these 
lucrative industries will continue to be geographically concentrated in only a small number of 
locations, and the regional disparities in economic performance will tend to grow.  
 
1.2. Industrial Cluster Size, Catch-up Regions, and NTBF Performance 
The definition of “catch-up regions” used in this study is industry-specific. A region 
might take a leading position in one industry but not in others. The recent literature involves an 
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ongoing debate on the possibility of NTBFs to achieve superior performance in a catch-up 
region. The conventional wisdom suggests that firms located in or near clusters of similar firms 
perform better than their counterparts in sparse areas (Marshall 1920; Porter 1990; Krugman 
1991). Marshall (1920) identified three types of positive externalities stemming from 
agglomeration. First, the concentration of several firms in a single location offers a pooled 
market for highly skilled human capital, ensuring a lower probability of human capital shortage. 
Second, firm clustering creates a sufficient demand that enables local suppliers to provide highly 
specialized products and services, and lower the transportation costs. Third, clustered firms can 
benefit from localized knowledge spillovers. Following Marshall’s trinity of reasons for co-
location, Porter (1990; 1998) posits that firms especially benefit from the clustering of 
interrelated industries and supportive institutions. Krugman (1990) argues that the concentration 
of manufacturing in a limited number of sites mainly results from pecuniary externalities like 
minimizing transportation costs associated with either demand or supply linkages. In addition, 
the entrepreneurial culture that advocates norm-breaking behavior is particularly strong in 
mature industrial clusters and thus leads to relatively high entrepreneurial activities in these 
regions (Staber, 2005, in Fuchs & Shapira, 2005). An implicit assumption under these arguments 
is that the magnitude of positive externalities increases with the size of clustering. 
On the other hand, several recent empirical studies question the conventional wisdom that 
proximity to a leading mature industrial cluster enhances average firm performance. Sorenson 
and Audia (2000) examine the founding and failure rates of shoe manufacturing plants in the US 
from 1940 to 1989. Their study suggests that while new firms typically emerge in the vicinity of 
major industrial clusters, firms located in concentrated regions of shoe manufacturing 
experienced substantially higher failure rates than did isolated firms. Therefore, they posit that 
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locating in the large clusters adversely affects firms’ chance to survive and thrive because the 
concentration of structurally equivalent firms increases the extent of competition for valuable 
inputs. Stuart & Sorenson (2003) conduct a similar study in the U.S. biotechnology industry, and 
find that although entrepreneurs most frequently began new biotech firms in route 128 of Boston, 
Massachusetts and Palo Atlo, California, these areas offer the worst location for new venture 
performance. According to their performance models, firms perform best in the tri-state area, 
where New Jersey, Pennsylvania, and New York come together (p. 248). More recently, Folta et 
al. (2006) use various performance indicators to examine the relationship between cluster size 
and firm performance in the US biotech industry. Their findings indicate the diseconomies of 
agglomeration seem to dominate the economic benefits of agglomeration when clusters exceed 
about 65 firms.  
Other lines of research also indicate that firms in catch-up regions may succeed.  Dumais 
et al (2002) examine the dynamics of geographic concentration in the US manufacturing 
industries between 1972 and 1992. Their results suggest that while the overall agglomeration 
level of the U.S. manufacturing industries has only declined slightly in the last twenty years, 
there is a substantial degree of variation in the locations of these agglomerations, which was 
partially caused by the successful startup activities in isolated locations. Florida (2002a, 2002b) 
posits that leading industrial clusters provide a necessary but insufficient condition to attract 
highly creative talents (human capital), and other regional factors like regional tolerance matter 
more. Therefore, regions without mature industrial clusters may still be attractive to creative 
talents. 
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In sum, previous studies don’t entirely exclude the possibility for NTBFs in isolated 
locations to achieve superior performance. However, they leave the following questions 
unanswered:  
First, why do some catch-up regions have higher average-NTBF-performance than do the 
leading mature industrial clusters? Are there any commonalities among these “successful” catch-
up regions?   
Second, over time, why do some catch-up regions successfully become new hotbeds of 
technological entrepreneurs while others continue to lag behind?  
Third, besides the industrial cluster size, what other location-specific characteristics 
enhance the likelihood that a NTBF locating in a catch-up region will thrive? 
Fourth, how do these causality patterns vary across the life cycle of specific industries? 
Does the biopharmaceutical industry offer more opportunities for NTBFs in the isolated 
locations to catch up or even leapfrog than the IT service industry, or vice versa? 
 
1.3. Overview of the Dissertation 
This dissertation examines the spatial distribution of the US NTBF Initial Public 
Offerings (IPO) and acquisition activities from 1996 to 2005. Following the literature on the 
locational choices of the “creative class” (Florida 2002a; 2002b; 2003; Lee, Florida et al. 2004) 
and origins of dynamic externalities (Glaeser, Kallal et al. 1992; Feldman and Audretsch 1999; 
Ketelhohn 2002), the present research hypothesizes that the average firm performance in a catch-
up region is positively associated with the region’s attractiveness to technological entrepreneurs 
and its capacity of conducting radical innovations, which, in turn, are determined by the local job 
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market conditions for scientists, the availability of venture capital, cultural diversity, industry 
related academic research, industrial structure, and entrepreneurship dynamics.  
This dissertation makes several contributions to the technology-based economic 
development literature. First, in contrast to many of the previous studies that emphasize the “best 
practice” in the leading mature clusters, this study focuses on catch-up regions. The main interest 
of this research is to investigate why the average NTBF performance of some catch-up regions is 
better than others and how the spatial heterogeneity of NTBF performance varies over time and 
industry. As some scholars point out, looking at a fully mature industrial cluster reveals little 
prescriptive information about how such regions actually develop (Feldman, Francis et al. 2005; 
Tödtling and Trippl 2005).  
Second, this study develops a comprehensive theoretical model to explain the spatial 
heterogeneity in NTBF performance. Prior research has demonstrated a disproportionate focus 
on the impact of the industrial cluster size on the NTBF average performance in a region, but has 
been short of explanations on why the leading mature clusters in some industries are not 
associated with the highest average-NTBF-performance. This study investigates such a paradox 
by positing that a region’s NTBF performance is a function of its attractiveness to technological 
entrepreneurs and its capacity of conducting radical innovations, which in turn, are determined 
by the local labor market conditions for scientists and engineers, venture capital endowment, 
cultural diversity, academic research, industrial structures, and entrepreneurship dynamics. 
While the first three factors mainly affect the location decisions of technological entrepreneurs, 
the rest three determine the capacity of conducting radical innovations. The size of industrial 
clusters in a region is only positively associated with some dimensions of these factors.  
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Third, this study examines the most recent Initial Public Offerings and acquisition 
activities in the US over the past decade. Unlike many of the existing studies that approximated 
firm performance with survival, this study views the event of IPO and acquisition as the indicator 
of firm early-stage success. Folta et al. (2006) noted that survival is a biased measure of firm 
performance because entrepreneurs in larger clusters have greater access to alternative business 
opportunities and therefore are more likely to terminate business for a given level of 
performance. Both IPO and acquisition are a successful outcome for a NTBF started to develop 
an innovative idea, so the spatial distribution of these events reveals where the most successful 
NTBFs are located.  
Finally, this analysis accounts for detailed industry-specific conditions. This research 
focus on the biopharmaceutical and IT service industries, because they are widely-accepted high 
tech industries, and are most active in terms of IPO and acquisition activities over the past 
decade. In addition, these two industries vary in the degree of geographical concentration, the 
closeness to academic research, and the stage of industrial life cycle, and barriers for entry, 
which provide rich opportunities to investigate the impacts of industry-specific characteristics on 
the relationship between location and firm performance.  
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CHAPTER 2: THEORY AND HYPOTHESES 
 
This dissertation is built upon two streams of literature: location decisions of 
entrepreneurial talents and the sources of radical innovation. It assumed that location affects firm 
performance in high-tech industries mainly by clustering technological entrepreneurs and 
facilitating the conduction of radical innovation. Section 2.1 discusses the competing theories 
aimed to explain the location behavior of technological entrepreneurs and then presents three 
hypotheses in this regard. Section 2.2 derives four hypotheses regarding the underlying 
mechanisms of radical innovations. A theoretical framework is presented in the section 2.3.   
 
2.1. Location Decisions of Technological Entrepreneurs 
Technological entrepreneurs play a central role in a firm’s early-stage viability by 
identifying profitable opportunities and mobilizing needed resources from their immediate 
business environment. They may also utilize their network ties to outside prominent 
organizations to overcome inherent regional disadvantages, and access remote financial capital, 
skilled employees, and non-codified knowledge (Stuart and Sorenson 2005). Therefore, the 
uneven distribution of entrepreneurial talent greatly contributes to the regional variation in the 
average early-stage performance of NTBFs.  
Studies of the individual characteristics of technological entrepreneurs demonstrate that 
level of educational attainment amongst founders of NTBFs is significantly higher than that of 
the working population as a whole, or of founders of other types of new businesses (Storey and 
Tether 1998). NTBFs that are exploiting advanced technologies require entrepreneurs who 
understand the leading edge technologies. This is particularly true for the biotechnology industry, 
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in which NTBF founders typically have a science- or technology- based PhD. Other studies 
found that creative entrepreneurs also tend to be associated with idiosyncratic personalities and 
unorthodox ideas (Florida 2002a). In addition, some literature suggests that new immigrants are 
more likely to be entrepreneurs because they bring new ideas and cultures, are risk takers, and 
enjoy better access to capital through family or ethnic networks than others (Saxenian 1999; Lee, 
Florida et al. 2004). For example, Saxenian (1999) found that extensive networks of Chinese and 
Indian immigrants help people start new firms by providing contacts and financial support in 
Silicon Valley. In sum, technological entrepreneurs are not those who take self-employment as 
the last resort, but are typically highly educated individuals who possess resources, are 
economically mobile, and can exercise considerable choice in their locations (Florida 2002a). 
Places attract potential technological entrepreneurs through three interrelated mechanisms: labor 
market conditions, cultural diversity, and local attachments.  
 
2.1.1. Scientist job market conditions 
The traditional view offered by economists is that place attracts potential entrepreneurs 
by offering secure and high-paid job opportunities. Early in the 1920s, Marshall observed the 
“labor market pool effect” stating that individual workers could minimize their economic risk by 
locating in a place with many possible employers of their specialized skills. A concentration of 
similar firms would attract, develop, and benefit from a pool of labor with a common set of 
skills. Technology workers in a volatile labor market do not want to remain in a small labor 
market in which alternative job opportunities are few. More recently, Porter advocates this “labor 
market pooling” effect in his “Industrial Cluster” theory (Porter 1998; 2000). Porter (1998, p .81) 
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argues that “because a cluster signals opportunity and reduces the risk of relocation for 
employees, it can also be easier to attract talented people from other locations.” 
The availability of job opportunities for highly educated scientists and engineers in a 
region is particularly important because the potential technological entrepreneurs are mainly 
from those who have sufficient understanding of the leading edge technologies. As a result, 
regions with sufficient job opportunities for scientists and engineers are more likely to host a big 
pool of potential entrepreneurs than other regions. A stream of sociology literature suggests that 
entrepreneurs tend to be geographically inertial even though they are economically mobile 
(Sorenson and Audia 2000; Stuart and Sorenson 2003; Thornton and Flynn 2003). Entrepreneurs, 
like other people, develop geographically localized networks of friends, acquaintances, and 
contacts. Relocation entails serous social costs in the form of breaking old ties and making new 
ones (Sorenson and Audia 2000). Therefore, entrepreneurs usually want to stay in a place where 
they have local attachments generated from family connections, education, and work experience.  
 Hypothesis 1a: The size of local scientist job market positively affects the average 
NTBF performance in a region.  
 Hypothesis 1b: The average salary level of local scientists increases the average NTBF 
performance in a region.  
 
2.1.2. Venture capital  
A considerable literature affirms that venture capital is important to the birth and growth 
of NTBFs. For example, Shane and Stuart (2002) have shown that linkages with venture 
capitalists were more likely to lead to success, especially as it related to reaching an IPO stage. 
Venture capital firms can not only provide critical risk capital to a NTBF, but also serve as 
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business management experts. Since business mentoring requires frequent face-to-face contacts, 
NTBFs’ physical proximity to venture capitalists can improve the efficiency and effectiveness of 
such activities. As a result, local venture capital might serve as a talent magnet, attracting highly-
skilled potential entrepreneurs from outside. Other studies, however, argue that venture 
capitalists have only a moderate impact on the location decisions of technological entrepreneurs 
for two reasons. First, venture capitalists have strong incentives to hunt for outside high-quality 
NTBFs which have demonstrated significant growth potential. Second, as pointed out by 
Bygrave (2004),  most small high-techs are never likely to be VC targets, so self-financing and 
informal investment are far more important than venture capitals. Bygrave (2004) claims that “if 
self-financing and informal investment dried up, entrepreneurship would wither and die. On the 
other hand, if classic venture capital dried up, entrepreneurship in general would continue to 
flourish.” 1  Finally, the excess amount of venture capital in a region is likely to flow straight to 
low-quality entrepreneurship(Acs and Storey 2004; Venkataraman 2004).  
Hypothesis 2: The number of venture capital firms located in a region increases its 
average-NTBF-performance at a decreasing rate.  
 
2.1.3. Cultural diversity 
Florida argues that creative people typically have many job options, and they do not 
slavishly follow jobs to places (Florida 2002a; 2002b; Lee, Florida et al. 2004). In his “creative 
class” theory, he downplayed the importance of the labor market pooling effect in the location 
choice of creative people whose job is to “create meaningful new forms” and highlights the role 
of “cultural diversity” instead (Florida 2002b). Built upon Jacob’s thesis that open and diverse 
                                                 
1 William D. Bygrave, presentation in 2004 Globel Entrepreneurs Monitor Conference in London, 
http://www.gemconsortium.org/category_list.asp?cid=165 
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cities attract more talented people, he posits that diverse regions, which are tolerant and open to 
new ideas and have diverse lifestyle amenities, have distinct advantages in attracting and 
retaining creative people with unorthodox ideas. According to Florida, regional diversity can be 
measured by three indicators: the proportion of the population that is foreign born, the 
concentration of same-sex male unmarried partners, and the proportion of the population that is 
artists. Regions with high values on these indicators tend to have lower entry barriers, making it 
easier for people with various backgrounds to enter and stay within it, and thus are more likely to 
generate new combinations of creative ideas. Florida (2002a) empirically tests the relationship 
between regional diversity and the distribution of human capital in the US context, and finds that 
an area’s level of diversity, as measured by the percent of gay households, is positively and 
significant associated with the percentage of its population with a bachelor’s degree or above. 
Lee, Florida, and Acs (2004) find that social diversity, measured by the percentage of the 
population that is foreign born and the concentration of gay male couples, facilitates the influx of 
a particular kind of human capital that promotes innovation and accelerates information flow, 
leading to the higher rate of new firm formation. In sum, according to Florida and others, cultural 
diversity leads to the concentration of entrepreneurial talents, and, in turn, positively affects the 
average performance of a region’s NTBFs.  
Hypothesis 3: Cultural diversity increases the average NTBF performance in a 
region.  
 
2.2. Sources of Radical Innovations  
Radical innovations create entrepreneurial opportunities. Entrepreneurial opportunities 
not only come from a firm’s own Research and Development (R&D) activities, but also from 
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knowledge investments by incumbent enterprises, universities, and other research organizations. 
This is particularly true for NTBFs, which lack the resources of their larger counterparts and are 
more dependent on exploiting technologies underutilized by the original owners. As Audretsch 
and Lehmann (2005) point out, without knowledge spillovers, NTBFs should have not generated 
high innovative output given their negligible R&D expenditures. Knowledge spillover refers to 
the fact that a firm is able to freely exploit economically useful knowledge produced by other 
agents. The extant literature offers competing theories on how the magnitude of localized 
knowledge spillovers in a region is affected by the local academic research, industrial structures, 
and entrepreneurial climate.  
 
2.2.1. Academic research 
Research universities are a major source of new knowledge and radical innovation. New 
knowledge generated from basic and applied research conducted at the university spills over, and 
fuels the innovative activities of private firms. The studies of Jaffe et al (1993), Audretsch and 
Feldman(1996) and others provided evidence concerning the spatial dimension of knowledge 
spillovers. They suggest that knowledge spillovers tend to be geographically bounded within the 
region where the new economic knowledge was created. Geographic proximity to the original 
institutes helps a firm lower the cost of accessing and absorbing knowledge spillovers. This is 
particularly crucial for tacit knowledge, which requires face-to-face interaction to be 
communicated.  
Other studies, however, argue that strong network ties rather than geographic proximity 
to the knowledge sources affect the magnitude of knowledge spillovers (Stuart and Sorenson 
2005). Bee (2003) finds that proximity to universities with leading-edge research does not appear 
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to bestow geographic advantages to local companies, at least in the case of semiconductors. 
World-class universities like MIT and Stanford have worldwide networks. Companies on the 
other side of the world are as likely to access their cutting-edge research as local companies. His 
empirical analysis of blockbuster patents in semiconductors shows that technology spin-outs 
from major universities are not geographically concentrated in the region or state of origin. 
Similarly, Malmberg & Power (2005) argue that the global rather than local linkages may be the 
most useful method of boosting regional innovativeness, and firms can offset local factor 
disadvantages by building relations with key strategic partners globally.  
So, assuming proximity to knowledge source is critical to the magnitude of localized 
knowledge spillover, we can develop the following hypothesis: 
Hypothesis 4: Industry-specific academic research has a positive impact on the 
average NTBF performance in a region. 
 
2.2.2. Industrial specialization 
Whether industrial specialization (the degree to which a location specializes in one 
industry) or diversity (the range of different industries in a location) of economic activity better 
promotes knowledge spillovers and subsequent firm performance has been the subject of a 
heated debate in the economic literature (Glaeser, Kallal et al. 1992; Feldman and Audretsch 
1999; Ketelhohn 2002; Porter 2003). As characterized by Glaeser and colleagues (1992), there 
are three camps of competing arguments on how local industrial structures affect the magnitude 
of knowledge spillovers: Marshall (1920)-Arrow(1962)-Romer(1986)(MAR); Jacobs (1969); and 
Porter (1990, 2003).  
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The MAR framework maintains that the most relevant knowledge spillovers occur among 
firms in the same industry. Specialized locations with high-level of industry concentration should 
experience more innovation and faster growth. In contrast, the Jacobs framework posits that the 
most important knowledge spillovers take place across different industries. Jacobs’ theory 
predicts that industries will innovate more and grow faster in locations with greater diversity. 
Porter’s position lies between those of MAR and Jacobs, arguing that the most relevant 
knowledge spillovers occur among a set of related industries, which include buyer and supplier 
industries. Porter (2003) also questions the appropriateness of using individual industries as unit 
of analysis because of the externalities across related industries within clusters. He (2003) posits 
that “a diverse array of over-lapping clusters should be associated with better performance than a 
diversity of clusters that are unrelated” (p. 562)  
Hypothesis 5a: The degree of industrial specialization in a region promotes its 
NTBFs’ performance. 
Hypothesis 5b: Coagglomeration with buyer-industries promotes NTBFs’ 
performance. 
Hypothesis 5c: Coagglomeration with supplier-industries promotes NTBFs’ 
performance. 
 
2.2.3. Local entrepreneurial climate  
A region’s local entrepreneurial climate can affect the magnitude of localized knowledge 
spillovers by promoting inter-firm employee mobility. According to Saxenian (1996), the pivotal 
difference in the extent of inter-firm employee mobility was one of the reasons that the 
electronics and computer industry in Silicon Valley experienced continuing vitality and growth 
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in the 1970s and 1980s whereas those in Route 128 corridor in Massachusetts suffered from 
relative stagnation and decline. In Silicon Valley, engineers and other professionals often 
changed firms or quit their jobs to start firms of their own, and such decisions enjoyed 
widespread support. In contrast, in Massachusetts, leaving one firm for another was infrequent 
and frowned upon as disloyal. Saxenian (1996) claims that such regional heterogeneity brought a 
distinctive advantage to Silicon Valley companies over those in Route 128 because the frequent 
inter-firm mobility enables firms to keep strengthening and updating their technologies and 
competencies. Hence, the dynamic local entrepreneurial activities can facilitate knowledge 
spillovers and therefore increase the average performance of NTBFs.  
 Hypothesis 6: Entrepreneurial culture positively affects the average performance of 
NTBFs in a region.  
 
2.3. Conceptual Framework   
Figure 1 presents a schematic that incorporates the above ideas. It depicts the causal paths 
through which a set of location-specific characteristics impact the average performance of 
NTBFs in a region. 
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Figure 1: Conceptual Framework 
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CHPATER 3: METHODOLOGY 
 
This chapter presents an empirical methodology for investigating the effects of regional 
characteristics on the average performance of NTBFs in the catch-up regions.  Specifically, this 
study uses the events of Initial Public Offering (IPO) and Merger & Acquisition (M&A) as an 
indicator of early-stage success of NTBFs, and constructs a set of Zero-Inflated-Negative-
Binomial (ZINB) models to predict the spatial distribution of such events in the 
biopharmaceutical and IT service industries during the period from 1996 to 2005. The first 
section of the chapter defines the research setting of this study. A detailed description of the 
variable operationalization and data sources follows in the next section. The last part of the 
chapter presents the model specifications.  
 
3.1. Research Setting 
3.1.1. Definition of NTBFs 
NTBFs are a subset of small firms that are newly established, independently operated, 
and have a focus on commercializing a technology for the first time (Bollinger, Hope et al. 1983; 
Storey and Tether 1998). While one can usually clearly identify a firm’s age and organizational 
independence, it is not a simple matter to measure the extent to which a firm’s innovation 
discontinued from the extant knowledge base. According to a restricted definition, a NTBF 
should refer only to new independent enterprises which are developing new industries and have 
the potential to fundamentally transform the ways in which societies and markets operate (Storey 
&Tether, 1998). Other authors have embraced all new small firms operating in ‘high technology' 
sectors (Colombo and Grilli 2005; Motohashi 2005).  
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Recognizing that the definition has to reflect the available data and that a narrow 
definition of NTBFs was not feasible, this study defines NTBFs in a broad sense. Specifically, a 
firm is treated as a NTBF if it meets the following criteria:  
First, it has no more than 20-year-long operation history2;  
Second, it must have fewer than 500 employees, the size standard of small business 
defined by the US Small Business Administration;  
Third, it is totally independent rather than a part or subsidiary of another incumbent firm 
(Bollinger et al, 1983);  
Finally, it operates in a technology-based industry such as the biopharmaceutical and IT 
service industries.  
 
3.1.2. Choice of industries 
This study investigates the spatial heterogeneity of NTBF performance in the 
biopharmaceutical and IT service (computer-related) industries, subsequently. By studying a 
single industry subsequently instead of a cross-section of industries, it may enable us to identify 
industry-specific institutional factors that might explain our empirical findings (Ketelhohn 2002). 
The biopharmaceutical and IT service industries were selected mainly for three reasons.  
First, both are among the widely-accepted high tech industries. An industry is typically 
considered as “high tech” if it is associated with a high proportion of research and development 
(R&D) expenditures and a “high” proportion of scientific, technical, and engineering personnel. 
However, because there are no standardized threshold values for these input-based criteria, the 
lists of high-tech industries produced in the literature differ from one another. These two 
                                                 
2 Granstrand (1998, p. 466) argues that the newness of technology could be defined as less than 20 years, because 
according to the international patent system, the maximal patent lifetime is 20 years.  
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industries, however, are included in most high-tech industry lists (Walcott 2000; Brau, Brown et 
al. 2004; Hecker 2005).  
Second, they differ substantially in terms of their closeness to basic science and degree of 
geographical concentration so that the cross-industry comparisons can enhance the validity and 
generalizability of the results. Prior research shows that a strong link exists between basic 
research mainly conducted by university scientists and the innovative performance of NTBFs in 
the biopharmaceutical industry (Audretsch and Stephan 1996; Deeds, Decarolis et al. 1997; 
McMillan, Narin et al. 2000; Lim 2004). For example, based upon their patent citation analysis, 
McMillan et al.(2000) found that the biopharmaceutical industry relies on basic science much 
more heavily than other industries and that the biopharmaceutical NTBFs rely on basic science to 
a much greater extent than large, diversified pharmaceutical companies do. In contrast, the 
innovation activities in the IT service industries are more engineering-based problem-solving 
that seldom reflects fundamental new knowledge. Because of the inter-industry difference in the 
distance to basic research, proximity to academic research should play a more important role in 
determining the performance of biopharmaceutical NTBFs than that of IT service NTBFs.  
In terms of agglomeration, the biopharmaceutical industry is more spatially concentrated 
than the IT service industry. In 1996, 140 of 331 Metropolitan Statistical Areas (MSA) had no 
employment for the biopharmaceutical industry but all the MSAs had employment in the IT 
service industry3. The industrial agglomeration level corresponds to the degree of skewness of 
the spatial distribution of critical resources for the formation and growth of NTBFs (Stuart and 
Sorenson 2003). Thus, catch-up regions should have higher average-NTBF performance in the 
IT service industry than in the biopharmaceutical industry.  Chapter 4 and 5 will discuss more 
industrial idiosyncrasies such as size, structure, barriers for new firms to enter, etc.  
                                                 
3 Data source: calculated based upon the ‘County Business Pattern’ data of US Census Bureau. 
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Finally, this study measures the average performance of NTBFs in a region by counting 
the events of IPO and M&A between 1996 and 2005. The IPO and acquisition activities were 
highly active in these two industries during my study period. Thus, I can obtain a relatively large 
sample size by focusing upon these two industries.  
This study defines the industries by a 3-digit 1987 SIC code or a 5-digit 1997 North 
American Industry Classification System (NAICS) code. Specifically, the biopharmaceutical 
industry is defined by SIC 283 prior to 1997 and NAICS 32541 thereafter. The IT Service 
industry corresponds to SIC 737 prior to 1997 and NAICS 5112 and 5415 thereafter. The SIC 
code is still in use because the current Securities Exchange Commission (SEC) Filings & Forms, 
which are the main data sources of public-traded companies, still categorize a firm’s industrial 
affiliation based on the SIC code. The three-digit SIC level of analysis permits us to identify 
important differences that are missed at the two-digit level of aggregation. At the same time, 
further disaggregating to the four-digit level would sacrifice some of the coherence retained 
within the three-digit industry (Smith 2004). For example, in the IT service industry, there is no 
gain for our research purpose to make a distinction among Computer Programming Services 
(SIC= 7371), Prepackaged Software (SIC= 7372), and Computer Integrated Systems Design 
(SIC= 7373). 
 
3.1.3 Unit of geographical observation  
The units of observations in this study are the U.S. Metropolitan Statistical Area (MSA).  
Since the overwhelming majority of technology-based innovation and entrepreneurial activities 
occurred in urban areas, the metropolitan area is generally considered a more appropriate unit 
than a state to effectively capture the regional variation in technological entrepreneurship. For 
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example, Feldman and Audretsh (1999) find that in the U.S., 96 percent of new innovations in 
1982 originated in metropolitan areas. The U.S. Conference of Mayors and the National 
Association of Counties reported that 95 percent of high tech job creation between 1992 and 
1999 took place in metro areas4. Storey and Tether (1998) observe that in Europe, most NTBFs 
are also located in and around the major urban areas.  
One challenge to using the MSA-level data is that the Office of Management and Budget 
(OMB) frequently revises the definitions of MSAs to reflect the most recent Census Bureau 
population estimates. Consequently, the boundaries of some individual MSAs’ are not stable 
over the past decade, which makes their historical data incomparable.  Because the boundaries of 
sub-MSA spatial units like county or ZIP code are more stable over time than the MSA itself, 
this study resolved the incomparability issue by collecting most data at sub-MSA level and then 
aggregating them to a consistent set of MSAs.  
The MSA definition used in this study was published by the OMB in March 2004 (OMB 
Bulletin No. 04-03) 5. The study does not adopt more recent MSA definitions because the March 
2004 definition is used by the Bureau of Labor Statistics for its present and historical Quarterly 
Census of Employment and Salarys (QCEW) data, which is another important data source used 
in this study. The March 2004 definition listed 361 MSAs in the United States. Each individual 
MSA has at least one urbanized area of 50,000 or more population, plus adjacent territory that 
has a high degree of social and economic integration with the core.  In total, they cover about 83 
percent of the U.S. population and 1,090 of 3141 counties. 
This study excluded 49 MSAs which didn’t exist in the June 1999 MSA definition. This 
is because data for some independent variables used in this study (i.e., scientist job market 
                                                 
4 Source: http://www.usmayors.org/uscm/news/press_releases/documents/metroecon052300.htm 
5 The detailed definition is available at: http://www.whitehouse.gov/omb/bulletins/fy04/b04-03.html 
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conditions, proportion of foreign immigrants, and new firm birth rate) were only available upon 
the June 1999 MSA definition. This makes it impossible to include the 49 new MSAs into this 
study. The study is further limited to those MSAs where the biopharmaceutical or IT service 
industry consistently existed during the study period from 1995 to 2004. This guarantees that 
each observation in the sample has the same exposure time. In other words, we can count the 
IPO and M&A events that occurred in each MSA over the same period of time. In the end, 168 
MSAs were identified for the biopharmaceutical industry, and 316 MSAs for the IT service 
industry. 
  
3.1.4 Definition of catch-up and leading regions 
This study developed a high tech index, which is a variant of the Milken Institute’s  
‘Tech-Pole’ score (DeVol 1999), to measure the relative position of an MSA in the 
biopharmaceutical or IT service industry. Specifically, the high-tech index is an equally weighted 
indicator of two factors: (1) a region’s share of national total establishments in a specific high 
tech industry; and (2) its establishment density level, measured by the number of industrial 
establishments per square mile. While the first factor of the index favors large metropolitan 
areas, the second favors smaller regions with a relatively large number of high tech 
establishments. By combining them, the index creates a less biased indictor of a region’s overall 
strength in a specific high-tech industry.  
This study defines a region as a catch-up or leading region based upon its high tech index 
value in 1995, one year before I began to measure the regional variation in the NTBFs’ early 
stage performance. The index is based upon the establishments instead of employment data 
mainly for two reasons. First, the employment and establishment variables are typically highly 
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correlated with each other. For example, in 1995, the correlation between the number of 
establishment and number of employees across all the MSAs is 0.89 in the biopharmaceutical 
industry and 0.94 in the IT service industry. Thus, measures derived from either of them are 
qualitatively similar. Second, due to data disclose restrictions, many MSA regions only have 
rough estimates of industrial employment data. Thus, the establishment data is more accurate 
than the employment data for some regions.  
An MSA is defined as a ‘leading’ region if its high tech index value in 1995 was ranked 
95th percentile or above. The 95th percentile rank was chosen as the cutoff point because it can 
result in a fairly stable list of leading regions during the study period. Such an approach results in 
8 leading regions and 160 catch-up regions in the biopharmaceutical industry. In the IT service 
industry, there were 15 leading regions, and 301 catch-up regions. Figure 2 and 3 depict the 
spatial distribution of all the leading and catch-up regions in these two industries. Appendix 1 
presents the list of leading and top 20 catch up regions and their high-tech index values both in 
1995 and 2000. The results indicate that in the biopharmaceutical industry, 7 of 8 leading regions 
were consistently ranked above 95th percentile both in 1995 and 2000. In the IT service industry, 
11 of 15 leading regions were consistently ranked above 95th percentile. No leading region in 
1995 was ranked below 90th percentile in 2000.   
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Figure 2: Leading and Catch-Up Regions in the Biopharmaceutical Industry, 1995 
 
 
Figure 3: Leading and Catch-Up Regions in the IT Service Industry, 1995 
IT service industry
leading region
catch-up region
leading region
catch-up region
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 3.2. Measures and Data 
 Based upon the theoretical framework developed in chapter 2, this study models the 
average NTBF performance in a region as a function of local scientist job market condition, 
proximity to venture capital, cultural diversity, academic research, industrial structure, and 
entrepreneurial climate. This section presents the detailed description of variable 
operationalization and data sources. Table 2 in the end of this section summarizes the variable 
definitions used in the empirical estimation. 
 
3.2.1. Dependent variable 
Prior research developed several measures of firm performance such as survival rate, 
asset/sales/revenues/employee growth rate, number of patents, time to IPO, etc. The survival rate 
over a short-period time is a performance measure with low threshold-value. Usually, we not 
only want to know whether firms can survive, but also how they succeed.  The traditional 
financial indicators are of limited use for two reasons.  First, NTBFs generally have few assets, 
revenues, or net earnings because of their limited operation history. Second, when firms are still 
in private status, their financial data are typically not publicly available. Patenting is one of the 
best available and comparable measures of a firm’s innovative activity, primarily because 
“patent data are public, computerized, and represent a disinterested decision by an examiner that 
a non-obvious and potentially commercially useful invention has occurred” (Jaffe, p. 74, in 
Branscomb and Keller, 1998). However, since not all inventions are patentable and a firm’s 
desire to patent varies across industry, the pitfalls of using patent-related indicators to measure a 
firm’s success are not negligible.  
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This study measures the average NTBF performance in a region by counting the number of 
NTBF IPO and M&A events that occurred in that region during a specific period of time. This 
indictor of NTBF performance is based upon the fact that on average, NTBFs that have 
experienced an IPO or M&A event are more successful than those who have not.   
The extant literature demonstrates various benefits to NTBFs by going public. First, an IPO 
is a critical financing tool. NTBFs usually have poor access to debt finance because of their 
highly variable returns, substantial information asymmetries between firms and potential 
investors, and limited collateral values of R&D investments (Carpenter and Petersen 2002). By 
going public, the issuing firm can obtain a substantial amount of capital to finance its investment 
opportunities. Second, going public is an organizational milestone that increases a firm’s 
legitimacy in the business community and improves its internal management qualities. Finally, it 
offers an opportunity to reward the entrepreneurs and early-stage investors like venture 
capitalists. 
Similarly, NTBF owners are very likely to be rewarded with a very high payoff through 
merger and acquisition because the acquirers usually have more resources and are able to offer a 
good deal to the targets so that they can access their technology or eliminate the potential threats. 
In sum, both IPOs and acquisitions can be considered a successful outcome for an NTBF started 
to develop an innovative idea. As a result, I can approximate the average early-stage success of a 
region’s NTBFs by counting the number of IPO and acquisition events among them.  
IPO_Targetmt = Number of IPO and M&A events in industry i in MSA m at time t 
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This measure is by no means perfect, because it does not account for the fact that there is 
substantial variation among the IPO or acquired NTBFs in terms of their individual performance. 
Some IPOs fail to survive several years after they become public, and some acquired firms get 
much higher payoffs than others. Thus, it is necessary to compare the average performance of 
these “successful” NTBFs in a region to those located elsewhere. However, the data source this 
study uses indicates that while it is feasible to analyze the average performance of IPO firms 
across regions, it is not practical to do so for M&A firms. Furthermore, because IPO firms are 
highly concentrated in a small number of regions, only 34 MSAs had IPOs in the 
biopharmaceutical industry and 65 MSAs in the IT service industry during the study period. Due 
to such a small sample size, no independent variables turned out to be statistically significant. 
Therefore, I don’t report the details in this study.   
 
3.2.2. Independent variables 
         All the location-specific variables are defined at the MSA level. The measures of these 
variables are mainly drawn from prior studies (Glaeser, Kallal et al. 1992; Ketelhohn 2002; 
Stuart and Sorenson 2003). 
(1) Scientists job market conditions 
Three variables measure the local job market conditions for scientists and engineers. The 
first is a region’s share of national industry-related scientist occupational jobs. This variable 
reflects the absolute size of local occupational job opportunities for industry-related scientists 
(i.e., life scientists for the biopharmaceutical industry and computer scientists for the IT service 
industry). The second variable is the average annual salary for life scientists or computer 
scientists. The salary rate has mixed effects on firm performance. On the one hand, the current 
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employees, who might become entrepreneurs in the future, can be attracted by a region’s higher 
real salary rates. As a result, these regions will be able to accumulate a pool of latent 
entrepreneurs. On the other hand, regions with high salary rates become less attractive for those 
active entrepreneurs who are creating or running a NTBF, because high real salary rates mean 
high business costs. The ultimate effect of salary rates on a region’s NTBF performance is 
determined by the dominant mechanism. The third variable is calculated by dividing the average 
annual salary of scientist jobs by that of total occupational jobs in a MSA. This variable is 
constructed to adjust for the local living costs. 
Job_ sharemt = Share of national industry related scientist occupational jobs within a metro 
area m in time t  
Absolute_salarymt = Ratio of annual average salary of industry related scientist 
occupational jobs in a metro area m in time t to the corresponding national annual average 
salary  
Relative_salarymt = Ratio of annual average salary of industry related scientist 
occupational jobs to that of all jobs within a metro area m in time t 
(2) Venture capital 
Venture capitalists (VC) prefer to fund spatially proximate start-ups (Sorenson and Stuart 
2001). Because the size of venture capital investment fluctuates dramatically over time, this 
study counts the number of VC firms located within a metro area. In addition, many VC firms 
are highly specialized in a specific field. Thus, it is more appropriate to count VC firms that are 
actively investing in the biopharmaceutical or IT service firms than just use the total number of 
all the VC firms. The squared term of venture capital firms is constructed to account for the 
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adverse effects of excess amount of venture capital on firm performance as documented in some 
prior studies (Stuart and Sorenson 2003; Acs and Storey 2004; Venkataraman 2004). 
VC_firmmt = Number of industry specialized venture capital firms within a metro area m 
in time t 
 VC_firm_sqmt = Square of VC_firmit 
 (3) Cultural diversity 
Cultural diversity is a multidimensional concept and could stem from different ethnicity, 
religion, national origin or other characteristic(Ottaviano and Peri 2004). Florida (2002b) 
measures the level of cultural diversity, or the barriers to entry for diverse human capital in a 
region by four indices: the Gay and Lesbian index, Melting Pot Index (foreign born population), 
Bohemian Index (artistically creative people), and a Racial Integration Index. However, as the 
author acknowledged, the effects of these diversity measures vary by size of region. While the 
bohemian and gay measures matter much more for large regions with over 1 million people, 
immigration is a more appropriate indictor for small- and medium-sized regions6.  
Ottovanio & Peri (2004) define the cultural diversity index by 1 minus the Herfindal index of 
concentration across groups. This index reaches its maximum value 1 when each individual is in a 
different group and its minimum value of 0 when all individuals belong to the same group. They 
found a positive and high correlation coefficient between the share of foreign-born people in a city 
and its diversity index, ranging from 0.84 to 0.87 in the US context. This finding suggests that the 
presence of a large share of foreign-born, more than their group composition, is the largest source of 
diversity in US cities. Therefore, this study simply uses the share of foreign born in each MSA to 
measure its cultural diversity.   
                                                 
6 Florida(2004), “Response to Edward Glaeser’s review of The Rise of the Creative Class”, 
http://creativeclass.com/rfcgdb/articles/ResponsetoGlaeser.pdf, accessed on 8/30/2007. 
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Immi_sharemt = Percentage of population that were foreign born within a metro area m in 
time t 
 (4) Academic research 
 This study measures a region’s relative strength of industry relevant academic research by 
its share of national academic R&D expenditure in a specific industry related field in time t.  
 Univ_sharemt  = Share of industry related university R&D expenditure within a metro area 
m in time t 
 The academic R&D expenditure data was compiled from the National Science 
Foundation’s (NSF’s) Survey of Research and Development Expenditures at Universities and 
Colleges. In each year, the NSF reports the academic R&D expenditure by fields and institutions. 
Life science is the most relevant field for the biopharmaceutical industry. The detailed R&D 
expenditure data for the top 150 institutions are available, and these institutions usually accounts 
for more than 96 percent of total academic R&D expenditure in the life science field (Table 1). 
In the computer science field, which is the most relevant field to the IT service industry, data for 
the top 100 institutions were reported. These institutions accounted for about 90 percent of 
academic R&D expenditure in the field. I identify each of top institution’s ZIP code and 
corresponding MSA code, and aggregate the university-level expenditure data to the MSA level.  
Table 1: Statistics of Academic R&D Expenditures by Field, 1995 and 2000 
 
Computer science Life science  
1995 2000 1995 2000 
Total, included institutions  ($)   620,045 796,293 11,679,656 16,757,635
Total, all other sampled  institutions  ($)  60,762 79,708 484,106 709,899 
Total, all institutions ($)        680,807 876,001 12,163,762 17,467,534
Share of included institutions 91.08% 90.90% 96.02% 95.94% 
 
Source: National Science Foundation/Division of Science Resources Statistics, Survey of Research and 
Development Expenditures 
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(5) Industry specialization 
  Following Glaser et al (1992) and Ketelhohn (2002), I use three traditional “location 
quotients” to capture the positive externalities resulted from industry specialization and co-
agglomeration with the upstream and downstream industries. The location quotients are 
commonly used to measure the extent to which a region is more specialized in an occupation 
than the nation as a whole. Benchmarked at 1, a location quotient greater than 1 indicates that a 
MSA has a relatively high concentration of certain industries compared to the United States 
overall, while a value less than 1 indicates the concentration level in a MSA below the national 
average.  
 
 tat time employment  U.S.Total
 tat time Iindustry in   employment  U.S.Total
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 tat time mMSA in  Iindustry in   Employment
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 (6) Entrepreneurship 
There are a variety of measures used in the previous studies to gauge the amount of 
entrepreneurial activity in an economy as well as how the entrepreneurship changes over time. 
For example, Becker (1984) and Blau (1987) measure the level of entrepreneurship in the U.S. 
between 1948 and 1980s by identifying the number of self-employed individuals using data from 
the Current Population Survey conducted by the Census Bureau. Reynolds (1992) and Kirchhoff 
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and Philips (1992) focus on the rate of new firm formation using data from Dun & Bradstreet 
Market Identifier prepared by the Small Business Administration. Gartner and Shane (1995) 
argue that the number of organizations per capita is a more appropriate indicator of 
entrepreneurship over time then self-employment or firm formation measure. 
 This study focuses on the average performance of NTBF in a region, so the firm-level 
rather than individual-level indicator serves our purpose better. In addition, as mentioned before, 
due to the data disclose restriction, the establishment data is more accurate than the employment 
data for many MSAs. Therefore, there is no reliable data to calculate the industry-specific 
‘organization per capita’ measure proposed by Gartner and Shane (1995). This study uses the 
traditional small firm birth rate to measure the overall local entrepreneurial climate. 
100
mMSA in t year  of beginning at the entsestablishm small of Number
year t in  mMSA in born  entsestablishm small ofNumber 
Rate_Birth_Firm mt ×=  
 
3.2.3. Control variables 
 The empirical estimation analysis controls for the region size, industrial cluster 
characteristics, and time effect that might account for the regional variation in the average 
performance of NTBFs.  
 A region’s size is measured by its total employment: 
 tin time employment  U.S.Total
 t in time mMSA in  employment Total_ =mtshareEmp  
The industrial cluster characteristics are measured by two aspects of industrial 
establishments in a region: (1) number of small and medium establishments in the industry, and 
(2) number of industrial establishments per square mile. The establishment rather than 
employment data are used for the same reason discussed in section 3.1.4. That is, the 
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employment and establishment variables are highly correlated with each other and thus measures 
derived from either of them are qualitatively similar. Also, the establishment data is more 
accurate than the employment data for some regions. The first variable reflects the absolute size 
of industrial cluster in a region. The second one is constructed to measure the adverse effect of 
‘excess’ number of similar firms. The third one indicates whether firms in a region are highly 
concentrated or sparsely distributed.  
  Ind_SME_mt = Number of small and medium establishments in industry i within a metro 
area m in time t 
 Ind_SME sqmt = Ind_SME_mt 
mMSA ofsizelandTotal
 t at time mMSA in  iindustry in  entsestablishm ofNumber    _ =mtdensityEst  
The fixed time effect should be controlled in the panel data which will be discussed 
shortly. The capital market condition cycles from hot to cold (Ritter and Welch 2002; Helwege 
and Liang 2004). This is particularly true for the IPO market. The ability and intention of a firm 
to issue IPO is affected substantially by the varying equity market condition.  Even though there 
is no difference in their intrinsic values, firms that issue IPOs in a “hot market” can get a higher 
price than those in a “cold market”. This creates incentives for entrepreneurs to time their 
decisions to go public (Benninga, Helmantel et al. 2005). As a result, the volume of IPO within a 
specific period is affected substantially by the market condition. This study creates a dummy 
variable to control for the time effect. 
Period_dummy =  0 for the period from 1996 to 2000, and 1 for the period from 2001 to 2005.  
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Table 2: Definition of Variables 
 
Time index t value Variable name Definition 
Model 1a Model 2 b 
IPO_Targetmt Number of NTBF IPO and M&A events that 
occurred in industry i within a metro area m in 
time t  
1996-2005 1996-2000, 
2001-2005 
Job_ sharemt Share of national industry i related scientist 
occupational jobs within a metro area m in 
time t 
1999 1999, 2004 
Absolute_salarymt Ratio of annual average salary of industry i 
related scientist occupational jobs in a metro 
area m in time t to the national average 
1999 1999, 2004 
Relative_salarymt Ratio of annual average salary of industry i 
related scientist occupational jobs to that of all 
jobs within a metro area m in time t 
1999 1999, 2004 
VC_firmmt Number of industry i specialized venture 
capital firms within a metro area m in time t 
1999 1999, 2004 
VC_firm_sqmt Square of VC_firmit 2000 2000, 2005 
Immi_sharemt Percentage of population that were foreign 
born within a metro area m in time t 
1990 1990, 2000 
Univ_sharemt Share of industry i related university R&D 
expenditure within a metro area m in time t 
1995 1995, 2000 
Ind_lqmt Location quotient of industry i within a metro 
area m in time t 
1995 1995, 2000 
Buyer_lqmt Location quotient of the buyers of industry i 
within a metro area m in time t 
1995 1995, 2000 
Supplier_lqmt Location quotient of the suppliers of industry i 
within a metro area m in time t 
1995 1995, 2000 
Firm_birthmt New small firm birth rate within a metro area 
m in time t 
1995 1995, 2000 
Est_densitymt Number of establishments in industry i per 
square mile within a metro area m in time t 
1995 1995, 2000 
Ind_SMEmt Number of small and medium establishments 
in industry i within a metro area m in time t 
1995 1995, 2000 
Ind_SME _sqmt Square of Ind_SMEit 1995 1995, 2000 
Emp_sharemt Share of total national employment within a 
metro area m in time t 
1995 1995, 2000 
Period_dummy Dummy variable indicting whether (=1) or not (=0) it is the second time period 
2000-2005. 
Note: a: Cross-sectional models; b: Two-period panel data models.  
  
3.2.4. Data 
The 1996- 2005 IPO and M&A data were mainly retrieved from the Securities Data 
Company’s (SDC) new issues database. All unit offerings, American Depository Receipts 
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(ADRs), and closed-end funds are excluded. I made substantial efforts to obtain a comprehensive 
IPO list by cross-checking the SDC data with three other sources: Hoover’s IPO list (which only 
keep actively-traded public companies), Professor Jay Ritter's 1975-2005 IPO dataset, and 
University of Chicago’s Center for Research in Security Prices (CRSP). Because the accuracy of 
IPO industry affiliation and location information is critical for this study, I obtain each 
company’s four-digit SIC and ZIP code information from the Security Exchange Commission 
(SEC)’s Edgar database7.  
The occupational job data are from the Occupational Employment Statistics (OES) of the 
Bureau of Labor Statistics, U.S. Department of Labor. The OES survey collected both 
occupational employment and salary data nationwide for the first time in 1996. Since its 
inception, the OES program has adopted two occupational classification systems. Estimates from 
1999 and subsequent years are based upon the 2000 Standard Occupational Classification (SOC) 
system, and therefore are not directly comparable with previous years' OES estimates. This study 
uses data in 1999 to measure the job market condition for life scientists and computer scientists 
in each MSA for the period between 1995 and 2000, and data in 2004 for the period between 
2001 and 2005. Missing data are replaced with the average value between 1999 and 2004. Table 
3 lists the 2000 SOC occupational job titles for scientist and engineers who develop or routinely 
utilize technologies that are relevant to the biopharmaceutical and IT Service industries. 
                                                 
7SEC Edgar database: http://www.sec.gov/edgar/searchedgar/companysearch.html. 
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Table 3: Occupational Job Titles for Life Scientist and Computer Scientist 
 
SOC Code SOC title 
Life scientist group 
17-2031 Biomedical engineers 
19-1021 Biochemists and biophysicists 
19-1022 Microbiologists 
19-1041 Epidemiologists 
19-1042 Medical scientists except epidemiologists 
19-2031 Chemists 
19-4021 Biological technicians 
19-4031 Chemical technicians 
29-2011 Medical and clinical laboratory technologists 
29-2033 Nuclear medicine technologists 
29-2034 Radiologic technologists and technicians 
Computer scientist group 
15-1011 Computer and information scientists 
15-1021 Computer programmers 
15-1031 Computer software engineers applications 
15-1032 Computer software engineers systems software 
15-1051 Computer systems analysts 
15-1061 Database administrators 
15-1081 Network systems and data communications analysts 
17-2061 Computer hardware engineers 
17-2071 Electrical engineers 
17-3023 Electrical and electronic engineering technicians 
27-1014 Multi-media artists and animators 
 
Source: Bureau of Labor Statistics, U.S. Department of Labor, Occupational Employment Statistics 
 
Data on the locations of VC firms are from the MoneyTree™ Report, prepared by 
PricewaterhouseCoopers/National Venture Capital Association based on the survey data from 
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Thomson Financial8. The MoneyTree™ Report is a quarterly study of venture capital investment 
activity in the United States beginning with 1995. However, the industry-specific VC list is 
available only after the fourth quarter of 2001. This study identifies from this report 233 VCs 
that were actively invested in biopharmaceutical ventures and 712 VC firms that were actively 
investing in IT service ventures during the period from the fourth quarter of 2001 to the third 
quarter of 20029. In 2005, the number of VC firms that were funding biopharmaceutical and IT 
service start-ups was 298 and 550, respectively. Some venture capital firms have established 
satellite offices. Unfortunately, the MoneyTree™ Report, like other commonly-used venture 
capital data sources (e.g., SDC Venture, see Stuart and Sorenson(2003)), only reports the 
location of the headquarters office for each VC firm. Therefore, our calculations of the distances 
of biotechnology firms and geographic areas to VCs will be biased downward for some 
metropolitan areas that only have VC branch offices.  
The aggregate immigrant data for each MSA in the U.S. are from the American 
Communities Project, presented jointly by the Initiative in spatial Structures in the social 
sciences, Brown University, and the Lewis Mumford Center, University at Albany10. 
The academic R&D expenditure data was compiled from the National Science 
Foundation’s (NSF’s) Survey of Research and Development Expenditures at Universities and 
Colleges. 
 Data on industrial employment and establishments are mainly retrieved from the County 
Business Pattern (CBP) provided by the Census Bureau. The CBP is an annual series that reports 
subnational economic data by industry. Statistics include number of establishments, payroll 
                                                 
8 Money Tree Report, https://www.pwcmoneytree.com/MTPublic/ns/index.jsp 
9 The ‘biopharmaceutical’ industry used in this study corresponds to the ‘biotechnology’ industry classification 
adopted in the MoneyTree™ Report. The IT Service industry in this study includes both “IT Service” and 
“Software” the MoneyTree™ Report. 
10 Data source: http://www.s4.brown.edu/cen2000/data.html, accessed on 8/30/2007. 
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(annual and 1st quarter), and number of employees, etc. The CBP data has three major 
limitations that could affect the results of this study. First, the data is not completely comparable 
over time because of the change of industrial category system. Data for 1997 and earlier years 
are based on the SIC System. Since 1998, it has transferred to the NAICS system. Second, data 
for many counties are only a rough estimate. The CBP reported “flags’ (A, B, C, etc.) to avoid 
disclosing information in states and counties where industry participants can be easily identified. 
This study substituted the “flags” by the midpoint of the range shown in Table 4. Third, I found 
data for some MSAs in certain years are extremely unbelievable. So, I check the corresponding 
values reported by the Quarterly Census of Employment and Salarys (QCEW) data which is 
provided by the Bureau of Labor Statistics. I then chose the values to be more consistent with the 
historical trend. 
Table 4: Flags, Range, and Midpoints in the County Business Pattern Data 
Flag Range Midpoint
A 0-19 10 
B 20-99 60 
C 100-249 175 
E 250-499 375 
F 500-999 750 
G 1,000-2,4999 1750 
H 25,00- 4,999 3750 
I 5,000-9,999 7,500 
J 10,000-24,9999 17,500 
K 25,000-49,9999 37,500 
L 50,0000-99,9999 75,000 
M 100,0000 and more 100,000 
  
 This study uses the 1997 Input-Out (I-O) Benchmark account11 published by the Bureau of 
Economic Analysis (BEA) of the U.S. Department of Commerce to determine the most 
important specialized buyer- and supplier- industries for the biopharmaceutical and IT service 
                                                 
11 Source: http://www.bea.gov/industry/io_benchmark.htm#2002data, Bureau of Economic Analysis, U.S. 
Department of Commerce. 
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Industries. The 1997 Benchmark I-O account is the latest in a series of benchmark accounts that 
provide an extensive accounting of the commodity production and consumption in the U.S. 
economy12. We use its ‘MAKE’ table to identify the suppliers, and the ‘USE’ table to define the 
buyers. For example, to determine the suppliers of the biopharmaceutical industry, I first rank all 
the industries in the ‘MAKE’ table according to their sales to the biopharmaceutical industry. 
Industries with a rank of 10th or lower percentiles are deleted because of their trivial contribution 
to the biopharmaceutical industry. I then rank the rest industries according to the percentage of 
their output sold to the biopharmaceutical industry and select the top three industries as the most 
specialized and important suppliers of the biopharmaceutical industry. Similarly, I can use the 
‘USE’ table to determine the buyers of the biopharmaceutical industry. Ketelhohn’s (2002) has 
employed a similar approach to determine the buyer and supplier industries for the advertising, 
pharmaceutical, and semiconductor industries. 
Industries in the 1997 Input-Out Benchmark tables were defined by a six-digit NAICS 
code. Specifically, the biopharmaceutical industry in this study corresponds to the industry code 
‘325400’ (Pharmaceutical and medicine manufacturing). The IT service industry encompasses 
four six-digit codes: 511200 (Software publishers), 541511(Custom computer programming 
services), 541512 (Computer systems design services), and 54151A (Other computer related 
services).  Table 5 and 6 show the resulting set of top suppliers and buyers of the 
biopharmaceutical and IT service Industries.  
                                                 
12 The preliminary 2002 benchmark Input-Out tables are available now. However, industries in these tables were 
defined only at a three-digit NAICS level, and thus don’t provide information this study needs. 
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Table 5: Supplier- and Buyer- Industries of the Biopharmaceutical Industry 
Supplier 
NAICS code 
Supplier- industry name Buyer 
NAICS code 
Buyer-industry name 
334516 Analytical laboratory instrument 
manufacturing 
622 Hospitals 
311514 Dry, condensed, and evaporated 
dairy products 
621 Other ambulatory health care 
services 
339112 Surgical and medical instrument 
manufacturing 
54194 Veterinary services 
 
Table 6: Supplier- and Buyer- Industries of the IT Service Industry 
Supplier 
NAICS code 
Supplier- industry name Buyer 
NAICS code 
Buyer-industry name 
334113 Computer terminal manufacturing 334111 Electronic computer 
manufacturing 
5612 Facilities support services 334113 Computer terminal 
manufacturing 
5142 Data processing services 334112 Computer storage device 
manufacturing 
 
The small firm birth rate data at metropolitan level is from ‘Dynamic Firm Size’ database 
prepared by the Office of Advocacy, U.S. Small Business Administration. 
The industrial establishment data are from retrieved from the County Business Pattern 
data provided by the U.S. Census Bureau. The county-level land size data is Census 2000 
Summary File 1 provided by the U.S. Census Bureau. The county-level land size data is then 
aggregated to the MSA level based upon the 2003 December MSA definition.   
 
3.3. Models 
 This study employs both cross-sectional and two-period panel models to investigate the 
impacts of regional characteristics on average NTBF performance. A Zero-Inflated Negative 
Binomial (ZINB) model specification is used to account for the distributional characteristics of 
the count data which will be explained in next section. To check the robustness of the results, the 
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same regression models will also be applied to a set of distance-weighted variables and a larger 
size of sample (include both the leading and catch-up regions).  
 
3.3.1. Cross-sectional estimation 
  The cross-sectional model investigates the causal relationship between a catch-up 
region’s initial conditions and its subsequent NTBF performance. The dependent variable 
IPO_Targetim is the total number of NTBF IPO and M&A events occurred in industry i within a 
MSA m during the period from 1996 to 2005. The independent variables include measures for 
local scientists job market conditions, venture capital, cultural diversity, university research 
expenditure, industrial structures, and entrepreneurial climate in 1995, one year prior to our study 
period. However, due to the data availability, the measures for some independent variables were 
in 1999 or later year (see table 2 for details). Given that most regional variables don’t change 
dramatically over a very short period of time, such an approach is not expected to bias the 
findings substantially. The control variables include the industrial employment share, 
establishment density, number of small firms, and total employment in a metro area. The sample 
size for the biopharmaceutical industry is 168, and 301 for the IT service industry. 
Mathematically, the full cross-sectional model can be expressed as:   
 
Equation (1): 
IPO_Targetm  = f (β0 + β1Job_ sharem + β2salary_ logm + β3Relative_ salarym + β4VC_ logm 
           + β5VC_ log_sqm + β6Immi_ sharem + β7Univ_ sharem+ β8Ind_ lqm  
                             + β9 Buyer_ lqm + β10Supplier_ lqm + β11Firm_birth_ ratem+ β12 Est_ densitym 
         + β13Ind_SME_logm + β14Ind_ SME_log_sqm 
                                            + β15Employmentm + ε ) 
 
.  
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3.3.2. Two-period panel data estimation 
The panel data model investigates the temporal stability of the causal relationships 
between location and NTBF performance. Although the region-level factors may change 
dramatically at the societal level over periods greater than 10 years, they change very little over 
short periods of time(Gartner and Shane 1995). Therefore, in this study, I partition the 10-year-
long study period only into two five-year sub periods. The sample size is 168 for the 
biopharmaceutical industry, and 301 for the IT service industry. Due to the small sample size, 
this two-period panel data model doesn’t account for the group fixed effect. The occurrence of 
IPO and M&A events is very sensitive to the overall capital market condition, which fluctuates 
over time. Thus, the panel data model includes one time dummy variable, period_dummy, to 
account for the time fixed effect. The dependent variable is number of NTBF IPO and M&A 
events that occurred in industry I within MSA m over 1996-2005 or 2001-2005.  Most 
independent and controlled variables were measured in 1995 and 2000. For variables that were 
first measured in 1999 or later year, their subsequent values were measured five years later. This 
guaranteed that all variables were updated over the same length of time gap. Mathematically, the 
full panel data model can be expressed as:   
Equation (2): 
 
IPO_Targetimt  = f (β0 + β1Job_ sharemt + β2salary_ logmt + β3Relative_ salarymt + β4VC_ logmt 
           + β5VC_ log_sqmt + β6Immi_ sharemt + β7Univ_ sharemt+ β8Ind_ lqmt  
                             + β9 Buyer_ lqmt + β10Supplier_ lqmt + β11Firm_birth_ ratemt 
                             + β12Est_ densitymt + β13Ind_SME_logmt + β14Ind_ SME_log_sqmt 
                                            + β15Employmentmt++ β16Period_dummy+  εmt ) 
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3.3.3. ZINB model specification 
As discussed above, the dependent variable in this study is the number of 
biopharmaceutical or IT service IPO and M&A events occurred in a region within a specific time 
period. This is an event count variable which has limited non-negative integer values and is 
highly skewed towards the lower values. When the ordinary least squares (OLS) method is 
applied to such event count data, it usually results in biased, inefficient, and inconsistent 
estimates (Long 1997). Thus, it is much safer to use models specifically designed for count 
outcomes in this study.  
The ZINB model is chosen mainly for two reasons. First, the Negative Binomial 
Regression Model (NBRM) is preferred to the Poisson Regression Model (PRM) because 
overdisperson is apparent in the data. The PRM assumes that observed count is drawn from a 
Poisson distribution and that the equality of its conditional mean and conditional variance holds. 
When Var(y|x) > E(y|x), we are said to have overdispersion. Table 7 presents the preliminary 
evidence of overdispersion in our data. That is, the observed unconditional variance is much 
greater than the unconditional mean in both the cross-sectional and panel data models for two 
industries. The likelihood ratio tests for overdispersion (examines the null hypothesis of 
alpha=0), which will be reported in the Chapter 4 and 5, provide further evidence of 
overdispersion. In the presence of overdispersion,   the standard errors in the PRM will be biased 
downward, resulting in spuriously large z-values and spuriously small p-values (Long & Freese, 
2001, p. 243). The NBRM is a standard method used to model overdispersed Poisson data. The 
NBRM estimation incorporates observed and unobserved heterogeneity into the conditional 
mean, mu=exp(xb+e) (Long & Freese, 2001). Thus, the conditional variance of y becomes larger 
than its conditional mean, E(y|x)=mu, which remains unchanged. 
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Table 7: Descriptive Statistics of the Dependent Variable 
Industry N Mean Std Dev Min. Max. 
cross-sectional model 160 1.381 3.003 0 26 Biopharmaceutical 
panel model 320 0.691 1.751 0 19 
cross-sectional model 301 7.970 19.072 0 189 IT Service 
panel model 602 3.985 9.689 0 108 
 
Second, the zero-inflated version of NBRM is favored over the standard NBRM due to 
the issue of excess zeros. Because this study focuses on the catch-up regions, the dependent 
variable has many zeros both in the cross-sectional and panel data models. Table 8 reports that in 
the biopharmaceutical industry, almost 60 percent (95 of 160) of catch-up MSAs had 0 IPO and 
M&A events between 1996 and 2005. The IT service industry had a smaller proportion of zero 
cases, but it is still over 33 percent (102 of 301). The excess-zeros situation in the two-period 
panel models is no better than that of the cross-sectional models. The Zero-inflated version of 
Negative Binomial model respond to the failure of standard NBRM models to account for excess 
zero. The vuong test results, which will be reported in Chapter 4 and 5, show that the ZINB is 
favored over NBRM in this study.  
Table 8: Number of Zero and Non-Zero Observations for the Dependent Variable 
Cross-sectional model Two-period panel model Industry 
Total Zeros Non-zero Total Zeros Non-zero 
Biopharmaceutical 160 95 65 320 231 89 
IT Service 301 102 199 602 283 319 
 
The ZINB handles overdispersion by changing the mean structure to explicitly model the 
production of zero counts (Long & Freese, 2001). The model assumes that there are two latent 
groups: always-0 group that has an outcome of 0 with a probability of 1; not-always-0 group that 
 47
might have a zero count, but there is a nonzero probability that the observation has a positive 
count. Since there is no observed variable indicating group membership, we do not know 
whether an observation is in the Always-0 group or Not-Always-0 group (Long & Freese, 2001, 
p. 251).  
The cross-sectional version of ZINB model is implemented in the following three steps:  
Step 1) Use the logit model to predict the probability of being Always-0 group for each 
metro area i. Because there is no theory suggesting which variables are the best predictors of the 
probability of being always-0 group, I use all the independent variables plus two control 
variables (est_density and ind_SME_log) as the predictors13. Here these variables are referred to 
as inflation variables since they serve to inflate the number of 0s. Suppose yim  = equation (1) and 
the probability of being in Always-0-group for individual MSA m is ψim, we have: 
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13 In some model specifications defined in Chapter 4 and 5, the algorithm doesn’t converge to a solution if I use all 
the independent variables as the inflation variables. If this happened, I first drop the squared terms of independent 
variables, and then try to drop one or two variables if it still doesn’t converge. The two control variables (ind_share 
and employment) are excluded because they are highly correlated with Ind_SME_lg in both industries.   
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Step 3) Compute observed probabilities as a mixture of the probabilities for the two 
groups.   
The panel data version of ZINB model can be implemented in the similar way except that 
the index is ‘imt’ instead of ‘im’.  
3.3.4. Robustness check methods 
This study employed three approaches to check the robustness of the results we will get 
from the above model specification.  
First, conduct Breusch-Pagan / Cook-Weisberg heteroskedasticity test for each model 
specification.  If the ‘constant variance of error term’ assumption is violated, run the regression 
models with robust option. In stata, when we use the’ robust’ option, it specifies that the 
Huber/White/sandwich estimator of variance be used in place of the traditional calculation.  
Second, estimate the full model by including both the leading and catch-up regions. By 
doing so, I can explore which causal relationships are unique to the catch-up regions. 
Third, estimate the cross-sectional and panel full model based upon a set of distance-
weighted variables. Stuart and Sorenson (2003) point out that the traditional within-region 
measures ignore the presence of many objects that fall beyond the arbitrary geographic 
boundary, even if they lie very near to the borderline. For example, when we measure the 
impacts of venture capital firms on firm performance in a MSA, we should not only account for 
venture firms that are located within that MSA, but also for those located in immediately 
neighboring MSAs. This is particularly crucial when the spatial unit of study is at the county, 
ZIP code, or smaller level. This study is based upon the metropolitan area level, so the 
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‘neighboring’ effect is unlikely to be a serious problem. However, some MSAs are very close to 
each other so that the ‘neighboring’ effect can not be simply ignored. Therefore, as a robustness 
check, this study will replicate the full models based upon a set of distance-weighted measures. 
The distance-weighted measures are constructed in the following way: 
 Step 1, identify the most ‘crowded’ zip code in each MSA based upon 2005 5-digit ZIP 
Code Business Pattern data provided by the Census Bureau. The most ‘crowded’ zip code refers 
to the area that hosts the largest number of establishments in the industry. Thus, the 
corresponding ZIP code of the same MSA could vary across industries. For example, for the 
Atlanta-Sandy Springs-Marietta (GA) metropolitan area, the most crowded ZIP code in the 
biopharmaceutical industry is ‘30071’. In the IT service industry, however, the most crowded 
ZIP code is ‘30004’. By focusing on the 5-digit ZIP code level, this study aims to create a finer 
distance measure of economic exchange between two MSAs. 
 Step 2, obtain the longitude and latitude at the center of the most crowded ‘ZIP’ code in 
each MSA, and follow the formula used by Stuart and Sorenson  (2003, p.238) to calculate the 
physical distance between the two points, i and j, as 
  dij = 3437*{arccos [sin(lati)*sin(latj)+cos(lati)cos(latj)cos(|longi –longj|)]} 
 where latitude (lat) and longitude (long) are measured in radians. The constant 3437 
converts the distance into units of miles. The distances among all the leading and catch-up MSAs 
are calculated. That is, in the end, I obtain a 168*168 dimensions of distance matrix for the 
biopharmaceutical industry, and a 316*316 dimensions of distance matrix for the IT service 
industry. 
 Step 3, weight the contribution of each MSA to the focal MSA by the inverse of their 
distance, and then sum these weighted contributions across all MSAs to yield a distance-
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weighted value for the focal MSA. For example, the value of distance-weighted life science 
academic research for MSA i is calculated as: 
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 Similarly, the value of distance-weighted computer science academic research for MSA i is 
calculated as: 
0,
1
__
316
1
_ ==+= ∑= dd
csUniv
ij
j ij
j
i jiwhenweightedshareUniv  
 Among the independent and control variables defined in section 3.2, the following five 
variables are most likely to have spill over effects on the adjacent regions: scientist job market 
size, venture capital firms, immigrants, academic R&D expenditure, and industrial 
establishments. Correspondingly, I follow the above approach to recalculate the values of 
Job_share, VC_log, VC_log_sq, Immi_share, Univ_share, Ind_sme_log, and Ind_sme_log_sq.  I 
then re-estimate the cross-sectional and two-period panel models using these distance-weighted 
variables as a robustness check.  
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CHAPTER 4: BIOPHARMACEUTICAL INDUSTRY 
 
This chapter analyzes the spatial heterogeneity in the performance of US 
biopharmaceutical NTBFs during the period from 1996 to 2005. The basic industry 
characteristics are discussed in Section 4.1. Section 4.2 describes the spatial distribution of 
NTBF IPO and M&A activities in the industry. Section 4.3 uses a set of Zero Inflated Negative 
Binomial regression models to investigate the determinants of the average NTBF performance in 
a region. Section 4.4 summarizes the main findings.  
 
4.1. The Biopharmaceutical Industry 
This study defines the biopharmaceutical industry by SIC 283 prior to 1997 and NAICS 
32541 thereafter14. Some authors (Guo, Lev et al. 2005) define the modern ‘biotechnology’ 
industry in a similar way except that they also include the sector of ‘commercial physical and 
biological research’ (SIC 8731 prior to 1997 and NAICS 541712 thereafter). This study is 
limited to the manufacturing firms in the industry, mainly because data for biological research is 
not separated from the total physical and biological research after 1997. According to the NAICS 
classification, the biopharmaceutical firms primarily engaged in one or more of the following 
activities: “(1) manufacturing biological and medicinal products; (2) processing (i.e., grading, 
grinding, and milling) botanical drugs and herbs; (3) isolating active medicinal principals from 
botanical drugs and herbs; and (4) manufacturing pharmaceutical products intended for internal 
                                                 
14 Some authors use similar SIC or NAICS codes to define the ‘biotechnology’ industry.  It corresponds to two SIC 
code: 283, and 8731. Or, it covers two 2002_NAICS codes: 3254-Pharmaceutical and medicine manufacturing; and 
54171-Scientific R&D services 
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and external consumption in such forms as ampoules, tablets, capsules, vials, ointments, 
powders, solutions, and suspensions”15. 
This section characterizes the US biopharmaceutical industry as an industry with a 
relatively small size, plenty of high-paid jobs, high barrier for entry, and skewed spatial 
distribution.   
 
4.1.1. Industry employment and earnings 
The biopharmaceutical industry defined in this study includes both traditional large 
pharmaceutical producers and new biotech start-ups. While the beginnings of the U.S. traditional 
pharmaceutical industry can be traced back to the 1820s (Ketelhohn, 2002), the modern 
biotechnology industry originated in the 1970s when the recombinant DNA technology was 
discovered by Stanford geneticist Stanley Cohen and University of California, San Francisco, 
biochemist Herbert Boyer (Zhang and Patel 2005).  
Despite its popularity in the economic development policy-maker community, the 
biopharmaceutical industry still remains relatively small. According to data from County 
Business Patterns, the Bureau of Census, the number of biopharmaceutical establishments was 
1836 in 2005 (Table 9). In the same year, its total number of employees was 247,847, only 
accounting for 0.2 percent of total national employment. As will be discussed in next chapter, the 
biopharmaceutical industry is one-sixth the size of the IT service industry in terms of 
employment.. 
Over the last decade, the biopharmaceutical industry experienced only a moderate growth 
in employment. From 1995 to 2005, the biopharmaceutical industry employment increased by 21 
percent, with an annual growth rate of 2%.  This growth rate is no faster than the growth in the 
                                                 
15 Source: http://www.census.gov/epcd/naics02/def/NDEF325.HTM#N3254. 
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national total employment. As a result, its share of total national employment was fairly stable 
over the last decade, with a range from 0.19 percent in 1999 to 0.22 in 2003. However, the 
biotechnology industry organization reports that biotech revenues grew from $12.7 billion in 
1995 to $50.7 billion in 2005, with an annual growth rate of nearly 30 percent16. Also, Hecker 
(2005) projected that there is extensive room for this industry to grow in the near future. His 
study estimates that the biopharmaceutical industry will add 68,000, or 23 percent new jobs from 
2002-12 (p.59). This is contrast to many High-Tech manufacturing industries in which 
employments are projected to decline substantially. 
The biopharmaceutical industry generates high-paid jobs. The average annual salary of 
U.S. biopharmaceutical workers was $87,818 in 2005, $47,000 greater than the national average 
annual salary.  Over the last decade, the ratio of industry to national average annual salary was 
consistently high, ranging from 1.9 in 1996 to 2.2 in 2005. Given its growth potential, the 
biopharmaceutical industry is likely to continue to be a key source of high-paid jobs in the 
future. 
Table 9: U.S. Biopharmaceutical Industry Statistics: 1995-2005 
Year Establishments Employment Share of total US 
employment 
(Percent) 
Annual 
average 
salary 
Ratio of industry 
to national annual 
average salary 
1995 1,529 204,851 0.204 51,610 1.82 
1996 1,637 207,295 0.203 54,959 1.90 
1997 1,704 212,610 0.202 59,921 1.94 
1998 1,812 217,111 0.201 64,781 2.03 
1999 1,830 218,804 0.198 69,100 2.06 
2000 1,823 227,461 0.199 75,250 2.13 
2001 1,825 233,503 0.203 72,394 2.00 
2002 1,779 237,905 0.212 73,162 1.99 
2003 1,825 251,855 0.222 78,036 2.07 
2004 1,833 246,297 0.214 82,055 2.09 
2005 1,836 247,847 0.213 87,818 2.16 
                                                 
16 The Biotechnology Industry Organization, http://www.bio.org/speeches/pubs/er/statistics.asp, accessed 
on 9/4/2007. 
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Source: (1) Data for employment were from the County Business Pattern, Bureau of the Census, 
Department of Commerce; (2) Data for average salary were from Quarterly Census of Employment and 
Salarys (QCEW), Bureau of Labor Statistics, Department of Labor. 
4.1.2. Industry structure 
The biotech industry is associated with a relatively concentrated size structure as 
compared to the national average. Table 10 reports that in 2005, firms with no more than 99 
employees accounted for 75.9 percent of total industry establishments. The percentage with 100-
499 employees was 18.2. Firms with 500 employees or more accounted for 5.4 percent. 
Compared to the national average level, the biopharmaceutical industry has higher proportion of 
large companies and lower proportion of small firms. Such a pattern has been fairly stable during 
the past decade. Because barriers to entry in the concentrated industries are typically higher than 
in the slightly concentrated industry, it is expected that it is more difficult for catch-up regions to 
catch up in the biopharmaceutical industry than in other lower concentration industries like IT 
service industry.   
Table 10: Share of Total Establishments by Firm Size Classes for Biopharmaceutical 
Industry and National Average: 1995-2005 
Firm with 1~99  
Employees  
Firm with  100~499 
employees 
Firm with  500 or more 
employees 
Year 
Biopharmaceutical National Biopharmaceutical National Biopharmaceutical National
1995 77.44 97.72 16.15 2.03 6.41 0.25 
1996 78.56 97.70 15.64 2.05 5.80 0.25 
1997 79.11 97.68 15.43 2.07 5.46 0.25 
1998 80.02 97.63 15.29 2.12 4.69 0.26 
1999 79.51 97.57 15.79 2.17 4.70 0.26 
2000 79.21 97.51 15.96 2.22 4.83 0.27 
2001 78.63 97.51 16.55 2.21 4.82 0.27 
2002 77.74 97.68 17.14 2.07 5.12 0.25 
2003 76.71 97.67 17.86 2.09 5.42 0.25 
2004 76.21 97.67 18.22 2.08 5.56 0.25 
2005 75.93 97.66 18.68 2.09 5.39 0.25 
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
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4.1.3. Spatial distribution 
The U.S. biopharmaceutical industry is highly geographically concentrated. The 
traditional pharmaceutical firms were concentrated in the east coast and in a few areas around 
Lake Michigan. For example, the New York/New Jersey area was the home base for a number of 
large pharmaceutical companies like Johnson & Johnson, Pfizer, Merck & Co, Bristol-Myers 
Co., Squibb and Sons, Wyeth, etc. The Abbott Laboratories was located in Chicago, Illinois, and 
Eli Lilly & Co. was in headquartered in Indianapolis, Indiana. All these traditional 
pharmaceutical companies were founded in the 1800s or the beginning of the 19th century. 
Beginning in the early 1970s, the industry was heavily affected by the biotechnology revolution, 
which is based on the recombinant DNA technology. This round of biotechnology revolution 
was led by small entrepreneurial firms that tended to locate near the academic centers that 
created the relevant knowledge and the source of venture capital (Galambos and Sturchio 1998, 
p.254). As a result, new industrial clusters were mainly formed in the East and the South 
(Ketelhohn, 2002).  
The present spatial distribution of U.S. biopharmaceutical industry reflects such a 
historical transformation. Appendix 2 presents the industry’s geographical distribution at the 
state level between 1995 and 2004. In 2004, 32 of the 51 states (including the District of 
Columbia) had 1000 or more employees in this industry, accounting for 97.6 percent of total 
biopharmaceutical employment. California had the largest share of 15.1 percent, followed by 
New Jersey and New York, with shares of 14.0 percent and 8.7 percent, respectively. Over the 
last decade, 28 states had higher shares in 2004 than in 1995, and 15 states had lower shares. 
However, the magnitude of increase or decrease is only moderate for most states. Florida had 
experienced the largest share increase from 1.6 percent in 1995 to 2.6 percent in 2004, gaining 
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3356 jobs. Illinois had the largest share drop from 9.2 percent to 7.7 percent, with a loss of 1.5 
share point, or equivalent to a job loss of 899. Moreover, nine of the ten largest states in terms of 
biopharmaceutical employment in 1995 continued to be ranked among top ten in 2004. Only 
Texas slid from the tenth in 1995 to the twelfth in 2004. The combined share of these ten states 
was 73.4 percent in 1995 and 71.8 percent in 2004.  
At the Metropolitan area level, 240 of 361 MSAs had the presence of biopharmaceutical 
establishments in 2004. However, only 50 MSAs have more than 1000 employees and 26 MSAs 
have a size between 500 and 1000. Table 11 lists the twenty largest Metropolitan Areas in terms 
of industry employment share in 2004. New York, Chicago, and Philadelphia are the top three 
metropolitan areas, with share of 20.6 percent, 7.1 percent, and 5.1 percent, respectively.  These 
three metropolitan areas accounted for 32.8 percent of total industry employment. They mainly 
represent the geographical locations of traditional pharmaceutical producers. It depicts a clearly 
defined biopharmaceutical corridor that starts in Philadelphia and ends in Boston. Four of ten 
largest metropolitan areas are in California:  San Francisco, Los Angeles, Oxnard, and San 
Diego.   
In terms of the changes in industry share from 1995 to 2004, 80 of the 168 metropolitan 
areas that have data available in 1995, 2000, and 2004 had higher shares in 2004 than in 1995, 67 
had lower shares, and 35 had the same portion of industry employment17. Boston-Cambridge-
Quincy (MA-NH) had experienced the largest share increase, followed by San Francisco-
Oakland-Fremont and Oxnard-Thousand Oaks-Ventura. All of these three metropolitan areas 
underwent increases of more than one share point, or equivalent of more than 3000 employees. 
In contrast, New York-Northern New Jersey-Long Island, Chicago-Naperville-Joliet, Rochester, 
                                                 
17 CBP data is not completely comparable over time. 
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NY, and San Jose-Sunnyvale-Santa Clara, CA had the largest share drop, ranging from -3.1 to -
1.1 share point. 
Table 11: Twenty Largest Biopharmaceutical Metropolitan Areas in 1995 and 2004 
Metropolitan Statistical Areas 2004 
Share 
2004 
Rank
2000 
Share  
2000 
Rank 
1995 
Share 
1995 
Rank
New York-Northern New Jersey-Long Island, NY-NJ-
PA 
20.58 1 21.61 1 23.67 1
Chicago-Naperville-Joliet, IL-IN-WI 7.68 2 8.17 2 9.44 2
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 5.11 3 4.60 4 4.30 4
San Francisco-Oakland-Fremont, CA 5.01 4 3.43 5 3.85 5
Los Angeles-Long Beach-Santa Ana, CA 4.83 5 5.85 3 5.53 3
Boston-Cambridge-Quincy, MA-NH 3.42 6 2.68 7 2.25 6
Oxnard-Thousand Oaks-Ventura, CA 2.93 7 2.33 8 1.83 13
Indianapolis, IN 2.44 8 3.30 6 1.83 11
San Diego-Carlsbad-San Marcos, CA 1.74 9 1.52 13 1.43 16
Miami-Fort Lauderdale-Miami Beach, FL 1.70 10 0.89 22 0.74 34
Kalamazoo-Portage, MI 1.53 11 1.71 9 1.91 9
Dallas-Fort Worth-Arlington, TX 1.46 12 1.44 15 2.06 8
Norwich-New London, CT 1.44 13 1.47 14 1.24 18
St. Louis, MO-IL 1.41 14 1.24 17 2.10 7
Baltimore-Towson, MD 1.33 15 1.12 18 1.38 17
Raleigh-Cary, NC 1.32 16 1.53 12 1.67 15
New Haven-Milford, CT 1.20 17 1.64 10 1.83 12
Kansas City, MO-KS 1.07 18 1.31 16 1.00 20
Tampa-St. Petersburg-Clearwater, FL 0.92 19 0.94 19 0.62 38
Bridgeport-Stamford-Norwalk, CT 0.91 20 0.76 28 0.85 23
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
As discussed in Chapter 3, this study defines a MSA as a ‘leading’ region if its high tech 
index value in 1995 was ranked 95th percentile or above. Such an approach results in 8 leading 
regions and 160 catch-up regions in the biopharmaceutical industry. Table 12 reports that in 
1995, the 160 catch-up MSAs accounted for 47.5 percent of total biopharmaceutical 
employment, 63.18 percent of total biopharmaceutical establishments, and 59.07 percent of small 
and medium biopharmaceutical establishments. From 1995 to 2000, the catch-up regions haven’t 
gained much share in all these three measures.  
 
Table 12: Share of Biopharmaceutical Industry for Leading and Catch-Up Regions,  
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in 1995 and 2000 
 
1995 2000   
Emp. 
Share  
Estab. 
Share  
SME Estab. 
Share 
Emp. 
Share  
Estab. 
Share  
SME Estab. 
Share  
Leading regions 52.48 36.82 40.93 49.73 34.83 40.87 
Catch-up regions 47.52 63.18 59.07 50.27 65.17% 59.13 
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
 
4.2. IPO and M&A Activities in the Biopharmaceutical Industry 
Of the 173 biopharmaceutical firms launched their IPO during the period from 1996 to 
2005, 149 had fewer than 500 employees and were less than 20-year old when they became 
public, and therefore meet our definition of NTBFs. Figure 4 shows the number of total and 
sample biopharmaceutical IPOs each year. It clearly depicts that the IPO market for the 
biopharmaceutical industry fluctuated over time. There were three relatively ‘hot’ periods which 
were associated with higher volume of issues and higher valuation by the public investors: 1996-
1997, 2000, and 2004-2005. The rest years were relative ‘cold’ markets in which only a few 
companies went public.  Overall, there were more IPOs in the first five years than in the second 
five years. Hence, when we analyze how the number of IPOs in a region varies over time, the 
industry-specific equity market condition should be controlled for.  
The SDC database doesn’t keep employment and operating history data for many M&A 
deals. This makes it very difficulty to judge whether the acquired firm is an NTBF or not. For 
those missing employment data, this analysis only counts privately-owned acquired firms. This is 
because in general, privately-owned firms are more likely to be a small and young NTBF than 
the publicly-traded firms. During the study period, there were 534 privately-held 
biopharmaceutical firms which were merged or acquired. 79 of them had no location 
information. The remaining 455 deals were treated as NTBF M&A events. Figure 4 shows the 
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number of missing cases is roughly proportional to the total number of acquisition activities each 
year. Therefore, it may not cause serious bias over time.  
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Figure 4: Number of Total and Sample Biopharmaceutical IPOs, 1996- 2005 
Source: Securities Data Company, New Issues Database; Hoover’s IPO list; Jay Ritter's 1975-2005 IPO 
dataset; and University of Chicago’s Center for Research in Security Prices database.  
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Figure 5: Number of Total and Sample Biopharmaceutical M&A, 1996- 2005 
             Source: Securities Data Company, New Issues Database. 
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The spatial distribution of the biopharmaceutical IPO and M&A events is highly skewed. 
Table 13 reports that 354, or 61.57 percent of total events occurred in the 8 leading MSAs. The 
catch-up regions, which comprise 160 MSAs, only had 221, or 38.43 percent. The share of IPO 
and M&A events for the catch-up regions is even lower than its share of industrial employment, 
which was 47.52 percent in 1995. The top five regions in terms of number of biopharmaceutical 
IPO and M&A events s are: New York-Northern New Jersey-Long Island (NY-NJ-PA), Boston-
Cambridge-Quincy (MA-NH), San Diego-Carlsbad-San Marcos(CA), San Francisco-Oakland-
Fremont (CA), and San Jose-Sunnyvale-Santa Clara (CA). These five regions in total had 290, or 
50.43 percent of total deals. 73 of 168 MSAs had one or more deals, and the remaining 95 MSAs 
had no deal at all. Among the 160 catch-up regions, only 65 MSAs had one or more deals. 
Washington-Arlington-Alexandria (DC-VA-MD-WV) was ranked first, with 26 deals. This is 
followed by Atlanta-Sandy Springs-Marietta (GA), Miami-Fort Lauderdale-Miami Beach (FL), 
and Seattle-Tacoma-Bellevue (WA), with 10 deals each. Figure 3 depicts the spatial distribution 
of biopharmaceutical IPO and M&A events in catch-up Regions. 
 
Table 13: Statistics of Biopharmaceutical IPO and M&A Events 
for the Leading and Catch-Up Regions 
  
 Sum Mean Max Min Std 
Leading regions 354 44.25 71 13 22.52 
Catch-up regions 221 1.38 26 0 3.00 
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Figure 6: Spatial Distribution of Biopharmaceutical IPO and M&A Events in Catch-Up 
Regions 
 
 
4.3. Determinants of Regional Variations in Biopharmaceutical NTBF 
performance 
4.3.1. Models 
Based on the research model and variable measures described in Chapter 3, this study 
employs both the cross-sectional and two-period panel ZINB models to identify the causal 
factors that affect the average biopharmaceutical NTBF performance in a catch-up region. The 
cross-section models predict the number of biopharmaceutical IPO and acquisition events that 
occurred in a region between 1996 and 2005 by a set of regional characteristics in 1995 or other 
years. These models are limited to 160 MSAs where the biopharmaceutical industry consistently 
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existed from 1995 to 2004 so that all the observations had the same exposure time to the events. 
The two-period panel data models predict the number of biopharmaceutical IPO and acquisition 
events that occurred in a region during two sub periods (1996-2000 and 2001-2005). The values 
for the predictor variables were updated every five years. The sample size for the panel data 
model is 320.  
The Breusch-Pagan / Cook-Weisberg heteroskedasticity test statistic is 631.18 (p<0.00) 
for the cross sectional model, and 1513.9 (p<0.00) for the two-period panel data, suggesting the 
presence of heteroskedasticity in the data. Therefore, this study only reports the robust estimation 
results. 
Table 14 and 15 report the descriptive statistics and table 16 and 17 presents the Pearson 
correlation coefficient matrix both for the cross-sectional and panel data. Some correlation 
coefficients are very large, indicating that multicollinearity might be a concern in the data. For 
example, Table 16 reports that in the cross-sectional dataset, the control variable, a region’s total 
job market size (emp_share), is strongly correlated with its life scientist job market size 
(job_share), with a correlation coefficient of 0.84. This control variable is also highly correlated 
with the number of small biopharmaceutical firms (SME_Biotech_lg), with a correlation 
coefficient of 0.68. In addition, the correlation coefficient between the absolute salary level of 
life scientists (Salary_log) and relative salary level (Relative_salary) is 0.72. In the panel data 
correlation matrix (Table 17), a region’s total job market size is also highly correlated with the 
life scientist job market size, with a correlation coefficient of 0.84. The full regression model 
specified in Chapter 3 includes all these highly correlated variables and therefore the 
‘multicollinearity’ becomes a concern. The presence of multicollinearity doesn’t affect the 
overall predictive power or the statistical significance of the model. However, it can increase the 
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standard errors of the regression coefficients and consequently underestimate their significant 
level.  
Two approaches are employed to address the potential multicollinearity problem. First, 
the control variable, a region’s total job market size, is excluded from the full model. This 
control variable is not only highly correlated with some independent variables, but also with 
another control variable (Ind_sme_log) that measures the size of industrial cluster in a region. 
Including the total job market size variable into the model might risk increasing the standard 
errors of its highly correlated variables, and consequently results in unreliable statistical 
inference. 
Second, besides the full model, three reduced models are constructed to distinguish the 
total effect of two life scientists salary level variables on firm performance from their direct 
effect (when hold the other variables constant). Specifically, Reduced model 1 only includes the 
absolute salary level variable (Absolute_salary ). Reduced model 2 only includes the relative 
salary level variable (Relative_salary). Reduced model 3 also only includes the relative salary 
variable, but it is based upon a smaller dataset in which 7 outlier regions were excluded. Regions 
with high absolute salary level are typically with a high relative salary level because they are 
highly correlated. However, in some cases, regions with low absolute salary level can also have 
high relative salary level because the denominator, the average salary level for all occupational 
jobs are very low. The presence of such outlier regions may completely distort the causal 
relationship between the life scientist relatively salary ratio and firm performance. To identify 
these outlier regions, I calculate the percentile ranks based upon the absolute and relative salary 
level of local life scientists, respectively. Seven regions were defined as the outliers because the 
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difference in the percentile ranks for these regions is over 60. See appendix 3 for the results of 
these three reduced models. 
All the model specifications use the same set of ‘inflate’ variables that predict the 
probability of being in the ‘always-0-group’ for a region. Because there are no solid theoretical 
arguments that point out the most significant variables for predicting the group membership, all 
the independent and control variables except their squared terms are used as the predictors. 
However, the algorithm for ZINB didn’t converge to a solution until two control variables: 
number of small biopharmaceutical establishments and establishment density were dropped. 
Chapter 5 will discuss a similar problem when the ZINB full model is applied to the IT service 
industry data. This suggests one drawback of using a complicated model specification.  
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Table 14: Descriptive Statistics for Biopharmaceutical Cross-Sectional Variables 
(N = 160) 
 
Variable Mean Std Dev Minimum Maximum 
IPO_Target 1.38 3.00 0.00 26.00 
Job_share 0.26 0.39 0.01 2.10 
Absolute_salary 0.99 0.13 0.57 1.27 
Relative_salary 1.19 0.13 0.85 1.57 
VC_firm 0.44 1.19 0.00 7.00 
VC_firm _sq 1.59 6.09 0.00 49.00 
Immi_share 4.68 4.31 0.49 24.69 
Univ_share 0.35 0.62 0.00 3.74 
Ind_lq 1.20 2.45 0.01 16.32 
Buyer_lq 0.03 0.02 0.00 0.12 
Supplier_lq 1.38 2.00 0.00 19.91 
Firm_Birth_Rate 12.04 2.08 7.84 18.80 
Ind_SME 4.74 5.50 0.00 31.00 
Ind_SME _sq 52.59 134.27 0.00 961.00 
Est_density 0.00 0.00 0.00 0.02 
Emp_share 0.45 0.55 0.05 3.00 
 
 
Table 15: Descriptive Statistics for Biopharmaceutical Panel Data Variables 
(N =320) 
 
Variable Mean Std Dev Minimum Maximum 
IPO_Target 0.69 1.75 0.00 19.00 
Job_share 0.29 0.41 0.01 2.58 
Absolute_salary 0.99 0.13 0.57 1.41 
Relative_Salary 1.25 0.15 0.85 1.88 
VC_firm 0.49 1.23 0.00 7.00 
VC_firm _sq 1.75 6.57 0.00 49.00 
Immi_share 5.84 5.04 0.49 31.21 
Univ_share 0.34 0.63 0.00 4.14 
Ind_lq 1.23 2.38 0.01 16.32 
Buyer_lq 0.41 0.46 0.00 4.20 
Supplier_lq 1.17 2.21 0.00 26.07 
Firm_Birth_Rate 1.17 2.10 7.80 21.30 
Ind_SME 5.17 6.18 0.00 37.00 
Ind_SME_sq 64.81 168.61 0.00 1369.00 
Est_density 0.00 0.00 0.00 0.04 
Emp_share 0.45 0.55 0.05 3.02 
Year_dummy 0.50 0.05 0.00 1.00 
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Table 16: Correlation Coefficient Matrix for the Biopharmaceutical Cross-Sectional Data 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 
(1) IPO_Target 1.00              
               
(2) Job_share 0.72 1.00             
 <.0001              
(3) Absolute_salary 0.32 0.30 1.00            
 <.0001 0.00             
(4) Relative_salary 0.05 0.05 0.72 1.00           
 0.50 0.56 <.0001            
(5) VC_firm 0.59 0.66 0.30 0.07 1.00          
 <.0001 <.0001 <.0001 0.38           
(6) Immi_share 0.23 0.16 0.31 0.10 0.04 1.00         
 0.00 0.04 <.0001 0.23 0.65          
(7) Univ_share 0.54 0.57 0.23 0.05 0.68 0.08 1.00        
 <.0001 <.0001 0.00 0.49 <.0001 0.31         
(8) Ind_lq -0.07 -0.12 -0.01 0.01 -0.07 -0.12 -0.07 1.00       
 0.39 0.15 0.93 0.89 0.39 0.13 0.40        
(9) Buyer_lq 0.05 0.04 0.13 0.06 0.07 0.07 0.09 -0.05 1.00      
 0.56 0.65 0.10 0.45 0.36 0.39 0.25 0.51       
(10) Supplier_lq -0.02 -0.01 0.09 0.05 0.03 0.08 0.09 -0.06 -0.02 1.00     
 0.76 0.88 0.25 0.49 0.72 0.33 0.27 0.46 0.82      
(11) Firm_Birth_Rate 0.24 0.18 -0.04 0.06 0.14 0.24 0.11 -0.17 -0.08 -0.05 1.00    
 0.00 0.02 0.61 0.48 0.08 0.00 0.17 0.03 0.33 0.51     
(12) Ind_ SME 0.54 0.72 0.22 -0.04 0.53 0.21 0.48 -0.05 0.05 -0.02 0.24 1.00   
 <.0001 <.0001 0.01 0.65 <.0001 0.01 <.0001 0.51 0.53 0.82 0.00    
(13) Est_density 0.27 0.22 0.25 -0.05 0.17 0.11 0.17 0.25 0.18 0.04 -0.13 0.37 1.00  
 0.00 0.00 0.00 0.52 0.03 0.17 0.03 0.00 0.02 0.60 0.09 <.0001   
(14) Employment 0.72 0.84 0.28 -0.01 0.58 0.23 0.52 -0.17 0.08 -0.06 0.19 0.77 0.13 1.00 
 <.0001 <.0001 0.00 0.90 <.0001 0.00 <.0001 0.03 0.32 0.44 0.01 <.0001 0.09
Note: a. The square terms are not included in order to save space; b. the first contains the correlation coefficient, and the p-values are in the second row 
         b. Number of observations: 160 
.  
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Table 17: Correlation Coefficient Matrix for the Biopharmaceutical Panel Data 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14)  
(1) IPO_Target 1.00              
               
(2) Job_share 0.67 1.00             
 <.0001              
(3) Absolute_salary 0.34 0.42 1.00            
 <.0001 <.0001             
(4) Relative_salary 0.05 0.11 0.58 1.00           
 0.36 0.05 <.0001            
(5) VC_firm 0.57 0.70 0.37 0.08 1.00          
 <.0001 <.0001 <.0001 0.15           
(6) Immi_share 0.26 0.22 0.29 0.12 0.10 1.00         
 <.0001 <.0001 <.0001 0.04 0.08          
(7) Univ_share 0.45 0.58 0.29 0.05 0.65 0.10 1.00        
 <.0001 <.0001 <.0001 0.37 <.0001 0.08         
(8) Ind_lq -0.06 -0.12 -0.05 -0.02 -0.08 -0.11 -0.08 1.00       
 0.25 0.03 0.39 0.72 0.15 0.06 0.17        
(9) Buyer_lq -0.02 0.00 -0.06 0.33 -0.03 0.07 -0.02 -0.01 1.00      
 0.72 0.96 0.30 <.0001 0.57 0.22 0.66 0.89       
(10) Supplier_lq -0.04 -0.04 0.13 0.06 0.00 0.02 0.06 -0.03 -0.12 1.00     
 0.51 0.44 0.02 0.28 0.97 0.72 0.30 0.58 0.03      
(11)Firm_Birth_Rate 0.20 0.16 0.07 0.01 0.15 0.30 0.10 -0.16 -0.21 -0.05 1.00    
 0.00 0.00 0.23 0.92 0.01 <.0001 0.09 0.00 0.00 0.39     
(12) Ind_ SME 0.56 0.75 0.36 0.07 0.60 0.29 0.48 -0.06 -0.06 -0.03 0.25 1.00   
 <.0001 <.0001 <.0001 0.18 <.0001 <.0001 <.0001 0.27 0.32 0.59 <.0001    
(13) Est_density 0.30 0.19 0.25 -0.04 0.12 0.15 0.13 0.19 0.00 0.01 -0.08 0.33 1.00  
 <.0001 0.00 <.0001 0.47 0.03 0.01 0.02 0.00 0.96 0.84 0.18 <.0001   
(14) Employment 0.62 0.84 0.38 0.06 0.64 0.27 0.52 -0.18 -0.09 -0.07 0.20 0.79 0.11 1.00 
 <.0001 <.0001 <.0001 0.31 <.0001 <.0001 <.0001 0.00 0.11 0.23 0.00 <.0001 0.06
Note: a. The square terms are not included in order to save space; b. the first contains the correlation coefficient, and the p-values are in the second row 
b. Number of observations: 320 
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4.3.2 Results 
This section presents the results for the empirical estimation of the effects of regional 
characteristics on the average biopharmaceutical NTBF performance in a region, measured by 
the number of IPO and M&A events. I first report the estimation results from the cross-sectional 
models. The temporal stability test findings based upon two-period panel data models are 
followed. Finally, I present the robustness check results which are based upon distance-weighted 
dataset.  
(1) Cross-sectional models 
Table 18 presents the coefficient estimates of the cross-sectional zero-inflated negative 
models both for catch-up regions and all the regions.  In each model, the top set of coefficients 
corresponds to the NBRM for those in the ‘Not- Always-0-Group’. The lower set of coefficients, 
labeled ‘inflate’, corresponds to the binary logistic model predicting membership in the group 
that always has zero counts. Table 18 also reports the results of alpha and Vuong test in the end. 
The alpha test in each model is larger than 1.96, which provides strong evidence of 
overdispersion. In the presence of overdispersion, “estimates from the Poisson Regress Model 
are inefficient with standard errors that are biased downward, even if the model includes the 
correct variables” (Long & Freese, 1997, p.246). Therefore, the negative binomial regression 
model is preferred to the Poisson regression model in this data. The Vuong test compares the 
zero-inflated regression model specification with the standard negative binomial regression 
model. The Vuong test statistic in each model is larger than 1.96, indicating that the zero-inflated 
regression model specification is favored in this data.  
The size of local life scientist job market is found to have a significant and positive 
impact on the number of biopharmaceutical IPO and M&A events that occurred in a catch-up 
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region which belongs to the ‘not-always-0-group’. The estimated coefficient of this variable is 
0.493 (p <0.1), suggesting that for one unit (i.e. one percentage point) change in an MSA’s life 
scientist job market share, the expected count of biopharmaceutical IPO and M&A events 
changes by a factor of exp(0.493), or 1.64, holding all other variables constant. This finding 
indicates that in catch-up regions, the clustering of life scientist occupational jobs plays a 
significant role in fostering the growth of local biopharmaceutical NTBFs. When the leading 
regions are included into the sample, this variable has a smaller and positive coefficient (0.223), 
but its significance diminished. In terms of predicting the odds of being the ‘always-0-group’, the 
variable is negative and insignificant for catch-up regions, but negative and significant (p<0.1) in 
the full sample model.  Therefore, the results provide some evidence that the local scientist job 
market size in a catch-up or leading region has positive impact on biopharmaceutical NTBF 
performance.  
There is little evidence that local life scientist salary level has significant impacts on 
NTBF performance in catch-up regions. The life scientist absolute salary rate, which is measured 
by the ratio of local average salary rate to the national average rate, has positive but insignificant 
impacts on the rate of IPO and M&A events. The relative salary ratio, which is calculated by 
dividing the average salary of ‘life scientists’ jobs in a region by the average salary of all 
occupational jobs in that region, has negative and insignificant impact. Table 3.1 in Appendix 3 
reports the results of three reduced models defined in the above section. Neither variable is 
statistically significant even in the reduced model. Therefore, multicolinearity is not the cause for 
the insignificance of these two variables.  However, in the full sample model which consists of 
both the leading and catch-up regions, both variables are statistically significant, with a 
significant level of 0.01 and 0.1 respectively. In addition, in the full model, the absolute salary 
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rate variable is negative and significant (p<0.1) in terms of predicting the odds of ‘always-being- 
0”.  Therefore, the results indicate that life scientist salary level matters more in leading regions 
than in catch-up regions. In other words, it suggests that one advantage of the leading regions is 
that they can provide nationally competitive high-paid jobs for talented life scientists and 
technicians.   
Proximity to biotech venture capital firms is found to have non-linear but insignificant 
effect on the rate of expected biopharmaceutical IPO and M&A events both in the catch-up 
region and full sample models. The number of biotech VC firm has a positive coefficient, and its 
squared term has a negative coefficient. Both variables are statistically insignificant. However, in 
terms of predicting the odds of being the ‘always-0-group’, the venture capital is negative and 
highly significant (P<0.01) both for the catch-up and full sample models. This suggests that the 
presence of additional biotech VC firms will reduce the odds of not having biopharmaceutical 
IPO and M&A events. Therefore, the results provide some evidence that is consistent with 
previous studies. For example, Shane and Stuart (2002) have shown that linkages with venture 
capitalists were more likely to lead to success, especially as it related to reaching an IPO stage. 
 Cultural diversity has positive but insignificant impact on the performance of NTBF 
performance. The coefficient of foreign born population share is positive and insignificant for 
catch-up regions, and negative and insignificant in the full sample model. Furthermore, in 
predicting the likelihood of having zero IPO and M&A event, this variable has a positive sign, 
even though it is not statistically significant. This indicates that in the sample, regions that have 
high proportion of foreign-born immigrants are more likely to experience zero IPO and M&A 
events in the biopharmaceutical industry. Therefore, the results provide little evidence supporting 
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Florida’s (2002) argument that diverse place are more attractive to creative people and therefore 
have better NTBF performance than regions that have higher barriers for immigrants.   
The results provide little evidence of the direct and significant impact of academic life 
science research on the performance of local small biopharmaceutical firms. The estimated 
coefficient of life science academic research and development expenditure is positive but 
insignificant both in the catch-up and full sample models. In terms of predicting the odds of 
having no biopharmaceutical IPO and M&A events, the variable is negative but insignificant. 
There are two possible explanations for the insignificance of academic research. The first 
explanation, which here we don’t have data to prove, is that academic scientists tend to 
collaborate more frequently with large biopharmaceutical firms than with the smaller ones. 
Another explanation is that there are few high-quality universities or research institutes in the 
catch-up regions. 
The coefficients of three industrial structures variables are not statistically significant. 
The concentration of biopharmaceutical industry and the concentration of its supplier industries 
have negative and insignificant coefficients in two models. The concentration of buyer industries 
is positive but insignificant. As ‘Inflation’ variables, they are also insignificant. This finding 
suggest that the extent of industrial specialization in a region is not a determinant factor of the 
rate of biopharmaceutical IPO and M&A events, nor the likelihood of being ‘always-zero-
group’.  
The findings provide strong evidence that the overall entrepreneurial climate in a region 
has significant and positive impacts on the performance of biopharmaceutical NTBFs. The local 
entrepreneurial climate, measured by the small firm birth rate, is positive and statistically 
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significant at 0.1 level. The model predicts that for one percentage point change in the firm birth 
rate, the expected count will change by a factor of exp (0.12), or 1.13.  
The three control variables, which are used to measure the characteristics of local 
industrial clusters, are insignificant in the catch-up model. However, in the full sample model, 
the number of small biopharmaceutical firms is positive and significant at 0.05 level. Its squared 
term is negative and highly significant (p<0.01). This result suggests that the size of industrial 
cluster has positive but non-linear effect on NTBF performance. The model predicts when the 
size of impact on industrial clusters on firm performance reaches the maximum when there are 
about 68 small biopharmaceutical firms. This finding is consists with Folta et al (2006). They 
found that in the US biotech industry, the diseconomies of agglomeration dominate the economic 
benefits of agglomeration when clusters exceed about 65 firms.  
 
 
 73
Table 18: Results of Cross-Sectional ZINB Models of Biopharmaceutical IPO and M&A 
Events between 1996 and 2005  
 
Independent variables Catch-up regions (N=160)  
Leading and catch-up 
regions (N=168) 
Life scientists job market share 0.493*  0.223 
 (0.294)  (0.222) 
Life scientists absolute salary ratio 3.179  4.936*** 
 (2.324)  (1.780) 
Life scientists relative salary ratio -2.824  -3.805* 
 (3.064)  (2.202) 
Number of biotech VC firms 0.283  0.019 
 (0.227)  (0.088) 
-0.044  -0.000 Square of number of biotech VC firms 
(0.047)  (0.002) 
Foreign born population share 0.039  -0.002 
 (0.058)  (0.022) 
0.155  0.247 Life science academic research share 
(0.371)  (0.154) 
-0.007  -0.005 Biopharmaceutical industry location 
quotient (0.062)  (0.052) 
Buyer- industry location quotient 3.007  2.499 
 (6.009)  (4.296) 
Supplier- industry location quotient -0.059  -0.063 
 (0.090)  (0.065) 
Small firm birth rate  0.123*  0.181*** 
 (0.072)  (0.053) 
0.123  0.044** Number of small biopharmaceutical firms 
(0.105)  (0.022) 
-0.004  -0.000*** Square of number of small 
biopharmaceutical firms (0.003)  (0.000) 
48.462  20.277 Number of small biopharmaceutical firms 
per square mile (34.200)  (35.340) 
Constant -2.240  -2.772* 
 (1.828)  (1.502) 
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Table 18 (continued)  
 
Inflation variables Catch-up regions (N=160)  
Leading and catch-up regions 
(N=168) 
Life scientists job market share -5.758  -7.020* 
 (3.683)  (3.860) 
Life scientists absolute salary -19.551  -15.851* 
 (19.555)  (9.184) 
Life scientists relative salary 6.660  6.077 
 (10.948)  (7.219) 
Number of biotech VC firms -15.633***  -19.322*** 
 (4.676)  (2.582) 
Foreign born population share 0.349  0.260 
 (0.361)  (0.201) 
-4.126  -3.160 Life Science academic research share 
(11.058)  (4.078) 
-0.026  -0.067 Biopharmaceutical industry location 
quotient (0.308)  (0.130) 
Buyer- industry location quotient -2.383  -2.913 
 (32.234)  (21.158) 
Supplier- industry location quotient -0.426  -0.489 
 (0.399)  (0.394) 
Small firm birth rate  -0.301  -0.274 
 (0.247)  (0.186) 
Constant 15.207  12.760 
 (25.569)  (11.356) 
    
Log likelihood -155.958  -208.024 
Overdispersion test 
(alpha =0) 
12.25  123.84 
Vuong test  
(ZINB vs. NBRM) 
4.45  2.50 
Number of nonzero observations 65  73 
Number of zero observations 95  95 
 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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 (2) Two-period panel data models 
Table 19 reports the coefficient estimates of two-period panel zero-inflated negative 
models both for catch-up regions and the full sample. In both models, the time fixed effect is 
controlled for by using one dummy variable, which equals 0 for the period from 1996 to 2000, 
and 1 for the period from 2001 to 2005. The MSA-level regional fixed effects are not controlled 
for in these models due to the limited number of observations. The state-level variables are not 
appropriate either because some MSAs are cross several states. Table 19 also reports the results 
of overdispersion and Vuong tests. Each statistic value is larger than 1.96, indicating that the 
NBRM is preferred to PRM, and ZINB is preferred to NBRM in this data. 
The two-period panel results for the majority of predictors are qualitatively similar to the 
findings in the cross-sectional models, indicating the temporal stability of the causal patterns 
discussed in the previous section.  In particular, life scientist job market size and small firm birth 
rate, which are the only two statistically significant variables in the cross-sectional model, now 
have bigger coefficients and higher significant level. In terms of predicting effects on the rate of 
biopharmaceutical NTBF IPO and M&A events, the coefficient of local life scientist job market 
size has been increased from 0.493 to 0.854, and its significant level has changed from 0.1 to 
0.05. Similarly, the coefficient of small firm birth rate has been increased from 0.123 to 0.161, 
and its significant level has changed from 0.1 to 0.05. Therefore, the two-period panel data 
provides further evidence that local life scientist job market size and entrepreneurial climate are 
the two key determinants of biopharmaceutical NTBF performance in catch-up regions.  
The coefficients for other independent variables are not statistically significant, but most 
of them keep the same sign as in the cross-sectional model. For example, the following variables 
are found to have positive impacts on the rate of biopharmaceutical IPO and M&A events in the 
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sample catch-up regions: life scientist absolute salary ratio, cultural diversity, life science 
academic research. The impact of relative salary ratio and biopharmaceutical industry 
specialization is negative. Proximity to biotech venture capital firms has positive but non-linear 
effects. Only the sign of buyer- and supplier-industry location quotient has been flipped over. 
The control variable, number of small biopharmaceutical firms per square mile, is found 
to be positive and significant (p<00.05), suggesting that local industrial cluster density has 
positive impact on NTBF performance, holding other variables constant.   
The time fixed effect is positive and significant (p<0.1) in both the catch-up and full 
sample models. This result is consistent with the evidence that overall, the second 5-year-period 
(2001-2005) has more biopharmaceutical IPO and M&A events than in the first 5-year-period 
(1996-2000). 
In terms of predicting the odds of ‘being-always-0-group’, the absolute salary ratio of 
local life scientists is found to be negative and significant (p<0.1). The result suggests that 
regions with higher absolute salary level of life scientists are less likely to experience have zero 
number of IPO and M&A events. 
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Table 19: Results of Two-Period Panel ZINB Models of Biopharmaceutical IPO and M&A 
Events between 1996 and 2005  
Independent variables Catch-up regions (N=320)  
Leading and catch-up 
regions (N=336) 
Life scientists job market share 0.854**  0.220 
 (0.360)  (0.148) 
Life scientists absolute salary ratio 1.068  1.760 
 (2.613)  (1.252) 
Life scientists relative salary ratio -2.698  -0.791 
 (1.732)  (1.810) 
Number of biotech VC firms 0.284  0.063 
 (0.316)  (0.043) 
-0.040  -0.001 Square of number of biotech VC firms 
(0.051)  (0.001) 
Foreign born population share 0.006  -0.011 
 (0.024)  (0.018) 
0.073  0.102 Life Science Academic research share 
(0.192)  (0.157) 
-0.019  -0.087 Biopharmaceutical industry location 
quotient (0.091)  (0.090) 
Buyer- industry location quotient -0.502  -0.677 
 (1.568)  (0.538) 
Supplier- industry location quotient 0.018  0.058 
 (0.110)  (0.081) 
Small firm birth rate  0.161**  0.175*** 
 (0.072)  (0.065) 
0.084  0.022 Number of small biopharmaceutical firms 
(0.090)  (0.018) 
-0.002  -0.000 Square of number of small 
biopharmaceutical firms (0.002)  (0.000) 
52.747**  46.521*** Number of small biopharmaceutical firms 
per square mile (23.615)  (15.482) 
Time fixed effect 1.079*  0.894* 
 (0.654)  (0.511) 
Constant -1.464  -3.437** 
 (2.578)  (1.417) 
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Table 19 (continued)  
 
Inflation variables Catch-up regions  
Leading and catch-up 
regions  
Life scientists job market share -2.389  -3.527*** 
 (1.853)  (1.253) 
Life scientists absolute salary -24.003*  -10.746*** 
 (12.442)  (4.058) 
Life scientists relative salary 2.687  6.746* 
 (18.884)  (4.054) 
Number of biotech VC firms -3.881  -1.353 
 (5.553)  (1.218) 
Foreign born population share 0.060  0.046 
 (0.257)  (0.063) 
-10.815  -2.321 Life Science academic research share 
(18.632)  (2.200) 
0.140  -0.080 Biopharmaceutical industry location quotient
(0.630)  (0.152) 
Buyer- industry location quotient 0.402  -1.326 
 (9.153)  (1.293) 
Supplier- industry location quotient 0.580  0.160 
 (1.132)  (0.205) 
Small firm birth rate  0.170  -0.056 
 (0.884)  (0.175) 
Constant 17.967**  4.830 
 (9.067)  (4.095) 
    
Log likelihood -226.414  -302.885 
Overdispersion test 
(alpha =0) 
9.92  124.76 
Vuong test  
(ZINB vs. NBRM) 
2.39  3.06 
Number of nonzero observations 89  105 
Number of zero observations 231  231 
 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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(3) Distance-weighted results 
This study replicates the cross-sectional and two-period models to a set of distance-
weighted variables. The following variables are recalculated using the method defined in Chapter 
3: life scientist job market share, number of biotech VC firms and its squared term, foreign born 
population share, life science academic research, number of small biopharmaceutical firms, and 
its squared term. These variables are likely to have impacts on the neighboring metropolitan 
areas. Table 20 presents the results. Again, the overdispersion and Vuong test statistics in each 
model are larger than 1.96, indicating that the ZINB specification is still the best choice.  
The distance-weighted models provide further evidence of the significance of local 
entrepreneurial climate, measured by the small firm birth rate. In the cross-sectional model for 
catch-up regions, the small firm birth rate variable is the only significant (p<0.05) predictor of 
the expected event count. In the two-period panel model, this variable is more significant 
(p<0.01), and its coefficient has been increased from 0.14 to 0.18. This variable is also positive 
and highly significant (p<0.01) in the full sample models. Therefore, the result shows that local 
entrepreneurship is a key determinant of biopharmaceutical NTBF performance both in catch-up 
and leading regions. 
The cross-sectional and panel models for catch-up regions also provide evidence 
supporting the following causal relationships: (1) the job market size of life scientist has positive 
and significant impact (p<0.05) on biopharmaceutical NTBF performance in a catch-up region; 
(2) the impact of relative salary level is negative and significant (p<0.1); (3) proximity to biotech 
venture capital firms and local life scientist absolute salary ratio decrease the odds of having zero 
IPO and M&A events; and (4) the industrial cluster density has positive and significant (p<0.05) 
impact over time.   
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When the leading regions are added to the dataset, more variables become significant. 
For example, in the cross-sectional model, life scientist absolute salary ratio has positive and 
highly significant (p<0.01) impact on the rate of events. The coefficient of relative salary ratio is 
negative and significant at 0.1 level. More interesting, life science academic research is positive 
and significant (p<0.1). This finding suggests that the impact of life science academic research 
on biopharmaceutical NTBF performance is significant only after we take into account the 
evidence of leading regions, and the impact from both the focal metropolitan area and it 
neighboring regions. 
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Table 20: Distance-Weighted Results of ZINB Models of Biopharmaceutical  
IPO and M&A Events between 1996 and 2005  
 
 Catch-up regions 
 
 Leading and  
catch-up regions  
Independent variables Cross- Sectional Panel   
Cross- 
Sectional Panel 
 (N=160) (N=320)  (N=168) (N=316) 
Life scientists job market share 0.255 0.547**  0.118 0.108 
 (0.220) (0.252)  (0.165) (0.106) 
Life scientists absolute salary ratio 2.936 0.790  4.817*** 1.758 
 (1.999) (2.435)  (1.656) (1.170) 
Life scientists relative salary ratio -2.573 -2.612*  -3.580* -0.569 
 (3.855) (1.502)  (2.151) (1.617) 
Number of biotech VC firms 0.211 0.219  -0.004 0.033 
 (0.179) (0.209)  (0.071) (0.033) 
-0.033 -0.030  0.000 -0.000 Square of number of biotech VC firm 
(0.047) (0.035)  (0.002) (0.001) 
Foreign born population share 0.042 0.009  0.009 -0.002 
 (0.086) (0.021)  (0.017) (0.014) 
0.141 0.075  0.210* 0.097 Life Science academic research share 
(0.399) (0.132)  (0.110) (0.109) 
-0.025 -0.034  -0.016 -0.095 Biopharmaceutical industry location 
quotient (0.095) (0.099)  (0.052) (0.089) 
Buyer- industry location quotient 1.607 -0.459  1.526 -0.646 
 (12.692) (1.208)  (4.338) (0.535) 
Supplier- industry location quotient -0.058 0.028  -0.060 0.072 
 (0.067) (0.093)  (0.059) (0.076) 
Small firm birth rate  0.142** 0.181***  0.191*** 0.183*** 
 (0.069) (0.064)  (0.055) (0.064) 
0.103 0.069  0.036** 0.021 Number of small biopharmaceutical 
firms (0.110) (0.061)  (0.017) (0.013) 
-0.003 -0.002  -0.000*** -0.000** Square of number of small 
biopharmaceutical firms (0.002) (0.001)  (0.000) (0.000) 
40.872 48.172*  12.875 31.303***Number of small biopharmaceutical 
firms per square mile (37.733) (25.291)  (24.902) (10.648) 
Time fixed effect  1.054*   0.856* 
  (0.559)   (0.491) 
Constant -2.475 -1.566  -3.044* -3.861*** 
 (2.948) (2.376)  (1.570) (1.449) 
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Table 20 (continued)  
 
 Catch-up regions  Leading and catch-up 
regions dataset 
Inflation variables Cross- 
Sectional 
Model 
Panel 
Model  
 Cross- 
Sectional 
Model 
Panel  
Model  
Life scientists job market share -4.666 -1.935  -4.955** -2.789*** 
 (3.279) (1.248)  (1.971) (0.961) 
Life scientists absolute salary ratio -22.029 -23.794**  -18.548* -10.830*** 
 (34.415) (11.645)  (11.268) (4.042) 
Life scientists relative salary ratio 8.608 2.803  7.793 7.076* 
 (8.280) (11.717)  (6.994) (3.790) 
Number of biotech VC firms -12.367** -3.084  -18.594*** -1.092 
 (5.017) (2.846)  (1.907) (0.826) 
Foreign born population share 0.329 0.047  0.266 0.044 
 (0.474) (0.152)  (0.191) (0.049) 
-2.844 -7.792  -2.480 -1.742 Life science academic research share 
(7.891) (8.020)  (2.527) (1.449) 
-0.072 0.146  -0.079 -0.078 Biopharmaceutical industry location 
quotient (0.443) (0.492)  (0.142) (0.152) 
Buyer- industry location quotient -3.325 0.503  -5.321 -1.317 
 (49.099) (5.953)  (23.218) (1.186) 
Supplier- industry location quotient -0.483 0.586  -0.495 0.168 
 (0.355) (0.719)  (0.377) (0.193) 
Small firm birth rate  -0.343 0.164  -0.306 -0.067 
 (0.324) (0.569)  (0.198) (0.169) 
15.750 17.673**  13.492 4.565 Constant 
 (36.501) (8.458)  (12.514) (3.922) 
      
Log likelihood -160.483 -228.653  -208.131 -303.645 
Overdispersion test (alpha =0) 9.58  10.05   127.88 134.03 
Vuong test (ZINB vs.NBRM) 4.33 2.44  2.59 2.41 
Number of nonzero observations 65 89  73 101 
Number of zero observations 95 231  95 231 
 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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4.4. Summary 
In this chapter, I find that the US biopharmaceutical industry has a relatively small size, 
plenty of high-paid jobs, high barrier for entry, and skewed spatial distribution. Over the last 
decade, there were a limited number of IPO and M&A events occurred in the biopharmaceutical 
industry, and most of them were concentrated in the leading regions.  
The major findings from the regression analysis of the spatial distribution of 
biopharmaceutical IPO and M&A events are: first of all, there is strong evidence that local 
entrepreneurial climate is a key determinant of biopharmaceutical NTBF performance. This 
variable is consistently positive and significant in all model specifications. It is a key factor both 
for catch-up regions and leading regions; second, the impact of local life scientist job market size 
matters more in catch-up regions than in leading regions. In contrast, the salary ratio variables 
are more significant in leading regions than in catch-up regions; third, there is some evidence of 
the positive impact of proximity to VC firms on NTBF performance; fourth, there is little 
evidence of the significant impact of cultural diversity, academic research, industrial 
specialization, and coaggolomeration with buyer- or supplier- industries on NTBF performance; 
and finally, the adverse impact of proximity to too many biopharmaceutical firms is apparent in 
leading regions. .  
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CHAPTER 5: IT SERVICE INDUSTRY 
 
This chapter analyzes the regional variations in the performance of Information 
Technology (IT) service NTBFs during the period from 1996 to 2005. The basic industry 
characteristics are discussed in Section 5.1. Section 5.2 describes the spatial distribution of 
NTBF IPO and acquisition activities in the industry. Section 5.3 uses a set of regression models 
to explore the determinant factors of the average NTBF performance in a region. Section 4 
summarizes the main findings.  
 
5.1. The IT Service Industry 
In this study, the IT Service industry is defined by SIC 737 prior to 1997 and NAICS 
5112 and 5415 thereafter. The IT service firms primarily engaged in Software Publishing, 
Computer Systems Design, Data Processing, and Other Computer Related Services18. 
 
5.1.1. Industry employment and earnings 
The IT service industry is much larger than the biopharmaceutical industry in terms of 
employment (Table 21). The County Business Patterns data reveals that in 2005, the IT service 
industry had more than 1.5 million employees, accounting for 1.25 percent of total US 
employment. As reported in the previous chapter, the biopharmaceutical industry only had 
247,847 employees in 2005, which is one sixth of the size of IT service industry.  
From 1995 to 2005, the IT service industry employment increased by more than 30 
percent, a gain of 342,004 new jobs. The industry reached its peak in 2001, when it employed 
more than 1.6 million employees, or with a share of national total employment of 1.4 percent. 
                                                 
18 Source: Census Bureau, http://www.census.gov/epcd/naics02/def/NDEF325.HTM#N3254. 
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The burst of the Internet bubble in 2001 adversely affected the growth of the industry. Since 
2002, the industry has grown no faster than the national average, and consequently its share of 
national employment has basically stagnated at 1.25 percent.  In terms of the future growth, 
Hecker (2005) projected that the IT service industry will continue to grow and will add more 
than 50 percent new jobs from 2002-12 (p.59). This is in contrast to many high tech 
manufacturing industries in which employments are projected to decline. 
Similar to the biopharmaceutical industry, the IT service industry provides high-paid 
jobs. The annual average salary in the IT service industry was at least twice the national annual 
average for all the years from 1995 to 2005. In 1999, it was even 3 times as high. Given its 
growth potential and high-paid jobs, the IT service industry is likely to continue to be a key 
source of economic growth for many regional economies. 
Table 21: U.S. IT Service Industry Statistics: 1995-2005 
Year Employment Share of total US 
employment (Percent)
Annual 
average salary
Ratio of industry to 
national annual average 
salary 
1995 1,117,475 1.11 58,087 2.05 
1996 1,266,890 1.24 62,707 2.16 
1997 1,456,693 1.38 69,748 2.26 
1998 1,156,452 1.07 81,197 2.54 
1999 1,317,712 1.19 100,419 3.00 
2000 1,502,721 1.32 95,012 2.69 
2001 1,608,149 1.40 89,826 2.48 
2002 1,401,599 1.25 86,497 2.35 
2003 1,403,225 1.24 88,318 2.34 
2004 1,433,721 1.25 86,529 2.20 
2005 1,459,479 1.25 90,364 2.22 
Source: (1) Data for employment were from the County Business Pattern, Bureau of the Census, 
Department of Commerce; (2) Data for average salary were from Quarterly Census of Employment and 
Salarys (QCEW), Bureau of Labor Statistics, Department of Labor. 
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5.1.2. Industry organization 
The IT service industry is dominated by small firms. Table 22 reports that in 2005, firms 
with 1-99 employees accounted for 97.71 percent of total IT service establishments. The 
percentage for firms with 100-499 employees was 1.86. Firms with 500 employees or more only 
accounted for 0.23 percent. The size structure of the IT service industry is similar to the national 
pattern over the last decade. Compared to the biopharmaceutical industry, the IT service industry 
has much higher proportion of small firms and lower proportion of large companies. For 
example, as reported in Chapter 4, in 2005, the share for the size class 0-99, 100-499, and 500- in 
the biopharmaceutical industry was 75.93, 18.22, and 5.39 percent, respectively. Because the IT 
service has a lower barrier for new firms, which are typically small, the chance for the catch-up 
regions to catch up in the IT service industry should be higher than in the biopharmaceutical 
industry. 
Table 22: Share of Total Establishments by Firm Size Classes for IT Service Industry and 
National Average: 1995-2005 
1~99 100~499 500~ Year 
IT Service National IT Service National IT Service National 
1995 97.22 97.72 2.51 2.03 0.27 0.25 
1996 97.31 97.70 2.41 2.05 0.28 0.25 
1997 97.39 97.68 2.34 2.07 0.26 0.25 
1998 97.83 97.63 1.97 2.12 0.20 0.26 
1999 97.68 97.57 2.11 2.17 0.22 0.26 
2000 97.50 97.51 2.27 2.22 0.23 0.27 
2001 97.33 97.51 2.39 2.21 0.28 0.27 
2002 97.85 97.68 1.93 2.07 0.22 0.25 
2003 97.88 97.67 1.90 2.09 0.23 0.25 
2004 97.93 97.67 1.84 2.08 0.23 0.25 
2005 97.91 97.66 1.86 2.09 0.23 0.25 
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
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5.1.3. Spatial distribution 
The IT service industry is not as geographically concentrated as the U.S. 
biopharmaceutical industry. All the 51 states (including the District of Columbia) had IT service 
firms in 2004 (see Appendix 2), and 26 states had more than 10,000 employees in this industry. 
Only Wyoming had fewer than 1,000 employees. California had the largest share of 17.07 
percent. It is followed by Virginia and Texas, with a share of 8.54 percent and 6.91 percent, 
respectively. The top ten states accounted for 62.89 percent of total IT service industry 
employment. As discussed in the previous chapter, the corresponding share for the 
biopharmaceutical industry was 71.81 percent, another indication that the biopharmaceutical 
industry is more concentrated than the IT service industry at the state level. 
The spatial distribution of the IT service industry at state level has been relatively stable 
over time. Over the last decade, 27 states had higher shares in 2004 than in 1995, and 22 states 
had lower shares. However, the magnitude of increase or decrease is only moderate for most 
states. Washington experienced the largest share increase from 2.00 percent in 1995 to 4.07 
percent in 2004. Illinois had the largest share drop, from 4.68 percent to 3.65 percent. Moreover, 
nine of the ten largest states in terms of IT service employment in 1995 continued to be ranked 
among top ten in 2004. Only Illinois fell out of the top ten, from the seventh in 1995 to the 
eleventh in 2004. The cumulative share for top ten states was 62.33 percent in 1995, which is 
only slightly lower than the 62.89 percent in 2004.  
At the metropolitan area level, all 361 MSAs in 2004 had IT service establishments. 
Among them, 27 MSAs had more than 10,000 IT service employees, 87 MSAs had 1,000-10,000 
employees, 47 MSAs had 500-1,000 employees, and the remaining 200 MSAs had fewer than 
500 employees. Table 23 lists the twenty largest Metropolitan Areas in terms of industry 
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employment in 2004. Washington-Arlington-Alexandria, New York-Northern New Jersey-Long 
Island, and San Francisco-Oakland-Fremont are the top three metropolitan areas, with a share of 
10.18 percent, 7.0 percent, and 5.1 percent, respectively.  The cumulative share for the top three 
metropolitan areas accounted for 22.28 percent of industry employment. This is compared to the 
32.8 percent in the biopharmaceutical industry. Thus, the biopharmaceutical industry is more 
concentrated than the IT service industry even at the metropolitan area level.   
Table 23: Twenty Largest IT Service Metropolitan Areas in 1995 and 2004 
Metropolitan Statistical Areas 2004 
Share 
2004 
Rank
2000 
Share  
2000 
Rank 
1995 
Share 
1995 
Rank
Washington-Arlington-Alexandria, DC-VA-MD-WV 10.18 1 8.93 1 8.57 1
New York-Northern New Jersey-Long Island, NY-NJ-
PA 
7.00 2 8.46 2 8.03 2
San Francisco-Oakland-Fremont, CA 5.10 3 5.40 3 4.20 6
Boston-Cambridge-Quincy, MA-NH 4.76 4 5.09 4 5.33 3
San Jose-Sunnyvale-Santa Clara, CA 4.31 5 5.07 5 3.13 9
Los Angeles-Long Beach-Santa Ana, CA 4.31 6 4.03 7 5.22 4
Seattle-Tacoma-Bellevue, WA 3.65 7 3.05 11 2.56 11
Dallas-Fort Worth-Arlington, TX 3.34 8 3.25 10 3.98 7
Philadelphia-Camden-Wilmington, PA-NJ-DE-MD 3.23 9 3.30 9 2.93 10
Chicago-Naperville-Joliet, IL-IN-WI 3.21 10 4.48 6 4.27 5
Atlanta-Sandy Springs-Marietta, GA 2.83 11 3.40 8 3.17 8
Detroit-Warren-Livonia, MI 1.84 12 1.51 15 2.11 12
Minneapolis-St. Paul-Bloomington, MN-WI 1.78 13 1.98 12 2.10 13
Baltimore-Towson, MD 1.54 14 1.15 18 0.85 21
Houston-Baytown-Sugar Land, TX 1.51 15 1.59 14 1.63 15
San Diego-Carlsbad-San Marcos, CA 1.48 16 1.38 16 1.27 16
Miami-Fort Lauderdale-Miami Beach, FL 1.32 17 1.07 20 0.65 33
Denver-Aurora, CO 1.30 18 1.79 13 1.70 14
Phoenix-Mesa-Scottsdale, AZ 1.18 19 1.11 19 0.78 25
Austin-Round Rock, TX 1.18 20 1.22 17 0.66 31
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
In terms of the changes in industry share from 1995 to 2004, 109 of 361 MSAs had 
higher shares in 2004 than in 1995, 134 had lower shares, and the remaining 118 had the same 
share of industry employment19. Seattle-Tacoma-Bellevue (WA) had experienced the largest 
                                                 
19 One should be cautious when interpreting the industrial employment changes at the metropolitan level because the 
CBP data is not completely comparable over time. 
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share increase, followed by Washington-Arlington-Alexandria (DC-VA-MD-WV) and San Jose-
Sunnyvale-Santa Clara (CA). All of these three metropolitan areas saw increases of more than 
one share point. In contrast, Chicago-Naperville-Joliet (IL-IN-WI), New York-Northern New 
Jersey-Long Island (NY-NJ-PA), and Los Angeles-Long Beach-Santa Ana (CA) had the largest 
share drops, ranging from -1.06 to -1.90 share point.  
Because this study defines a MSA as a ‘leading’ region if its high tech index value in 
1995 was ranked 95th percentile or above, 15 MSAs are classified as leading regions, and the 
other 301MSAs are categorized as catch-up regions in the IT service industry. Table 24 reports 
that in 1995, the 301 catch-up MSAs accounted for 42.68 percent of total IT service 
employment, 48.12 percent of total IT service establishments, and 45.06 percent of small and 
medium IT service establishments. From 1995 to 2000, the catch-up regions had lost some share 
in all these three measures.  
Table 24: Share of IT Service Industry for Leading and Catch-Up Regions, 
in 1995 and 2000 
 
1995 2000   
Emp. 
Share  
Estab. 
Share  
SME Estab. 
Share 
Emp. 
Share  
Estab. 
Share  
SME Estab. 
Share  
Leading regions 57.32 51.88 54.94 59.88 57.86 57.84 
Catch-up regions 42.68 48.12 45.06 40.12 42.14 42.16 
Source: the County Business Pattern, Bureau of the Census, Department of Commerce. 
 
5.2. IPO and M&A Activities in the IT Service Industry 
The IPO and M&A activities were much more active in the IT service industry than in the 
biopharmaceutical industry during the period from 1996 to 2005. Over this period, 636 IT 
service firms launched their Initial public offerings. Most qualify as NTBFs: 414 had fewer than 
500 employees and were younger than 20 years when they became public. Figure 7 shows the 
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number of total and small IT service IPOs each year. It suggests that the IPO market for the IT 
Service industry also fluctuated over time. There were far more IT service IPOs in the first five 
years than in the second five years. This is because after the burst of Internet bubble in 2000, the 
IT service firms became extremely unpopular in the equity market.  
In terms of M&A activities, there were 7868 deals completed during the study period. 
Because 1170 of them had no location information, this analysis is restricted to the remaining 
6698 deals. Figure 8 shows the number of missing cases is roughly proportional to the total 
number of acquisition activities each year. Therefore, it may not cause serious bias over time.  
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Figure 7: Number of Total and Sample IT Service IPO Events, 1996- 2005 
Source: Securities Data Company, New Issues Database; Hoover’s IPO list; Jay Ritter's 1975-2005 IPO 
dataset; and University of Chicago’s Center for Research in Security Prices database.  
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Figure 8: Number of Total and Sample IT Service M&A Events, 1996- 2005 
    Source: Securities Data Company, New Issues Database. 
 
The spatial distribution of the IT service IPO and M&A events is highly skewed. Table 25 
reports that 4583, or 65.64 percent of total events occurred in the 15 leading MSAs. The 301 
catch-up MSAs only had 2399, or 34.35 percent, much lower than its share of industrial 
employment, which was 42.68 percent in 1995. The top five regions in terms of number of IT 
service IPO and M&A events are: San Francisco-Oakland-Fremont (CA), New York-Northern 
New Jersey-Long Island (NY-NJ-PA), San Jose-Sunnyvale-Santa Clara (CA), Boston-
Cambridge-Quincy (MA-NH), and Los Angeles-Long Beach-Santa Ana (CA). These five 
regions in total had 2756, or 39.47 percent of total deals. Among the 301 catch-up regions, 199 
MSAs, or 66.12 percent, had one or more deals. San Diego-Carlsbad-San Marcos (CA) was the 
leading catch-up region, with 189 deals. Miami-Fort Lauderdale-Miami Beach (FL), Austin-
Round Rock (TX), and Phoenix-Mesa-Scottsdale (AZ) followed, with 126, 115, and 84, 
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respectively. Figure 9 depicts the spatial distribution of IT service IPO and M&A events in 
catch-up Regions. 
 
Table 25: Statistics of IT Service IPO and M&A Events 
for the Leading and Catch-Up Regions 
  
 Sum Mean Max Min Std 
Leading regions 4583 305.53 697 53 197.88 
Catch-up regions 2399 7.97 189 0 19.07 
 
Figure 9: Spatial Distribution of IT Service IPO and M&A Events in Catch-Up Regions 
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5.3. Determinants of Regional Variations in the IT Service NTBF 
Performance 
5.3.1. Models 
This study employs both the cross-sectional and two-period panel ZINB models to 
identify the causal factors that affect the average IT service NTBF performance in a catch-up 
region. The cross-section models predict the number of IT service IPO and acquisition events 
that occurred in a region between 1996 and 2005 by a set of regional characteristics in 1995 or 
other years. These models are limited to the 301 catch-up MSAs where the IT service industry 
had consistently existed from 1995 to 2004 so that all the observations had the same exposure 
time to the events. The two-period panel data models predict the number of IT service IPO and 
M&A events occurred in a region during two sub periods (1996-2000 and 2001-2005). The 
values for the predictor variables were updated every five years. The sample size for the panel 
data model is 602.  
The Breusch-Pagan / Cook-Weisberg heteroskedasticity test statistic is 2362.90 (p<0.00) 
for the catch-up cross-sectional model, and 4681.21 (p<0.00) for the catch-up two-period panel 
model, suggesting the presence of heteroskedasticity in the data. Therefore, this study only 
reports the robust estimation results. 
Table 26 and 27 report the descriptive statistics and table 28 and 29 presents the Pearson 
correlation coefficient matrix both for the cross-sectional and panel data. As in the 
biopharmaceutical industry, some correlation coefficients are very large, indicating that 
multicollinearity might be a concern in the data. For example, Table 28 reports that in the cross-
sectional dataset, the control variable, a region’s total job market size (emp_share), is strongly 
correlated with its computer scientist job market size (job_share), with a correlation coefficient 
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of 0.95. In addition, the correlation coefficient between the absolute salary level of life scientists 
(Salary_log) and relative salary level (Relative_salary) is 0.72. The presence of multicollinearity 
doesn’t affect the overall predictive power or the statistical significance of the model. However, 
it can increase the standard errors of the regression coefficients and consequently underestimate 
their significant level.  
As in the biopharmaceutical industry, this study employs two approaches to address the 
potential multicollinearity problem. First, the control variable, a region’s total job market size, is 
excluded from the full model. Second, besides the full model, three reduced models defined in 
Chapter 4 are adopted to distinguish the total effect of two computer scientists salary level 
variables on firm performance from their direct effect (when hold the other variables constant). 
Specifically, Reduced model 1 only includes the absolute salary level variable (Absolute_salary 
). Reduced model 2 only includes the relative salary level variable (Relative_salary). Reduced 
model 3 also only includes the relative salary variable, but it is based upon a smaller dataset in 
which 15 outlier regions were excluded. Regions with high absolute salary level are typically 
with a high relative salary level because they are highly correlated. However, in some cases, 
regions with low absolute salary level can also have high relative salary level because the 
denominator, the average salary level for all occupational jobs are very low. The presence of 
such outlier regions may completely distort the causal relationship between the life scientist 
relatively salary ratio and firm performance. To identify these outlier regions, I calculate the 
percentile ranks based upon the absolute and relative salary level of local life scientists, 
respectively. Seven regions were defined as the outliers because the difference in the percentile 
ranks for these regions is over 60. See appendix 3 for the results of these three reduced models. 
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All the model specifications use the same set of ‘inflate’ variables that predict the 
probability of being in the ‘always-0-group’ for a region. For the panel data, all the independent 
and control variables except their squared terms are used as the predictors of the odds of ‘being-
always-0-group.  
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Table 26: Descriptive Statistics of IT Service Cross-Sectional Variables  
(N=301) 
 
Variable Mean Std Dev Minimum Maximum 
IPO_Target 7.97 19.07 0.00 189.00 
Job_share 0.15 0.39 0.00 5.04 
Absolute_salary 0.99 0.13 0.62 1.35 
Relative_Salary 1.53 0.17 0.91 2.19 
VC_firm 0.48 1.47 0.00 12.00 
VC_firm _sq 2.37 12.80 0.00 144.00 
Immi_share 4.22 4.56 0.39 25.00 
Univ_share 0.18 0.86 0.00 10.95 
Ind_lq 0.37 0.40 0.01 2.88 
Buyer_lq 0.59 2.93 0.00 33.21 
Supplier_lq 2.23 4.02 0.00 53.97 
Firm_Birth_Rate 1.17 2.10 6.60 18.80 
Ind_SME 105.94 176.40 1.00 1097.00 
Ind_SME _sq 42237.56 145474.03 1.00 1203564.00 
Est_density 0.05 0.09 0.00 1.02 
Emp_share 0.25 0.33 0.04 2.38 
 
 
Table 27: Descriptive statistics for variables in the IT service panel data models 
(N=602) 
 
Variable Mean Std Dev Minimum Maximum 
IPO_Target 3.99 9.69 0.00 108.00 
Job_share 0.17 0.41 0.00 6.26 
Absolute_salary 0.99 0.13 0.62 1.35 
Relative_Salary 1.63 0.20 0.91 2.56 
VC_firm 0.43 1.32 0.00 12.00 
VC_firm _sq 1.93 11.22 0.00 144.00 
Immi_share 5.15 5.25 0.39 31.21 
Univ_share 0.19 0.85 0.00 10.95 
Ind_lq 0.35 0.40 0.01 3.71 
Buyer_lq 0.55 3.02 0.00 40.91 
Supplier_lq 2.04 3.32 0.00 53.97 
Firm_Birth_Rate 1.13 2.10 6.20 21.30 
Ind_SME 126.39 226.71 1.00 2192.00 
Ind_SME _sq 67285.43 287502.06 1.00 4804864.00 
Est_density 0.06 0.12 0.00 1.72 
Emp_share 0.25 0.33 0.04 2.43 
Period_dummy 3.99 9.69 0.00 108.00 
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Table 28: Correlation Coefficient Matrix for the IT Service Cross-Sectional Data 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 
(1) IPO_Target 1.00              
               
(2) Job_share 0.48 1.00             
 <.0001              
(3) Absolute_salary 0.36 0.34 1.00            
 <.0001 <.0001             
(4) Relative_salary 0.14 0.14 0.72 1.00           
 0.01 0.02 <.0001            
(5) VC_firm 0.70 0.43 0.29 0.12 1.00          
 <.0001 <.0001 <.0001 0.04           
(6) Immi_share 0.27 0.08 0.19 0.01 0.07 1.00         
 <.0001 0.17 0.00 0.92 0.22          
(7) Univ_share 0.36 0.21 0.17 0.05 0.64 0.03 1.00        
 <.0001 0.00 0.00 0.41 <.0001 0.57         
(8) Ind_lq 0.41 0.24 0.32 0.10 0.32 0.07 0.15 1.00       
 <.0001 <.0001 <.0001 0.10 <.0001 0.22 0.01        
(9) Buyer_lq 0.11 0.14 0.14 0.11 0.33 -0.01 0.08 0.25 1.00      
 0.05 0.01 0.02 0.06 <.0001 0.80 0.17 <.0001       
(10) Supplier_lq 0.12 0.07 0.07 0.02 0.08 0.01 0.03 0.46 0.06 1.00     
 0.03 0.21 0.20 0.71 0.16 0.80 0.57 <.0001 0.31      
(11)Firm_Birth_Rate 0.32 0.12 0.15 0.22 0.16 0.27 0.00 0.16 0.14 0.10 1.00    
 <.0001 0.03 0.01 <.0001 0.01 <.0001 1.00 0.01 0.02 0.10     
(12) Ind_ SME  0.85 0.56 0.41 0.14 0.63 0.20 0.39 0.41 0.06 0.18 0.22 1.00   
 <.0001 <.0001 <.0001 0.02 <.0001 0.00 <.0001 <.0001 0.28 0.00 0.00    
(13) Est_density 0.45 0.29 0.40 0.06 0.36 0.19 0.25 0.42 0.14 0.20 0.05 0.54 1.00  
 <.0001 <.0001 <.0001 0.30 <.0001 0.00 <.0001 <.0001 0.01 0.00 0.41 <.0001   
(14) Emp_share 0.75 0.53 0.36 0.11 0.56 0.22 0.35 0.30 -0.01 0.14 0.17 0.95 0.44 1.00 
 <.0001 <.0001 <.0001 0.06 <.0001 0.00 <.0001 <.0001 0.86 0.02 0.00 <.0001 <.0001
Note: a. The square terms are not included in order to save space; b. the first contains the correlation coefficient, and the p-values are in the second row. 
          b: number of observations: 301   
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Table 29: Correlation Coefficient Matrix for the IT Service Panel Data 
 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 
(1) IPO_Target 1.00              
               
(2) Job_share 0.46 1.00             
 <.0001              
(3) Absolute_salary 0.37 0.32 1.00            
 <.0001 <.0001             
(4) Relative_salary 0.06 0.05 0.54 1.00           
 0.12 0.20 <.0001            
(5) VC_firm 0.66 0.40 0.31 0.03 1.00          
 <.0001 <.0001 <.0001 0.42           
(6) Immi_share 0.28 0.13 0.30 0.22 0.08 1.00         
 <.0001 0.00 <.0001 <.0001 0.04          
(7) Univ_share 0.42 0.23 0.19 0.03 0.64 0.07 1.00        
 <.0001 <.0001 <.0001 0.50 <.0001 0.11         
(8) Ind_lq 0.44 0.25 0.37 -0.01 0.38 0.09 0.21 1.00       
 <.0001 <.0001 <.0001 0.84 <.0001 0.03 <.0001        
(9) Buyer_lq 0.09 0.10 0.11 0.05 0.26 0.01 0.07 0.23 1.00      
 0.03 0.02 0.01 0.20 <.0001 0.75 0.11 <.0001       
(10) Supplier_lq 0.12 0.10 0.09 -0.04 0.11 -0.02 0.03 0.40 0.03 1.00     
 0.00 0.01 0.02 0.31 0.01 0.70 0.40 <.0001 0.43      
(11)Firm_Birth_Rate 0.33 0.12 0.19 0.08 0.16 0.35 0.02 0.22 0.08 0.08 1.00    
 <.0001 0.00 <.0001 0.04 <.0001 <.0001 0.64 <.0001 0.04 0.04     
(12) Ind_ SME  0.82 0.53 0.40 0.10 0.59 0.27 0.39 0.42 0.04 0.16 0.23 1.00   
 <.0001 <.0001 <.0001 0.02 <.0001 <.0001 <.0001 <.0001 0.30 <.0001 <.0001    
(13) Est_density 0.43 0.27 0.40 0.03 0.35 0.22 0.24 0.46 0.08 0.16 0.08 0.54 1.00  
 <.0001 <.0001 <.0001 0.47 <.0001 <.0001 <.0001 <.0001 0.04 0.00 0.06 <.0001   
(14) Emp_share 0.75 0.51 0.36 0.05 0.55 0.24 0.34 0.31 -0.01 0.15 0.20 0.92 0.41 1.00
 <.0001 <.0001 <.0001 0.23 <.0001 <.0001 <.0001 <.0001 0.78 0.00 <.0001 <.0001 <.0001
Note: a. The square terms are not included in order to save space; b. the first contains the correlation coefficient, and the p-values are in the second row. 
       b: number of observations: 602
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5.3.2 Results 
This section presents the results for the empirical estimation of the effects of regional 
characteristics on the average IT service NTBF performance in a region, measured by the 
number of IPO and M&A events. I first report the estimation results from the cross-sectional 
models. The temporal stability test findings based upon two-period panel data models are 
followed. Finally, I present the results from the distance-weighted dataset, which is created to 
capture the ‘neighboring’ effect.   
(1) Cross-sectional models 
Table 30 presents the coefficient estimates of the cross-sectional zero-inflated negative 
models both for catch-up regions and all the regions. In each model, the top set of coefficients 
corresponds to the NBRM for those in the ‘Not- Always-0-Group’. The lower set of coefficients, 
labeled ‘inflate’, corresponds to the binary logistic model predicting membership in the group 
that always has zero counts. Table 30 also reports the results of alpha and Vuong test in the end. 
The alpha test in each model is larger than 1.96, which provides strong evidence of 
overdispersion. Therefore, the negative binomial regression model is preferred to the Poisson 
regression model in this data. The Vuong test compares the zero-inflated regression model 
specification with the standard negative binomial regression model. The Vuong test statistic in 
each model is larger than 1.96, indicating that the zero-inflated regression model specification is 
favored in this data.  
The results provide less evidence of the significance of local scientist job market size in 
the IT service industry than in the biopharmaceutical industry. The estimated coefficient of this 
variable is negative and insignificant for catch-up regions. Multicolinearity is unlikely to be the 
cause for the lack of the significance of this variable because it has only modest correlation 
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coefficient with other variables. The correlation coefficient matrix (Table 28) shows that this 
variable has the strongest correlation with number of small IT service firms (Ind_sme_lg), but 
the correlation coefficient is only 0.56. When the 15 leading regions are included into the 
analysis, the variable became negative and significant (p<0.05). One explanation for the negative 
impact of local computer scientist job market is that the spatial distribution of computer scientist 
jobs is less concentrated than that of life scientist jobs. In terms of predicting the odds of being 
the ‘always-0-group’, this variable is negative and insignificant. 
The absolute salary level of computer scientists in a region is found to have positive and 
significant (p<0.05) impact on NTBF performance, but the effect of relative salary level is 
negative and insignificant. The empirical evidence again suggests that it is the absolute salary 
rate rather than the relative salary rate that can positively affect the performance of local NTBFs 
in catch-up regions. It indicates that regions that can provide nationally competitive high-paid 
jobs for computer scientists are more likely to be associated with better NTBF performance. The 
negative impact of relative salary ratio is significant (p<0.001) only in the full sample data. In 
terms of predicting the odds of being the ‘always-0-group’, the absolute salary ratio is negative 
and insignificant, and the relative salary ratio is positive and insignificant.   
The results report that the nonlinear effect of proximity to VC firms is more apparent in 
the IT service industry than in the biopharmaceutical industry. For catch-up regions, the number 
of IT service VC firms has a positive and highly significant (p<0.01) coefficient. Its squared term 
is also significant (p<0.05), but with a negative sign. The model predicts that the negative impact 
began to dominate the positive impact of proximity to specialized VC firms when there are 7 or 
more VC firms in a metropolitan area. For the full sample model in which both the leading and 
catch-up regions are included, the coefficient of number of IT service VC firm even became 
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negative and significant (p< 0.05). This finding is consistent with previous studies suggesting the 
adverse effects of ‘excess’ venture capital.  Some literature has argued that the excess amount of 
venture capital in a region is likely to flow straight to low-quality entrepreneurship(Acs and 
Storey 2004; Venkataraman 2004). Stuart and Sorenson (2003) pointed out that proximity to 
many VCs implies that a focal organization may compete against well-financed rivals in local 
factor market.  
Cultural diversity is found to have positive and significant (p<0.05) impact on the 
performance of IT service NTBF performance in catch-up regions. This finding supports 
Florida’s (2002) argument that place can attract talented people by cultural diversity or openness 
to all lines of lifestyles. However, an alternative explanation is that the IT service industry hires 
more foreign-born scientists and engineers than the biopharmaceutical industry does.  
In contrast to the biopharmaceutical industry, the industrial specialization has significant 
(p<0.01) and positive effect on NTBF performance. This finding provides evidence of positive 
spillovers associated with proximity to similar firms. The impact of buyer industries is negative 
and insignificant. Coaggolomeration with supplier-industries has negative and significant (p<0.1) 
effect. Therefore, the results are not completely consistent with Porter’s cluster theory (1990, 
1998). 
The results provide little evidence of the direct and significant impact of academic 
computer science research on the performance of local small IT service firms in catch-up 
regions.  However, when the 15 IT service leading regions are included into the analysis, this 
variable became positive and significant (p<0.05). This finding suggests that academic research 
plays a more important role in the leading regions than in catch-up regions.  
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As in the biopharmaceutical industry, the findings provide strong evidence that the 
overall entrepreneurial climate in a region has significant and positive impacts on the 
performance of IT service NTBFs. The local entrepreneurial climate, measured by the small firm 
birth rate, is positive and highly significant (p<0.01) both in catch-up regions and the full sample 
data.  
The control variables, number of small IT service firms its squared term, are significant 
both in the catch-up and full sample model. The number of small IT service firms is positive and 
its squared term is negative. Both variables are significant at 0.05 level in catch-up regions and 
0.01 level in the full sample model. The model predicts when the size of impact of industrial 
clusters on firm performance reaches the maximum when there are about 742 small IT service in 
firms in catch-up regions.  
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Table 30: Results of Cross-Sectional ZINB Models of IT Service IPO and M&A Events 
between 1996 and 2005  
Independent variables Catch-up regions (N=301)  
Leading and catch-up regions 
(N=316) 
-0.136  -0.418** Computer scientists job market share 
(0.140)  (0.199) 
1.952**  5.142*** Computer scientists absolute salary 
ratio (0.961)  (1.018) 
-0.734  -1.932*** Computer scientists relative salary ratio 
(1.090)  (0.724) 
Number of IT service VC firms 0.137***  -0.041** 
 (0.049)  (0.019) 
-0.010**  0.000 Square of number of IT service VC 
firms (0.004)  (0.000) 
Foreign born population share 0.036**  -0.012 
 (0.018)  (0.017) 
0.031  0.130** Computer science academic research 
share (0.027)  (0.064) 
0.476***  0.677*** IT service industry location quotient 
(0.093)  (0.154) 
-0.005  0.010 Buyer- industry location quotient 
(0.034)  (0.015) 
-0.011*  -0.005 Supplier- industry location quotient 
(0.007)  (0.011) 
Small firm birth rate  0.143***  0.189*** 
 (0.025)  (0.029) 
0.008**  0.003*** Number of small IT service firms 
(0.003)  (0.000) 
-0.000**  -0.000*** Square of number of small IT service 
firms (0.000)  (0.000) 
-0.152  0.247 Number of small IT service firms per 
square mile (0.351)  (0.375) 
Constant -2.289***  -3.552*** 
 (0.532)  (0.744) 
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Table 30 (continued)  
 
Inflation variables Catch-up regions 
(N=301)  
Leading and catch-up regions 
(N=316) 
    
-0.596  -1.183 Computer scientists job market share 
(0.534)  (2.541) 
-7.435  -4.543 Computer scientists absolute salary 
(8.873)  (4.359) 
5.361  3.592 Computer scientists relative salary 
(3.591)  (2.776) 
0.535  1.191 Number of IT service VC firms 
(3.204)  (1.146) 
Foreign born population share 0.103  0.029 
 (0.110)  (0.064) 
1.611  3.432* Computer science academic research 
share (3.795)  (1.888) 
-0.189  -0.120 IT service industry location quotient 
(1.088)  (1.168) 
0.026  0.105 Buyer- industry location quotient 
(0.281)  (0.094) 
-0.131  -0.141 Supplier- industry location quotient 
(0.141)  (0.124) 
Small firm birth rate -0.126  0.033 
 (0.472)  (0.160) 
-0.082  -0.172*** Number of small IT service firms 
(0.240)  (0.048) 
16.417  33.790*** Number of small IT service firms per 
square mile (54.581)  (10.451) 
Constant 1.056  0.484 
 (2.794)  (3.336) 
    
Log likelihood -576.923  -652.489 
Overdispersion test 
(alpha =0) 
130.53  1716.31 
Vuong test  
(ZINB vs. NBRM) 
3.73  3.46 
Number of nonzero observations 199  214 
Number of zero observations 102  102 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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(2) Two-period panel data models 
Table 32 reports the coefficient estimates of the two-period zero-inflated negative models 
both for catch-up regions and the full sample which consists of both the leading and catch-up 
regions. Again, the overdispersion and Vuong test statistics suggest that the ZINB specification 
is the best choice for this data.  
The results from the two-period panel data models indicate the following causal patterns 
are persistent over time: (1) the impact of the absolute salary level of computer scientists is 
significant and positive, but the effect of relative salary level is insignificant and negative; (2) 
proximity to IT service venture capital firms has significantly positive but nonlinear effect; (3) 
industrial specialization has positive and significant impacts; (4) the overall entrepreneurial 
climate in a region has positive and highly significant impact on IT service NTBFs performance; 
and (5) the number of small IT service firms has significantly positive and non-linear impact. 
Compared to the cross-sectional design, the two-period panel models provide less 
evidence of the significance of cultural diversity. The estimated coefficient of foreign born 
population is positive but insignificant both in the catch-up and full sample model.  
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Table 31: Results of Two-Period Panel ZINB Models of IT Service IPO and M&A Events 
between 1996 and 2005 
Independent variables Catch-up regions 
(N=602)  
Leading and catch-up regions 
(N=632) 
-0.101  -0.040 Computer scientists job market share 
(0.108)  (0.184) 
1.993*  4.774*** Computer scientists absolute salary 
ratio (1.071)  (0.762) 
-0.098  -1.236** Computer scientists relative salary ratio 
(0.724)  (0.622) 
Number of IT service VC firms 0.224***  0.004 
 (0.052)  (0.020) 
-0.017***  -0.000 Square of number of IT service VC 
firms (0.005)  (0.000) 
Foreign born population share 0.014  -0.015 
 (0.013)  (0.015) 
0.010  0.090** Computer science academic research 
share (0.031)  (0.046) 
0.450***  0.464*** IT service industry location quotient 
(0.098)  (0.154) 
-0.020  -0.021* Buyer- industry location quotient 
(0.014)  (0.012) 
-0.011  0.006 Supplier- industry location quotient 
(0.010)  (0.020) 
Small firm birth rate  0.101***  0.155*** 
 (0.019)  (0.025) 
0.004***  0.001*** Number of small IT service firms 
(0.001)  (0.000) 
-0.000***  -0.000*** Square of number of small IT service 
firms (0.000)  (0.000) 
-0.102  0.118 Number of small IT service firms per 
square mile (0.236)  (0.316) 
Time fixed effect -0.168  0.183 
 (0.247)  (0.146) 
Constant -2.777***  -3.950*** 
 (0.696)  (0.778) 
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Table 31 (continued)  
 
Inflation variables Catch-up regions 
(N=602)  
Leading and catch-up regions 
(N=632) 
    
-0.061  -0.025 Computer scientists job market share 
(0.261)  (0.251) 
-2.932  -1.715 Computer scientists absolute salary 
(2.182)  (2.311) 
3.669***  3.425** Computer scientists relative salary 
(1.392)  (1.349) 
0.243  -0.011 Number of IT service VC firms 
(0.532)  (0.688) 
0.015  -0.014 Foreign born population share 
(0.032)  (0.040) 
-0.060  -0.025 Computer science academic research 
share (0.243)  (0.233) 
1.510*  1.421** IT service industry location quotient 
(0.825)  (0.692) 
-0.273*  -0.252* Buyer- industry location quotient 
(0.143)  (0.137) 
-0.176  -0.152 Supplier- industry location quotient 
(0.108)  (0.108) 
Small firm birth rate -0.175*  -0.163* 
 (0.095)  (0.096) 
-0.049***  -0.051*** Number of small IT service firms 
(0.017)  (0.012) 
3.907  4.734 Number of small IT service firms per 
square mile (7.818)  (7.455) 
Constant 0.225  -0.544 
 (2.195)  (2.233) 
Log likelihood -863.451  -1170.906 
Overdispersion test 
(alpha =0) 
384.44  2587.92 
Vuong test  
(ZINB vs. NBRM) 
2.35  5.02 
Number of nonzero observations 319  349 
Number of zero observations 283  283 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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(3) Distance-weighted results 
This study replicates the cross-sectional and two-period models to a set of distance-
weighted variables. The following variables are recalculated using the method defined in Chapter 
3: computer scientist job market share, number of IT service VC firms and its squared term, 
foreign born population share, computer science academic research, number of small IT service 
firms, and its squared term. These variables are likely to have impacts on the neighboring 
metropolitan areas. Table 33 presents the results. Again, the overdispersion and Vuong test 
statistics in each model are larger than 1.96, indicating that the ZINB specification is favored.  
The distance-weighted models provide further evidence supporting the following causal 
relationships: (1) the job market size of computer scientist has negative and significant impact in 
both the catch-up and full sample models; (2) the impact of the absolute salary level of computer 
scientist is positive and highly significant (p<0.01), but the effect of relative salary level is 
negative and significant (p<0.1 in the catch-up cross-sectional model and p<0.05 or 0.01 in the 
full sample models; (3) proximity to the IT service venture capital firms has positive but non-
linear impact; (4) cultural diversity is positive and highly significant in catch-up region models; 
(5) the positive impact of academic life science research on NTBF performance is significant  
only when the leading regions are included into the analysis; (6) industrial specialization is found 
to have positive and highly significant impact; (7) the overall entrepreneurial climate in a region 
has positive and highly significant impact; (8) the number of small IT service firms has positive 
and non-linear impact. Such a non-linear impact is apparent both in IT service catch-up and 
leading regions. 
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Table 32: Distance-Weighted Results of ZINB Models of IT Service  
IPO and M&A Events between 1996 and 2005  
 Catch-up regions  Leading and  
catch-up regions  
Inflation variables Cross- Sectional Panel   
Cross- 
Sectional Panel 
 (N=301) (N=602)  (N=316) (N=632) 
Computer scientists job market share -0.173** -0.106  -0.272* -0.054 
 (0.083) (0.073)  (0.140) (0.103) 
2.083*** 2.120***  5.129*** 5.016*** Computer scientists absolute salary ratio (0.618) (0.787)  (1.039) (0.808) 
-0.869* -0.199  -1.939*** -1.382** Computer scientists relative salary 
ratio (0.486) (0.618)  (0.732) (0.648) 
Number of IT service VC firms 0.056* 0.136***  -0.027* 0.005 
 (0.031) (0.035)  (0.014) (0.014) 
-0.003 -0.010***  0.000 -0.000 Square of number of IT service VC 
firm (0.003) (0.003)  (0.000) (0.000) 
Foreign born population share 0.038*** 0.021**  -0.000 -0.006 
 (0.010) (0.009)  (0.013) (0.011) 
0.001 -0.001  0.075** 0.055** Computer Science academic research 
share (0.021) (0.018)  (0.037) (0.027) 
0.496*** 0.454***  0.696*** 0.480*** IT service industry location quotient 
(0.089) (0.101)  (0.163) (0.164) 
Buyer- industry location quotient -0.004 -0.022*  0.011 -0.022* 
 (0.017) (0.013)  (0.016) (0.012) 
Supplier- industry location quotient -0.010 -0.008  -0.005 0.008 
 (0.006) (0.011)  (0.011) (0.021) 
Small firm birth rate  0.179*** 0.133***  0.202*** 0.173*** 
 (0.038) (0.017)  (0.029) (0.271) 
0.006*** 0.003***  0.002*** 0.001*** Number of small IT service firms 
(0.001) (0.000)  (0.000) (0.000) 
-0.000*** -0.000***  -0.000*** -0.000*** Square of number of small IT service 
firms (0.000) (0.000)  (0.000) (0.000) 
-0.573 -0.346  0.047 0.037 Number of small IT service firms per 
square mile (0.378) (0.216)  (0.204) (0.193) 
Time fixed effect  -0.178   0.208 
  (0.214)   (0.150) 
Constant -2.735*** -3.224***  -3.746*** -4.225*** 
 (0.612) (0.616)  (0.774) (0.817) 
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Table 32 (continued)  
 Catch-up regions  Leading and catch-up 
regions  
Inflation variables Cross- Sectional Panel   
Cross- 
Sectional Panel 
 (N=301) (N=602)  (N=316) (N=632) 
Computer scientists job market share -0.355 -0.050  -0.625 -0.009 
 (0.367) (0.157)  (1.326) (0.151) 
-7.176 -2.625  -4.111 -1.419 Computer scientists absolute salary 
ratio (6.002) (2.194)  (4.430) (2.321) 
5.185 3.417**  3.627 3.246** Computer scientists relative salary 
ratio (3.877) (1.334)  (2.836) (1.329) 
Number of IT service VC firms 0.463 0.177  0.746 -0.014 
 (0.922) (0.380)  (0.996) (0.491) 
Foreign born population share 0.072 0.012  0.015 -0.011 
 (0.056) (0.023)  (0.043) (0.027) 
1.459 0.011  2.505* 0.025 Computer science academic research 
share (1.584) (0.152)  (1.286) (0.139) 
-0.429 1.267*  -0.411 1.169* IT service industry location quotient 
(1.170) (0.755)  (1.235) (0.671) 
Buyer- industry location quotient 0.048 -0.262*  0.102 -0.254* 
 (0.133) (0.140)  (0.093) (0.140) 
Supplier- industry location quotient -0.104 -0.154  -0.123 -0.136 
 (0.108) (0.100)  (0.125) (0.104) 
Small firm birth rate  -0.081 -0.164*  0.021 -0.171* 
 (0.165) (0.099)  (0.157) (0.099) 
Number of small IT service firms -0.066 -0.032***  -0.111*** -0.033*** 
 (0.066) (0.011)  (0.032) (0.008) 
22.287 4.350  22.004*** 3.771 Number of small IT service firms per 
square mile (26.187) (7.479)  (6.914) (3.912) 
0.681 0.118  -0.666** -0.722*** Constant 
 (2.881) (2.240)  (0.278) (0.250) 
Log likelihood -583.163 -904.99  -741.301 -1176.113 
Overdispersion test (alpha =0) 160.19  398.02   1859.80  2783.6  
Vuong test (ZINB vs.NBRM) 3.73 5.02  3.45 4.78 
Number of nonzero observations 199 319  214 349 
Number of zero observations 102 283  102 283 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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5.4. Summary 
In this chapter, I find that compared to the biopharmaceutical industry, the IT service 
industry has much larger size, lower barrier for entry, and less degree of spatial concentration. 
Over the last decade, the industry is most active in IPO and M&A events. However, as in the 
biopharmaceutical industry, more than half of the deals occurred in a small number of leading 
regions.  
The analysis of the spatial distribution of IT service IPO and M&A events in the catch-up 
regions provides further evidence of the significant impact of the absolute salary level of 
scientists, cultural diversity, proximity to venture capital firms, and local entrepreneurial climate 
on the average NTBF performance in region. The results also suggest that there are noticeable 
cross-industry differences. There is less evidence of the significance of local scientist job market 
size in the IT service industry than in the biopharmaceutical industry. The adverse effect of 
‘excess’ venture capital and IT service firms is very strong in the IT service industry. Moreover, 
the industrial specialization is found to be significant and positive only in the IT service industry. 
Such causal relationships are robust over time, qualitatively similar to the distance-weighted 
measures and similar to the leading regions.  
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CHAPTER 6: CONCLUSIONS 
 
This concluding chapter comprises three sections. Section 1 summarizes the main findings 
of this research. In Section 2, I will discuss the policy implications emerged from the findings. 
The chapter ends with the discussion of the limitations of this work and future research 
directions. 
 
6.1. Summary of Main Findings 
The empirical analysis presented in this study has endeavored to expand the understanding 
of the relationship between regional characteristics and the early-stage performance of new 
technology based firms in the catch-up regions. It introduced a novel measure of NTBF early-
stage performance, the event of Initial Public Offering and Merger & Acquisition. It has 
empirically examined over the past decade how the number of biopharmaceutical or IT service 
NTBF IPO and M&A events in a catch up region was affected by the local scientist job market 
conditions, presence of specialized venture capital firms, cultural diversity, industry relevant 
academic research, industrial structure, and local entrepreneurial climate.  
The most striking finding of this study is that the local entrepreneurial climate is a 
significant determinant of the average NTBF performance in a region. The evidence suggests 
that the local entrepreneurial climate, measured by the small firm birth rate, is a positive and 
significant predictor of the number of IPO and M&A events in a region both for the 
biopharmaceutical and IT service industry. It is also found that its impact has not become weaker 
over time.  
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This study also provides some evidence supporting Florida’s ‘creative class’ theory 
stating that open and diverse regions have distinct advantages in attracting and retaining creative 
people with unorthodox ideas and therefore are associated with better firm performance. Cultural 
diversity is found to be significant only in the IT service industry. One explanation is that this 
study measures a region’s cultural diversity by its proportion of foreign born population. Such a 
measure appears to favor the IT service industry over the biopharmaceutical industry because the 
former has a relatively higher proportion of foreign born work force.  
The empirical findings suggest that among the three variables that measure the local job 
market conditions for industry-relevant scientists, only the absolute salary level has consistently 
positive and significant impacts on NTBF performance in both industries. The size of scientist 
job market has positive and significant impact only in the biopharmaceutical industry. Its impact 
is insignificant and negative in the IT service industry. The relative salary rate is a negative 
predictor of the NTBF performance in both industries. Therefore, the results suggest that the 
“labor market pool” effect is significant only in the highly concentrated industries. In the less 
concentrated industry like IT service, regions that can provide nationally competitive high-paid 
jobs for scientists are more likely to attract and retain excellent scientists and technologists and 
therefore have better NTBF performance. 
Proximity to the specialized venture capital firms is found to promote NTBF performance 
in both industries. However, the results also provide strong evidence of the adverse effects of 
‘excess’ venture capital, particularly in the IT service industry. Similar results regarding the role 
of VC firms have been previously obtained by Stuart and Sorenson (2003), Acs and Storey 
(2004), and Venkataraman (2004). The prior literature has pointed out that proximity to many 
VCs implies that a focal organization may compete against well-financed rivals in local factor 
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market. In addition, the excess amount of venture capital in a region is likely to flow straight to 
low-quality entrepreneurship.  
There is little evidence of the direct effects of industry-related academic research in 
determining the NTBF performance in catch-up regions. Prior research shows that a strong link 
exists between academic research and the innovative performance of NTBFs in the 
biopharmaceutical industry (Audretsch and Stephan 1996; Deeds, Decarolis et al. 1997; 
McMillan, Narin et al. 2000; Lim 2004). This study finds that in catch-up regions, the academic 
research variable is not significant either in the biopharmaceutical or IT service industry. The 
impact of academic research becomes significant only after we take into account the evidence in 
leading regions, and the impact from both the focal metropolitan area and it neighboring regions.  
The study provides weak evidence supporting Porter’s (2000) industrial cluster theory 
stating that industrial specialization and proximity to buyer and suppliers are significant to firm 
performance. Industrial specialization is found to foster NTBF performance only in the IT 
service industry. Its impact is negative and insignificant in the biopharmaceutical industry. 
Proximity to buyer industries is found to have significant but negative impact in the 
biopharmaceutical industry. Proximity to supplier industry has negative and significant impact in 
the IT service industry. A possible explanation for the negative impact of industrial 
specialization and proximity to supplier or buyer industries is that industrial clusters affect the 
firm formation and post-entry performance differently as suggested by Stuart and Sorenson 
(2003). In their study of US biotech industry, they found that while new firms are generally 
formed in the mature industrial clusters, geographic proximity to the competing organization 
including specialized buyer and suppliers may result in adverse effect on performance.  
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The noticeable cross-industry difference in the direction, significance level, and size of 
the effect of the independent variables suggests that industry-specific factors are important in 
determining the causal relationship between regional factors and NTBF performance. The 
finding suggest that the IT service industry has a larger size, lower barrier for entry, and lower 
extent of spatial distribution compared to the biopharmaceutical industry.   
 
6.2. Policy Implications 
Over the past decade, the traditional industrial recruitment programs have become less 
appealing to the state and local governments because of their own exceptionally tight fiscal 
situations as well as the rising outsourcing practice of many U.S. companies ((NGA 2004). In 
contrast, fostering “homegrown” NTBFs is becoming a popular policy tool used to achieve 
regional economic prosperity (Feldman and Francis 2004; Feldman, Francis et al. 2005). While 
there are a plenty of studies exploring the “best practices” in several high-profile leading high 
technology clusters, namely Silicon Valley and Boston 128, few efforts have exclusively focused 
on catch-up regions where a critical mass of industrial cluster has not been established yet. As a 
result, there is a rising concern that policy initiatives derived from the “best practices” in well-
established high-technology regions may be of limited use for catch up regions (Feldman, 
Francis et al. 2005; Tödtling and Trippl 2005). This dissertation aims to explore the most 
effective strategies to foster “homegrown” NTBFs in catch up regions by examining the 
underlying mechanisms through which location affect its average NTBFs performance outside 
the leading mature clusters. Four distinct veins of policy implications emerge from this research.  
First, this study provides strong evidence that promoting local entrepreneurial climate is an 
effective policy instrument for catch-up regions to foster their NTBF growth. Prior studies have 
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found that entrepreneurship is a strong predictor of the spatial heterogeneity in firm formation. 
This study found that it is also a key contributor to firm performance. Moreover, the evidence 
indicates that there is only a modest correlation between local entrepreneurial climate and 
industrial cluster size. Therefore, this policy tool is particularly relevant for the catch-up regions 
in which there is a lack of strong industrial foundations. Krueger et al. (2000) pointed out that 
policy initiatives will increase entrepreneurship only if those initiatives positively influence 
attitudes and thus influence intentions. They argue that promoting entrepreneurial intentions 
requires promoting perceptions of both feasibility and desirability of entrepreneurial activities 
among all strata of society.   
Second, this study provides further evidence that the presence of industry specialized 
venture capital firms is a key determinant of biopharmaceutical and IT service NTBF 
performance and therefore justifies the public efforts to increase the availability of venture 
capitals. Financial obstacles to the growth of NTBFs have been the focus of much public policy 
discussion. Prior study shows that NTBFs typically have poor access to debt because of their 
highly variable returns, asymmetric information and a lack of collateral (Carpenter and Petersen 
2002). Thus, there is a concern that a lack of venture capital may be an important barrier to the 
development of the high-tech sector. The results of this study suggest that institutional factors 
that affect the availability and cost of venture capital financing may be an import determinant of 
the comparative advantage of regions in the growth of small high-tech firms.   
Third, this study also provides some evidence that supports the creative-class-based 
approach proposed by (Florida 2002). This approach posits that regions should attract talents by 
lowering the barrier to entry for human capital, increasing cultural diversity and regional 
tolerance, and improving local life amenities.  
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Finally, the weak impact of academic research on NTBF performance in catch up regions 
suggests that the quality of academic research determines the extent of its spillover effect. The 
story of Silicon Valley, Boston 128, and other mature clusters has manifested the role of top 
universities in fostering the birth and growth of local NTBFs. There are two possible 
explanations for the insignificance of academic research to NTBF performance in catch-up 
regions. One is that the academia-industry collaborations tend to be strongest between 
universities and larger, rather than smaller firms. As pointed out by Storey and Tether (1998), if 
the prime objective of outreach activities is to generate income, it is almost inevitable that 
universities give priority to the collaborations with large enterprises because such collaborations 
are usually more cost-effective and ‘prestigious’ than those with small and medium firms. 
However, this study shows that the impact of academic research is significant when the leading 
regions are included into the model. Thus, this explanation is not strongly supported. The other 
explanation is that there are few prominent universities or research institutes in catch-up regions 
so that the private firms don’t have strong incentives to collaborate with local academic research 
efforts. This study provides evidence supporting this argument. The data shows that 7 of the top 
20 life science academic departments are located in the leading regions and 13 are in the catch-
up regions. Given that catch-up regions account for 95 percent of all the U.S. metropolitan areas, 
they are associated with a disproportionally low share of high-quality universities. Similarly, in 
the IT service industry, the catch-up regions only have 11, or 55 percent of top 20 computer 
science academic departments. In sum, building up local research excellence is the key to 
enhance the spillover effect of academic research on NTBF performance.  
 
 
 118
6.3. Limitations and Future Research Directions 
The body of work in this research by no means fully answers question about the 
relationship between location and NTBF performance in the catch-up regions. The limitations of 
the analysis presented here point to several directions for future studies.   
First, the event of IPO and M&A is only a rude measure of the early stage success of 
NTBF. As mentioned before, this indicator doesn’t accounts for the fact that there are substantial 
variations among the IPO or acquired NTBFs in terms of their individual performance. There is a 
plenty of evidence that firms that have been issued a successful IPO performed poorly later on. 
The measure also missed those successful firms whose owners are reluctant to going public or 
being acquired. Thus, a more appropriate measure of firm performance is needed to obtain more 
robust results.  
Second, this study doesn’t decompose the impacts of industry-related entrepreneurial 
activities and that of general entrepreneurship. This study finds that the overall entrepreneurial 
climate is a key predictor of average NTBF performance in both the biopharmaceutical and IT 
service industry. However, it might be the case that the majority of entrepreneurial activities in a 
region just occurred in these two industries.  So, maybe the industry-specific entrepreneurship is 
the real predictor of NTBF performance. In order to formulate the most effective policies, it is 
worth to exploring whether industry-specific entrepreneurial activities or just the overall 
entrepreneurial activities are the true determinant of NTBF performance. 
Third, this study doesn’t explicitly examine the effect of existing economic development 
policies on local NTBF performance. A similar analysis at the state level would allow for the 
addition of policy instruments to the model, which could provide more insights about policy 
implications.  
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Finally, the temporal stability analysis in this study is based upon a two-period, ten-year-
long time frame. Gartner and Shane ((1995) point out that although the region-level factors may 
changes dramatically at the societal level over periods greater than 10 years, they change very 
little over short periods of time. Therefore, the length of time that a longitudinal study is based 
upon is likely to be a critical factor in itself. The 10-year-long time span may not capture the 
significant effects of the changes in some regional factors on local NTBF performance.  
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APPENDIX 1: LIST OF LEADING AND TOP 20 CATCH-UP REGIONS 
Table 1.1: List of ‘Leading’ Regions in the Biopharmaceutical Industry 
 
MSA name 1995  
index 
value 
1995  
percentile 
rank 
2000  
index 
value 
2000  
percentile 
rank 
New York-Northern New Jersey-Long 
Island, NY-NJ-PA 
5.998 99 6.133 99 
Los Angeles-Long Beach-Santa Ana, CA 3.510 98 2.973 98 
Boston-Cambridge-Quincy, MA-NH 1.806 98 1.764 97 
San Francisco-Oakland-Fremont, CA 1.673 97 1.707 97 
San Jose-Sunnyvale-Santa Clara, CA 1.447 97 0.663 92 
Philadelphia-Camden-Wilmington, PA-
NJ-DE-MD 
1.415 96 1.326 96 
San Diego-Carlsbad-San Marcos, CA 1.378 95 1.873 98 
Chicago-Naperville-Joliet, IL-IN-WI 1.245 95 1.045 95 
 
Table 1.2: List of Top 20 ‘Catch-Up’ Regions in the Biopharmaceutical Industry 
 
MSA name 1995 
index 
value 
1995 
percentile 
rank 
2000 
index 
value 
2000 
percentile 
rank 
St. Louis, MO-IL 1.081 94 0.934 94
Miami-Fort Lauderdale-Miami Beach, FL 0.984 94 1.018 95
Minneapolis-St. Paul-Bloomington, MN-WI 0.820 93 0.963 94
Baltimore-Towson, MD 0.724 92 0.525 88
Detroit-Warren-Livonia, MI 0.722 92 0.524 88
Kansas City, MO-KS 0.688 91 0.550 89
Dallas-Fort Worth-Arlington, TX 0.655 91 0.687 92
Houston-Baytown-Sugar Land, TX 0.590 90 0.605 91
Milwaukee-Waukesha-West Allis, WI 0.529 89 0.278 79
Portland-Vancouver-Beaverton, OR-WA 0.524 89 0.605 91
Atlanta-Sandy Springs-Marietta, GA 0.491 88 0.440 86
Denver-Aurora, CO 0.459 88 0.467 86
Austin-Round Rock, TX 0.427 87 0.331 81
San Antonio, TX 0.426 86 0.467 87
Tampa-St. Petersburg-Clearwater, FL 0.395 86 0.525 89
Washington-Arlington-Alexandria, DC-VA-
MD-WV 
0.393 85 0.743 93
Portland-South Portland-Biddeford, ME 0.362 85 0.387 84
Raleigh-Cary, NC 0.362 84 0.415 85
Sacramento--Arden-Arcade--Roseville, CA 0.361 84 0.303 81
Seattle-Tacoma-Bellevue, WA 0.361 83 0.550 90
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Table 1.3: List of ‘Leading’ Regions in the IT Service Industry  
MSA name 1995  
index 
value 
1995  
percentile 
rank 
2000 
index  
value 
2000  
percentile
 rank 
New York-Northern New Jersey-Long Island, 
NY-NJ-PA 
6.138 99 1.663 99 
Los Angeles-Long Beach-Santa Ana, CA 2.826 99 0.746 98 
Chicago-Naperville-Joliet, IL-IN-WI 2.614 99 0.674 97 
Washington-Arlington-Alexandria, DC-VA-
MD-WV 
2.521 98 0.705 98 
San Francisco-Oakland-Fremont, CA 2.512 98 1.153 99 
Boston-Cambridge-Quincy, MA-NH 2.182 98 0.749 98 
Atlanta-Sandy Springs-Marietta, GA 1.652 97 0.380 95 
Dallas-Fort Worth-Arlington, TX 1.569 97 0.300 94 
Philadelphia-Camden-Wilmington, PA-NJ-
DE-MD 
1.567 97 0.469 96 
San Jose-Sunnyvale-Santa Clara, CA 1.473 96 0.699 97 
Minneapolis-St. Paul-Bloomington, MN-WI 1.340 96 0.385 96 
Houston-Baytown-Sugar Land, TX 1.038 96 0.193 91 
Seattle-Tacoma-Bellevue, WA 0.936 95 0.239 93 
Denver-Aurora, CO 0.892 95 0.196 91 
Bridgeport-Stamford-Norwalk, CT 0.876 95 0.579 97 
 
Table 1.4: List of Top 20 ‘Catch-Up’ Regions in the IT Service Industry 
MSA name 1995 
index 
value 
1995 
percentile 
rank 
2000 
index 
value 
2000 
percentile 
rank 
Detroit-Warren-Livonia, MI 0.862 94 0.254 93 
Miami-Fort Lauderdale-Miami Beach, FL 0.837 94 0.313 95 
Baltimore-Towson, MD 0.741 94 0.311 95 
San Diego-Carlsbad-San Marcos, CA 0.684 94 0.228 92 
Trenton-Ewing, NJ 0.665 93 0.878 99 
Phoenix-Mesa-Scottsdale, AZ 0.628 93 0.104 85 
St. Louis, MO-IL 0.627 93 0.106 86 
Tampa-St. Petersburg-Clearwater, FL 0.605 92 0.262 94 
Portland-Vancouver-Beaverton, OR-WA 0.600 92 0.124 88 
Cleveland-Elyria-Mentor, OH 0.583 92 0.239 93 
Boulder, CO 0.479 91 0.401 96 
Milwaukee-Waukesha-West Allis, WI 0.478 91 0.229 92 
Austin-Round Rock, TX 0.455 91 0.152 89 
Pittsburgh, PA 0.436 90 0.107 86 
Orlando, FL 0.435 90 0.154 89 
Hartford-West Hartford-East Hartford, CT 0.425 90 0.186 90 
Manchester-Nashua, NH 0.405 89 0.258 94 
Indianapolis, IN 0.400 89 0.118 87 
Columbus, OH 0.387 89 0.128 88 
Cincinnati-Middletown, OH-KY-IN 0.382 88 0.104 85 
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APPENDIX 2: INDUSTRIAL SHARE BY STATE, IN 1995, 2000, AND 2004 
Table 2.1: Share of Biopharmaceutical Industry by State, 1995, 2000, and 2004 
 
State Employees in 2004 2004 Share 2000 Share 1995 Share Dif. 95-04
Alabama 764 0.30 0.22 0.11 0.18
Arizona 1119 0.44 0.48 0.72 -0.28
Arkansas 175 0.07 0.03 0.12 -0.05
California 38636 15.08 13.25 14.78 0.30
Colorado 3052 1.19 1.00 0.86 0.33
Connecticut 9758 3.81 4.50 4.37 -0.56
Delaware 2268 0.89 0.76 0.43 0.45
District of Columbia 10 0.00 0.08 0.00 0.00
Florida 6724 2.63 1.98 1.64 0.98
Georgia 2507 0.98 1.44 0.87 0.11
Hawaii 10 0.00 0.00 0.00 0.00
Idaho 750 0.29 0.08 0.09 0.21
Illinois 19745 7.71 9.28 9.18 -1.47
Indiana 11261 4.40 4.81 4.14 0.25
Iowa 1810 0.71 0.86 1.07 -0.37
Kansas 2485 0.97 0.82 1.00 -0.03
Kentucky 716 0.28 0.16 0.08 0.20
Louisiana 375 0.15 0.22 0.38 -0.23
Maine 1750 0.68 0.45 0.43 0.25
Maryland 4997 1.95 2.02 2.17 -0.22
Massachusetts 8759 3.42 2.94 2.98 0.44
Michigan 7792 3.04 3.87 3.82 -0.78
Minnesota 2396 0.94 0.87 0.92 0.01
Mississippi 1750 0.68 0.76 0.85 -0.17
Missouri 5570 2.17 2.06 2.98 -0.80
Montana 60 0.02 0.03 0.03 -0.01
Nebraska 2079 0.81 0.76 0.78 0.03
Nevada 361 0.14 0.16 0.05 0.10
New Hampshire 790 0.31 0.08 0.09 0.22
New Jersey 35845 13.99 13.35 13.67 0.32
New Mexico 60 0.02 0.13 0.03 -0.01
New York 22380 8.74 8.64 8.86 -0.13
North Carolina 14731 5.75 6.10 5.72 0.03
Ohio 3847 1.50 1.66 1.25 0.25
Oklahoma 750 0.29 0.16 0.13 0.16
Oregon 657 0.26 0.33 0.30 -0.04
Pennsylvania 15033 5.87 5.51 5.52 0.35
Rhode Island 175 0.07 0.08 0.10 -0.03
South Carolina 3327 1.30 1.59 1.09 0.21
South Dakota 60 0.02 0.08 0.13 -0.10
Tennessee 2409 0.94 0.76 1.47 -0.53
Texas 6468 2.53 3.19 3.30 -0.78
Utah 2779 1.08 1.05 0.92 0.16
Vermont 375 0.15 0.00 0.00 0.14
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Virginia 3415 1.33 1.45 0.88 0.45
Washington 1615 0.63 0.43 0.49 0.15
West Virginia 1750 0.68 0.76 0.37 0.32
Wisconsin 2004 0.78 0.74 0.81 -0.03
Wyoming 10 0.00 0.00 0.00 0.00
 
Source:  
1. County Business Pattern, Census Bureau, Department of Commerce 
2.  Some extreme values were verified by Quarterly Census of Employment and Salarys 
(QCEW) data, Bureau of Labor Statistics (BLS) of the U.S. Department of Labor 
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Table 2.2: Share of IT Service Industry by State, 1995, 2000, and 2004 
State Employees in 2004 2004 Share 2000 Share 1995 Share Dif. 95-04
Alabama 17,898 1.25 0.98 0.98 0.27
Alaska 1,194 0.08 0.06 0.03 0.05
Arizona 23,068 1.61 1.51 1.22 0.39
Arkansas 3,560 0.25 0.28 0.43 -0.18
California 244,743 17.07 17.74 15.99 1.08
Colorado 36,863 2.57 3.19 2.67 -0.10
Connecticut 17,549 1.22 1.32 1.51 -0.29
Delaware 4,423 0.31 0.31 0.26 0.05
District of Columbia 10,328 0.72 0.46 0.56 0.16
Florida 59,833 4.17 3.74 4.00 0.17
Georgia 43,315 3.02 3.58 3.52 -0.50
Hawaii 2,496 0.17 0.12 0.13 0.05
Idaho 2,343 0.16 0.15 0.16 0.01
Illinois 52,347 3.65 5.01 4.68 -1.03
Indiana 10,460 0.73 0.90 1.17 -0.44
Iowa 5,310 0.37 0.46 0.90 -0.53
Kansas 9,040 0.63 0.64 0.54 0.09
Kentucky 6,907 0.48 0.47 0.77 -0.29
Louisiana 5,839 0.41 0.35 0.31 0.09
Maine 2,613 0.18 0.14 0.11 0.07
Maryland 59,810 4.17 3.56 3.70 0.47
Massachusetts 69,865 4.87 5.29 5.64 -0.76
Michigan 35,126 2.45 2.14 2.93 -0.48
Minnesota 28,065 1.96 2.19 2.34 -0.38
Mississippi 3,037 0.21 0.15 0.18 0.03
Missouri 24,842 1.73 1.54 1.72 0.01
Montana 2,128 0.15 0.11 0.11 0.04
Nebraska 6,113 0.43 0.45 1.17 -0.75
Nevada 5,931 0.41 0.27 0.14 0.27
New Hampshire 9,229 0.64 0.56 0.47 0.18
New Jersey 63,393 4.42 5.14 4.69 -0.27
New Mexico 4,596 0.32 0.21 0.24 0.08
New York 69,016 4.81 5.24 5.82 -1.00
North Carolina 35,655 2.49 1.94 1.64 0.84
North Dakota 3,768 0.26 0.17 0.10 0.17
Ohio 38,456 2.68 3.00 3.50 -0.82
Oklahoma 9,797 0.68 0.51 0.54 0.14
Oregon 15,687 1.09 1.13 0.95 0.14
Pennsylvania 55,133 3.85 3.87 3.69 0.16
Rhode Island 4,246 0.30 0.19 0.38 -0.08
South Carolina 8,640 0.60 0.49 0.62 -0.02
South Dakota 1,304 0.09 0.09 0.09 0.00
Tennessee 8,819 0.62 0.73 0.84 -0.22
Texas 99,018 6.91 6.64 7.21 -0.30
Utah 13,983 0.98 1.19 1.07 -0.10
Vermont 1,731 0.12 0.17 0.13 -0.01
Virginia 122,421 8.54 7.13 6.91 1.62
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Washington 58,386 4.07 3.44 2.00 2.07
West Virginia 2,053 0.14 0.10 0.14 0.00
Wisconsin 13,352 0.93 0.93 1.09 -0.16
Wyoming 529 0.04 0.03 0.02 0.02
  
  
 
Source:  
3. County Business Pattern, Census Bureau, Department of Commerce 
4.  Some extreme values were verified by Quarterly Census of Employment and Salarys 
(QCEW) data, Bureau of Labor Statistics (BLS) of the U.S. Department of Labor 
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APPENDIX 3: RESULTS OF REDUCED ZINB MODELS 
Table 3.1: Results of Cross-Sectional ZINB Models of Biopharmaceutical IPO and M&A 
Events between 1996 and 2005  
 
Independent variables  
Reduced 
Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
Life scientists job market share  0.403 0.559 0.564 
  (0.323) (1.927) (0.407) 
Life scientists absolute salary ratio  1.454   
  (1.751)   
Life scientists relative salary ratio   -1.006 -0.653 
   (16.575) (4.318) 
Number of biotech VC firms  0.330* 0.324 0.312 
  (0.181) (0.365) (0.202) 
 -0.049 -0.040 -0.038 Square of number of biotech VC 
firms  (0.039) (0.068) (0.058) 
Foreign born population share  0.054 0.061 0.061 
  (0.043) (0.205) (0.074) 
 0.086 0.094 0.043 Life Science Academic research 
share  (0.393) (0.829) (0.712) 
 -0.045 -0.014 0.058 Biopharmaceutical industry location 
quotient  (0.073) (0.320) (0.052) 
Buyer- industry location quotient  1.739 3.021 2.084 
  (5.801) (44.689) (9.097) 
Supplier- industry location quotient  -0.053 -0.054 -0.044 
  (0.070) (0.295) (0.104) 
Small firm birth rate   7.189 9.590 7.550 
  (5.510) (36.550) (10.158) 
 0.162* 0.147* 0.180* Number of small biopharmaceutical 
firms  (0.091) (0.081) (0.092) 
 -0.005** -0.005* -0.005** Square of number of small 
biopharmaceutical firms  (0.002) (0.003) (0.002) 
 57.028 71.128 1.249 Number of small biopharmaceutical 
firms per square mile  (40.654) (134.815) (59.221) 
Constant  -3.264* -1.039 -1.222 
  (1.670) (10.514) (3.032) 
 
 
 127
Table 3.1 (continued)  
 
Inflation variables  
Reduced 
Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
     
Life scientists job market share  -5.120 -5.613 -5.184* 
  (4.186) (6.886) (2.748) 
Life scientists absolute salary  -18.615 -25.433 -22.981 
  (11.788) (257.170) (36.033) 
Life scientists relative salary  11.178** 10.128 10.199 
  (5.653) (32.730) (8.826) 
Number of biotech VC firms  -15.958*** -19.548 -16.543** 
  (4.232) (43.860) (6.659) 
Foreign born population share  0.301 0.385 0.362 
  (0.212) (2.226) (0.463) 
 -2.552 -3.590 -3.292 Life Science academic research 
share  (2.138) (41.816) (9.084) 
 -0.075 -0.031 0.015 Biopharmaceutical industry 
location quotient  (0.122) (1.517) (0.288) 
Buyer- industry location quotient  -3.420 7.388  
  (41.289) (494.814)  
Supplier- industry location quotient  -0.336 -0.405 -0.389 
  (0.526) (1.615) (0.349) 
Small firm birth rate   -31.623 -33.698 -32.265 
  (32.440) (190.277) (35.665) 
Constant  9.264 16.722 14.282 
  (10.005) (200.923) (38.624) 
     
Log likelihood  -157.2407 -158.1929 -152.209 
/lnalpha  -3.831 -3.654 -3.499 
alpha  0.022 0.026 0.03 
Vuong test statistics 
(zinb vs. nbrm) 
 2.42 3.06 2.94 
Number of observations  160 160 153 
Number of nonzero observations  65 65 63 
Number of zero observations  95 95 90 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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Table 3.2: Results of Two-Period Panel ZINB Models of Biopharmaceutical IPO and M&A 
Events between 1996 and 2005  
Independent variables  
Reduced 
Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
Life scientists job market share  0.924*** 0.908*** 0.893***
  (0.304) (0.321) (0.291) 
Life scientists absolute salary ratio  -0.987   
  (0.852)   
Life scientists relative salary ratio   -2.095** -2.087** 
   (0.913) (0.913) 
Number of biotech VC firms  0.281 0.272 0.282 
  (0.206) (0.280) (0.262) 
 -0.033 -0.034 -0.035 Square of number of biotech VC 
firms  (0.031) (0.041) (0.037) 
Foreign born population share  0.014 0.010 0.011 
  (0.024) (0.022) (0.023) 
 0.002 0.045 0.045 Life Science Academic research 
share  (0.189) (0.166) (0.153) 
 -0.032 -0.017 0.006 Biopharmaceutical industry location 
quotient  (0.069) (0.075) (0.069) 
Buyer- industry location quotient  -0.603 -0.630 -0.616 
  (0.701) (0.768) (0.852) 
Supplier- industry location quotient  0.041 0.016 0.020 
  (0.109) (0.112) (0.110) 
Small firm birth rate   12.399** 15.245** 14.691**
  (5.711) (6.338) (6.185) 
 0.091 0.084 0.092 Number of small biopharmaceutical 
firms  (0.064) (0.082) (0.074) 
 -0.003* -0.002 -0.003 Square of number of small 
biopharmaceutical firms  (0.001) (0.002) (0.002) 
 70.289*** 58.390*** 44.136 Number of small biopharmaceutical 
firms per square mile  (15.307) (14.410) (31.180) 
Time fixed effect  0.810* 1.078** 1.047** 
  (0.442) (0.447) (0.466) 
Constant  -2.199 -0.985 -0.961 
  (1.425) (1.492) (1.568) 
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Table 3.2 (continued)  
 
Inflation variables  
Reduced 
Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
     
Life scientists job market share  -2.064 -2.200 -2.418 
  (1.390) (1.608) (1.556) 
Life scientists absolute salary  -23.381 -25.021** -24.178* 
  (14.275) (11.833) (12.496) 
Life scientists relative salary  7.589* 4.526 2.614 
  (4.168) (6.345) (8.135) 
Number of biotech VC firms  -2.485 -3.389 -4.083 
  (1.816) (3.204) (2.884) 
Foreign born population share  0.077 0.076 0.065 
  (0.116) (0.109) (0.136) 
 -7.858 -9.429 -10.930 Life Science academic research 
share  (5.639) (7.921) (11.117) 
 0.019 0.092 0.172 Biopharmaceutical industry 
location quotient  (0.200) (0.349) (0.338) 
Buyer- industry location quotient  -0.528 -0.196 0.134 
  (2.084) (2.835) (4.367) 
Supplier- industry location quotient  0.442 0.497 0.588 
  (0.352) (0.577) (0.672) 
Small firm birth rate   -1.016 9.358 16.207 
  (25.380) (40.985) (43.622) 
Constant  14.078 17.952** 18.432* 
  (10.441) (8.877) (9.495) 
     
     
Log likelihood  -230.38 -226.862 -221.587 
/lnalpha  -4.318 -3.831 -3.319 
alpha  0.013 0.022 0.036 
Vuong test statistics 
(zinb vs. nbrm) 
 2.37 2.9 2.83 
Number of observations  320 320 310 
Number of nonzero observations  89 89 87 
Number of zero observations  231 231 223 
 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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Table 3.3: Results of Cross-Sectional ZINB Models of IT Service IPO and M&A Events 
between 1996 and 2005  
Independent variables  Reduced Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
 -0.131 -0.060 -0.131 Computer scientists job market 
share  (0.163) (0.137) (0.081) 
 1.297***   Computer scientists absolute 
salary ratio  (0.446)   
  0.333 0.394 Computer scientists relative 
salary ratio   (0.624) (0.600) 
Number of IT service VC firms  0.152*** 0.144*** 0.143*** 
  (0.047) (0.054) (0.055) 
 -0.012** -0.011** -0.011** Square of number of IT service 
VC firms  (0.006) (0.005) (0.005) 
Foreign born population share  0.039* 0.048*** 0.052*** 
  (0.021) (0.011) (0.011) 
 0.031 0.037 0.045* Computer science academic 
research share  (0.028) (0.028) (0.025) 
 0.476*** 0.502*** 0.500*** IT service industry location 
quotient  (0.089) (0.094) (0.086) 
 -0.006 -0.003 -0.001 Buyer- industry location 
quotient  (0.031) (0.029) (0.025) 
 -0.013** -0.016*** -0.016*** Supplier- industry location 
quotient  (0.006) (0.006) (0.006) 
Small firm birth rate   13.034*** 12.445*** 12.449*** 
  (2.063) (2.416) (2.436) 
 0.008*** 0.009*** 0.009*** Number of small IT service 
firms  (0.003) (0.003) (0.003) 
 -0.000** -0.000** -0.000*** Square of number of small IT 
service firms  (0.000) (0.000) (0.000) 
 0.045 0.309 -0.180 Number of small IT service 
firms per square mile  (0.442) (0.311) (0.868) 
Constant  -2.594*** -1.811*** -1.916*** 
  (0.633) (0.610) (0.617) 
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Table 3.3 (continued)  
 
Inflation variables  Reduced Model 
1 
Reduced Model 
2 
Reduced Model 
3 
     
 -0.740 -0.803 -1.057 Computer scientists job market share 
 (1.108) (1.682) (2.707) 
 -6.673 -7.756** -9.918* Computer scientists absolute salary 
 (5.090) (3.872) (5.151) 
 4.994** 5.148** 6.662** Computer scientists relative salary 
 (2.292) (2.377) (2.762) 
 0.301 0.431 0.404 Number of IT service VC firms 
 (2.860) (2.234) (1.580) 
 1.710 1.772 1.816 Computer science academic research share 
 (3.375) (2.594) (2.160) 
 -0.093 -0.108 -0.274 IT service industry location quotient 
 (1.002) (0.965) (1.297) 
 0.018 0.029 0.033 Buyer- industry location quotient 
 (0.243) (0.175) (0.147) 
 -0.140 -0.136 -0.136 Supplier- industry location quotient 
 (0.104) (0.092) (0.105) 
Small firm birth rate  -8.171 -7.564 -6.840 
  (43.467) (34.509) (26.689) 
 -0.075 -0.080 -0.081 Number of small IT service firms 
 (0.199) (0.151) (0.114) 
 14.698 16.205 27.640 Number of small IT service firms per 
square mile  (43.156) (32.210) (41.907) 
Constant  0.768 1.567 1.098 
  (2.355) (2.397) (2.456) 
     
Log likelihood  -569.712 -572.173 -551.409 
/lnalpha  -2.617 -2.564 -2.587 
alpha  0.073 0.077 0.075 
Vuong test statistics 
(zinb vs. nbrm) 
 1.52 1.56 1.62 
Number of observations  301 301 290 
Number of nonzero observations  199 199 191 
Number of zero observations  102 102 99 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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Table 3.4: Results of Two-Period Panel ZINB Models of IT Service IPO and M&A Events 
between 1996 and 2005 
Independent variables  Reduced 
Model 1 
Reduced 
Model 2 
Reduced 
Model 3 
 -0.098 -0.020 0.020 Computer scientists job market 
share  (0.103) (0.096) (0.106) 
 1.899***   Computer scientists absolute 
salary ratio  (0.554)   
  0.880** 0.857** Computer scientists relative 
salary ratio   (0.370) (0.366) 
Number of IT service VC firms  0.226*** 0.226*** 0.228*** 
  (0.050) (0.051) (0.051) 
 -0.017*** -0.017*** -0.017*** Square of number of IT service 
VC firms  (0.005) (0.005) (0.005) 
Foreign born population share  0.014 0.029*** 0.029*** 
  (0.010) (0.009) (0.009) 
 0.010 0.011 0.007 Computer science academic 
research share  (0.030) (0.028) (0.028) 
 0.451*** 0.519*** 0.527*** IT service industry location 
quotient  (0.102) (0.112) (0.117) 
 -0.020 -0.018 -0.019 Buyer- industry location 
quotient  (0.013) (0.013) (0.013) 
 -0.011 -0.016 -0.017* Supplier- industry location 
quotient  (0.010) (0.010) (0.010) 
Small firm birth rate   9.952*** 7.669*** 7.488*** 
  (1.607) (1.617) (1.609) 
 0.004*** 0.004*** 0.004*** Number of small IT service 
firms  (0.001) (0.001) (0.001) 
 -0.000*** -0.000*** -0.000*** Square of number of small IT 
service firms  (0.000) (0.000) (0.000) 
 -0.082 0.200 0.058 Number of small IT service 
firms per square mile  (0.193) (0.217) (0.201) 
Time fixed effect  -0.187 -0.405*** -0.401*** 
  (0.136) (0.134) (0.142) 
Constant  -2.815*** -2.070*** -2.000*** 
  (0.809) (0.540) (0.543) 
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Table 3.4 (continued)  
 
Inflation variables  Reduced Model 
1 
Reduced Model 
2 
Reduced Model 
3 
     
 -0.060 -0.014 0.033 Computer scientists job market share 
 (0.262) (0.259) (0.254) 
 -2.985 -4.353** -5.368** Computer scientists absolute salary 
 (2.187) (2.198) (2.372) 
 3.726** 4.062*** 4.691*** Computer scientists relative salary 
 (1.485) (1.342) (1.475) 
 0.244 0.286 0.324 Number of IT service VC firms 
 (0.531) (0.498) (0.510) 
 0.015 0.023 0.019 Foreign born population share 
 (0.032) (0.033) (0.035) 
 -0.063 -0.068 -0.061 Computer science academic research share 
 (0.233) (0.224) (0.224) 
 1.506* 1.481* 1.585** IT service industry location quotient 
 (0.803) (0.762) (0.808) 
 -0.272* -0.285* -0.295** Buyer- industry location quotient 
 (0.141) (0.146) (0.144) 
 -0.176* -0.177* -0.195* Supplier- industry location quotient 
 (0.106) (0.105) (0.113) 
Small firm birth rate  -17.697* -19.280** -19.332* 
  (9.614) (9.555) (9.897) 
 -0.049*** -0.049*** -0.051*** Number of small IT service firms 
 (0.016) (0.014) (0.014) 
 3.900 3.886 5.037 Number of small IT service firms per 
square mile  (7.716) (7.264) (7.476) 
Constant  0.200 1.166 1.241 
  (2.238) (1.863) (1.910) 
Log likelihood  -864.266 -867.916 -851.304 
/lnalpha  -2.479 -2.555 -2.572 
alpha  0.084 0.078 0.076 
Vuong test statistics 
(zinb vs. nbrm) 
 2.60 2.1 2.11 
Number of observations  602 602 591 
Number of nonzero observations  319 319 314 
Number of zero observations  283 283 277 
Note:   Robust standard errors in parentheses; *** p<0.01, ** p<0.05, * p<0.1 
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